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Abstract 
Facial transplantation has emerged as the next step on the reconstructive ladder for 
severe facial disfigurement.  Clinical issues surrounding facial tissue donation are 
examined, comprising pre-transplant facial vessel delineation; pre-operative aesthetic 
matching; and attitudes towards donation. An anatomical study of 200 consecutive 
facial and transverse facial vessels was performed using colour Doppler ultrasound.  
Facial vessels were measured at three landmarks and their branching pattern 
documented.  The facial artery main branch was detected at the lower mandibular 
border in 99.5% of cases, the accompanying facial vein in 97.5%.  The transverse 
facial artery was present in 75.5% of cases, the vein found in 58%.  When the facial 
artery was undetectable, there was transverse facial artery dominance.  When the 
facial vein was absent it was replaced with a transverse facial vein.  This provides 
valuable pre-operative information regarding vessel status.  A quantitative eleven-
point skin tonal matching scheme is described using digital analysis of facial imagery.  
Attitudes towards tonal mismatch in facial and hand transplantation are examined in 
two representative skin types.  There was more scope for skin tonal mismatching in 
skin tone 2 (slightly tanned white) than in skin tone 6 (light golden brown) 
participants.  Tonal mismatches were more tolerated in facial than in hand transplant 
simulations in both groups.  More acceptable donor tonal groups exist for males than 
females.  Targeted matching of skin tone is thus required.  Attitudes and beliefs of 
170 transplant professionals were examined.  Areas of concern included the organ 
retrieval process; impact on the retrieval team and donor family.  In-depth analysis of 
a transplant donor focus group was performed; provision of information, post-
transplant contact, and post-retrieval donor facial appearance was deemed important.  
A method of fabricating a donor-specific artificial prosthesis within the time frame of 
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facial graft retrieval is described. Finally, a method of framing the informed consent 
process is described.   
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Chapter 1 
 
 
1. The Evolution of Facial Transplantation 
1.1. Facial Disfigurement and its Sequelae  
Many great writers from Shakespeare (‘to find the mind’s construction in the face’) to 
Oscar Wilde (‘it is only shallow people who do not judge by appearance’) have long 
held the view that the face gives insight into a person’s character (Rumsey and 
Harcourt 2005a).   History has often been unkind to those of an unusual appearance.  
Nineteenth-century paintings by Hogarth depicted people with mental health 
problems with unusual or unattractive faces (Munro 1981), and society continues to 
maintain that connections exist between inner character and outward appearance. 
 
The face is regarded as our most defining and recognisable feature; facial recognition 
is an essential characteristic of human interaction, which begins when we are newborn 
babies and continues throughout life.  Modern-day exploitation of the unique nature 
of facial identity has led to the explosion of facial recognition software as a method of 
identification.  The face is not however simply an anatomical storage place in which 
the mouth, eyes, nose and ears reside.  It is a unique identifier to all those with whom 
we interact.  It provides us with expressions that can convey our innermost feelings.  
It is an important marker for sexual attraction and an indicator of social status and 
identity (Furr et al. 2007).  There is evidence for example that facial attractiveness can 
favourably effect evaluation of job status, ability and earning power (Bull and 
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Rumsey 1988).  Facial disfigurement therefore presents a rather unique challenge to 
the facial surgeon.   
 
Facial disfigurement is surprisingly common.  In the UK, facial disfigurement-related 
disability is estimated to affect approximately 391,000 people (0.7% of the 
population) (Khan et al. 2007).  Facial disfigurement can occur following a variety of 
events, including surgery, trauma (including burns) and cancer.  The stigma of facial 
disfigurement plays a role in the morbidity of certain severe skin diseases such as 
acne, and can occur with congenital defects such as port wine stain and cleft lip.  
Disfigurement of the face is a significant life event associated with considerable 
psychological morbidity, lack of social interaction, feelings of withdrawal, and a 
lower self esteem and self image (Levine et al. 2005).   
 
Evidence suggests that the public treat the facially disfigured with less trust and 
respect (Furr et al. 2007).  Patients with facial scarring are rated as less honest than 
non-scarred individuals (Rumsey and Harcourt 2005a).  Social isolation and 
unhappiness in the facially disfigured can lead to anxiety, substance abuse, 
relationship breakdown and an increased risk of suicide (Robinson et al. 1996; Ye 
1998).  The facially disfigured can experience discrimination in their daily activities; 
evidence suggests that the facially disfigured can be treated adversely during the 
assessment of work-related skills in the job interview process (Stevenage and Mckay 
1999).  They experience bullying, staring, social avoidance and other more subtle 
forms of discrimination.  
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It has been suggested that facial disfigurement constitutes a ‘social disability’ in that it 
affects both the disfigured person and the people around that person with whom they 
interact (Rumsey and Harcourt 2005b).  For example, strangers leave a greater 
distance between themselves and a person with facial disfigurement than with 
someone of ‘normal’ appearance (Rumsey et al. 1982).  The inability to use muscles 
of facial expression can lead to difficulty ‘reading’ the non-verbal cues communicated 
by a disfigured face (Macgregor 1989).   The facially disfigured can be pre-occupied 
with the effect that their appearance has on others, which can lead to shyness and 
defensiveness, or at the other extreme, overconfidence and hostility (Rumsey and 
Harcourt 2005b).  The reconstruction of the severely disfigured face can lead to 
significant measurable improvements in an individual’s well-being (McGrouther 
1997). 
 
1.2. Facial Reconstruction 
The reconstruction of the face has fascinated surgeons for centuries.  The face 
represents the ultimate challenge: a group of unique structural and functional subunits 
made up of a variety of tissues which are difficult to replicate and mimic.  Traditional 
methods of facial reconstruction have included skin grafts, flaps and tissue expansion, 
but these methods often cannot replace lost tissue faithfully.   
 
There are numerous historical accounts of methods of facial reconstruction.  The 
chronicles of the ancient Indian physician Sushruta give the earliest recorded account 
of facial reconstruction, describing the use of facial cheek tissue to reconstruct the 
nose in around 600 BC (Singh and Kelly 2005).  In the 15th century the Sicilian 
surgeon Antonio Branca reconstructed the nose using pedicled forearm tissue.  In the 
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16th century the Italian physician Gaspare Tagliacozzi further popularised this 
method, subsequently describing the transplantation of a nose from a slave onto his 
master (Barker et al. 2007b).  In the 18th century, the ancient Indian technique of 
forehead flap reconstruction (the ‘Indian Method’) was popularised in the 
‘Gentleman’s Magazine of London’ in 1794 (Singh and Kelly 2005).  The subsequent 
work of Gillies and McIndoe reconstructing facial and other injuries during the early 
20th century is well-documented (Barron 1985; Triana 1999). 
 
1.3. The History of Composite Tissue Allotransplantation  
Composite tissue allotransplantation (CTA) is the surgical transfer of grafts composed 
of multiple tissue types.  Its origins pre-date even those of solid organ transplantation.  
The ‘Legend of the Black Leg’ recounts how in AD 348, twins Damian and Cosmos 
replaced a diseased leg of a sleeping man with the leg of a dead Ethiopian Moor 
(Kann et al. 2000).  Bunger famously described allotransplantation of sheep skin in 
1804 (Barker et al. 2007b).  In the early 20th century Carrel successfully performed 
orthotopic hind limb and kidney transplants in dogs (Carrel 1983).  In the early 20th 
century Guthrie described heterotopic allotransplantation of dog heads (Barker et al. 
2007b).   
 
Medawar and Gibson first described the problem of skin allograft rejection in 1943 
(Gibson and Medawar 1943).  It was later shown in a mouse model that it was 
possible to induce a selective state of tolerance to skin grafts (Billingham et al. 1953).  
Plastic surgery has thus been intricately associated with transplantation for many 
years; it is no coincidence that it was a plastic surgeon, Joseph Murray, who 
performed the first human kidney transplant in the 1950s (Friedrich 2004).   
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The first albeit unsuccessful human hand transplant was performed in Ecuador in 
1963 (Barker et al. 2007b).  In the late 1980s several more attempts were made at 
transplanting hands in primate CTA models, but the relative immunogenicity of the 
skin led to failure, with the limbs developing signs of rejection after only a few 
months.  This was despite the introduction of cyclosporine A which had been shown 
to prolong survival, dropping acute rejection rates from 70% to 50% (Borel et al. 
1994).  A number of swine CTA models were developed (Ustuner et al. 2000); the 
use of prednisolone, tacrolimus and mycophenolate mofetil in experimental models 
helped ascertain that prevention of skin rejection was indeed possible (Barker et al. 
2007b).  The first successful human hand transplants were performed in 1998 in Lyon 
(Dubernard et al. 1999), Louisville (Jones et al. 2000) and Guangzhou (Francois et al. 
2000) and there have been over 60 hand transplants (Schneeberger et al. 2011) 
including over 16 double hand transplants (Wysong 2010)  performed to date.  There 
have also been attempts at CTA reconstruction of non-skin containing tissue such as 
bone and joint (Hofmann and Kirschner 2000), penis (Hu et al. 2006), larynx (Strome 
et al. 2001), tendon (Guimberteau et al. 1992), nerve (Bain 2000), muscle (including 
abdominal wall) (Levi et al. 2003), tongue (Birchall 2004) and uterus (Fageeh et al. 
2002). 
 
1.4. The Recent History of Human Facial Transplantation  
Attention has in more recent years turned to alternative methods of facial 
reconstruction which could mimic tissue more precisely and provide satisfactory 
functional recovery of muscular sub-units.  The preliminary clinical work behind 
modern human facial transplant techniques began following a series of reports in the 
1990s.  In 1996 a series of scalp replantations was reported by Cheng et al (Cheng et 
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al. 1996), with replantation of the face following a degloving accident described in 
1998 by Thomas et al (Thomas et al. 1998).   In 2004 Jiang et al transplanted a 
cephalocervical skin flap and two ears onto a 72 year-old lady with malignant 
melanoma (Jiang et al. 2005), leading to some debate regarding patient selection 
(Siemionow and Agaoglu 2006).   
 
From these experimental procedures it became clear that future human facial 
transplantation was technically possible from a microsurgical perspective.  The 
previously considerable problem of skin rejection seemed to have been largely 
overcome using tacrolimus, prednisolone and mycophenolate mofetil combinations in 
both pre-clinical and clinical hand transplantation studies (Francois et al. 2000; Jones, 
Jr. et al. 1999). 
 
The various aspects of facial transplantation still to be resolved were discussed in a 
widely publicized report authored by the Royal College of Surgeons of England in 
2005 (Morris et al. 2004).  Although work had shown that facial transplantation was 
technically feasible, it was felt by the group that a number of outstanding issues still 
remained.   
 
Following further ethical debate (Banis et al. 2004; Barker et al. 2007a; Haughton 
2004; Summerton and Agha 2004; Thorburn et al. 2004; Wiggins et al. 2004), the 
first human partial face transplant was performed in 2005 in Amiens, France, on a 38 
year-old lady whose face was severely injured following a dog bite injury 
(Devauchelle et al. 2006).  A central triangular-shaped area of the face from the nose 
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to the chin was transplanted from a cadaveric donor.  The mouth and lips were badly 
disfigured and functionally redundant, and were thus included within the graft.   
The second partial face transplant took place in Xi’an, China in 2006 on a 30 year-old 
farmer whose face was mauled by a bear (Burd 2007; Guo et al. 2008).  The patient 
died two years later, after having stopped his immunosuppressive medication on the 
advice of his community doctor who substituted traditional medicines.  Later in 2006, 
a third partial facial transplant was successfully performed in Paris, this time on a 
young man with severe plexiform neurofibromatosis (Lantieri et al. 2008).  In the US, 
Siemionow performed a complex near-total facial transplant on a 54 year old woman 
following severe mid-face trauma (Siemionow et al. 2009).   
 
A total of 16 facial transplants have now been performed to date (Schneeberger et al. 
2011), including a full facial transplant performed in Spain in early 2010 (Eaton 2010) 
which included the nose, facial muscles and maxilla.  Later in 2010, Lantieri et al. 
performed a full facial transplant, this time also including eyelids and lacrimal system 
(Schpoliansky 2010).      A total of two mortalities have been reported thus far, one in 
a Chinese patient who stopped immunosuppression two years post-transplant, and the 
second a patient with extensive burns sequelae who underwent bilateral upper limb 
transplantation at the same sitting as the facial transplant (Gordon et al. 2009).  Two 
months post-transplant, the patient developed overwhelming infection requiring 
surgical revisions, and subsequently died following a cardiac arrest.  All transplants 
have been performed due to a lack of alternative surgical methods to reconstruct 
severe trauma, burns or congenital deformity.  
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1.5. Minimizing Rejection in Facial Transplantation 
Several factors are involved in matching facial transplant donor to recipient.  These 
include aesthetic considerations and donor-to-recipient matching for blood group and 
tissue-type to reduce rejection.  Additionally, transmissible infections may be 
prevented or managed if the viral disease status of donor and recipient is known.  The 
purpose of this section is to outline the rationale behind the components of the 
immunological matching system for facial transplantation.  
 
1.5.1. Human Leucocyte Antigen Matching in Organ Transplantation 
Human leucocyte antigen (HLA) molecules are encoded by a set of highly 
polymorphic genes located within the major histocompatibility complex (MHC) on 
chromosome 6.  There are three classical class I molecules (HLA-A, -B and -C) which 
are ubiquitously expressed on most cell types and recognized by both CD8+ T cells 
and natural killer (NK) cells (Lanier 2005; Zinkernagel and Doherty 1997).  Similarly, 
three classical class II molecules (HLA-DR, -DQ and -DP) exist, expressed 
predominantly on B cells, activated T cells and macrophages, and recognized by 
CD4+ T cells.  HLA class I and II gene loci are the most polymorphic in the human 
genome, with the HLA-B locus encoding over 900 alleles (see 
http://www.ebi.ac.uk/imgt/hla).  Functionally, HLA molecules present antigenic 
peptides to T cells that drive both humoral and cellular immune responses to foreign 
antigens, including allogeneic HLA molecules on transplanted tissues.  Techniques 
used to type HLA molecules and their allelic variants have largely evolved from the 
field of human transplant immunology and the need to predetermine compatible tissue 
types that will reduce the risk of organ rejection.  A variety of other class I (HLA-E, -
F and -G) and class II (HLA-DO and -DM) molecules (considered “non-classical” by 
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their unusual functions, restricted expression and limited polymorphism) are not 
considered relevant in mediating transplant rejection.  Conversely, non-classical MHC 
class I chain-related (MIC) molecules genes are polymorphic, expressed 
predominantly on epithelial cells, and may mediate transplant rejection (Stephens 
2001; Zou et al. 2007).  Rejection occurs when HLA antigens on donor cells are 
recognised by recipient lymphocytes or antibodies, leading to destruction of the 
antigen-bearing graft (Porter 1976; Tilney et al. 1979); rejection may be hyperacute 
(antibody-mediated) (Williams et al. 1968); acute (cell and antibody-mediated) 
(Porter 1976; Tilney et al. 1979); chronic; or a combination thereof.  
 
Different HLA matching requirements exist for different organs.  Renal 
transplantation in the UK is based on a matching for HLA-A, -B and -DR loci, 
because graft survival has been shown to progressively decrease with increasing 
number of HLA mismatches (Terasaki et al. 1996).   Evidence suggests that within 
this group, HLA-B and -DR may be the most important (UK Transplant 2006).  
Conversely, donor-recipient HLA matching in liver transplantation is of less 
importance and is not routinely performed in the UK, as the liver is relatively resistant 
to antibody-mediated rejection (Navarro et al. 2006).  In cardiac transplantation 
studies have been contradictory, with evidence for and against HLA matching 
(Almenar et al. 2005; Smith et al. 1995).  Prospective matching is logistically difficult 
however, because of the short ischaemic time tolerated by cardiac grafts. These 
matching requirements contrast markedly with bone marrow transplantation, where all 
six loci must be matched precisely at a very high resolution (Flomenberg et al. 2004). 
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The primary role of the HLA or tissue-typing facility is to provide advice on the 
relative risk of immunological rejection.  With kidney, pancreas and cardiothoracic 
transplants, high immunological risk is indicated by a high titre of circulating 
antibodies specific for mismatched donor classical HLA class I and II antigens, 
detectable at time of transplantation (British Transplantation Society 2004; Gebel et 
al. 2003).  Such antibodies may form in potential recipients through sensitisation to 
allogeneic HLA molecules during pregnancy, previous transplants and blood 
transfusions.  Intermediate immunological risk is considered if there are known 
historic donor-specific sensitisation events, but weak or undetectable antibodies to 
donor-specific allogeneic HLA mismatches at the time of the transplant.  Low 
immunological risk occurs if a recipient is non-sensitised, or is sensitised but has 
irrelevant alloreactive antibodies to HLA types not present on the donor graft (British 
Transplantation Society 2004; Gebel et al. 2003). 
   
1.5.2. HLA Matching in CTA  
Composite tissue allografts are by definition histologically heterogeneous.  A hand 
allograft, for example, contains elements of skin, muscle, cartilage, nerve, vasculature 
and bone, along with immunocompetent cells in lymphoid tissue or bone marrow.  
High-to-intermediate expression of donor HLA in transplanted skin, bone marrow and 
vasculature (Duquesnoy 1998) provides potential targets for alloreactive recipient 
responses.  
 
1.5.3. HLA Matching in CTA Animal Models 
Rodent models of CTA demonstrate a reduced immunological response to allografts 
of a closer histocompatibility match.  A hierarchy of tissue rejection has been 
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described in rats as: skin > muscle > bone > cartilage (Buttemeyer et al. 1996).  Both 
the intensity and timing of rejection of a vascularised bone transplant was found to be 
dependent on the genetic disparity between donor and recipient; allograft survival was 
significantly shorter when transplanted across major rather than minor 
histocompatibility barriers (Yaremchuk et al. 1985).  The importance of matching 
varies between the different MHC sub-regions, with mismatches at the RT1-A sub-
region having the greatest negative impact on allogeneic hindlimb transplant survival 
(Iwasaki et al. 2001).  This finding is not limited to limb allografts.  Compared with 
transplantation across a full MHC barrier, transplantation across a semi-allogeneic 
barrier is associated with immune hyporesponsiveness to donor antigen and increased 
graft survival in a rat hemi-facial allograft model (Siemionow et al. 2005). 
 
Benefits of genetic matching for CTA have also been suggested by work in MHC-
inbred miniature swine, which possess a defined genetic transplant barrier similar to 
human MHC.  Lee et al (Lee et al. 2001) compared survival of a limb allograft after 
transplantation between MHC-matched and MHC-mismatched animals.  In the MHC-
mismatched group, there was gross and histological evidence of allograft rejection by 
42 days post-transplant.  In comparison, the MHC-matched group showed no 
evidence of rejection at time of sacrifice (25 to 47 weeks), suggesting ongoing graft 
tolerance.  The transplant barrier in the MHC-matched group resembled that between 
human siblings sharing the same paternal and maternal haplotypes.  
 
Significant differences between animal models and humans have been observed in the 
response to composite tissue allografts and immunosuppressive regimes, such as the 
relative ease of tolerance induction in animals compared to humans (Cahill T.J. et al. 
 35 
2006).  Despite animal studies in favour of MHC matching for CTA, whether the 
results are applicable to human transplantation remains uncertain at present. 
 
1.5.4. HLA Matching in Human CTA Trials 
Early composite tissue allografts in humans have been variably matched for HLA.  In 
bone grafting, histoincompatibility between donor and recipient in animal models 
affects revascularization, graft union and new bone formation (Stevenson et al. 1996).  
All three human femoral transplants reported were not matched at the HLA-A,-B and 
-DR loci (222mm) (Hofmann and Kirschner 2000), but none were viable at 2 years 
(Hettiaratchy et al. 2004).  In comparison, the successful human laryngeal transplant 
performed in 1998 involved a total HLA-A,-B and -DR match between donor and 
recipient (000mm)(Strome et al. 2001).  HLA-A, -B and -DR matching for renal 
transplantation (111mm) was performed on six patients who underwent simultaneous 
renal and skin allograft transplantation from their respective donor (Wendt et al. 
1994).  All skin allografts survived, bar one who underwent renal graft rejection in the 
early stages; one skin allograft survived despite the discontinuation of 
immunosuppression after four weeks.  However, it is the outcome of HLA matching 
in hand transplantation which is most informative, as this group represents the human 
CTA model most analogous to facial transplantation.   The first two hand transplants 
performed in Lyon (France) and Louisville (USA) were poorly HLA-A, -B and -DR 
matched (222mm).  The next two (in Guangzhou, China) were performed on patients 
with three HLA-A, -B and -DR matches (111mm) (Barker et al. 2002).  In the large 
human hand transplant series so far there is currently no difference in allograft 
survival according to the number of HLA matches (Lanzetta et al. 2005).  It is 
noteworthy that the first hand transplant failed largely due to patient non-compliance 
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with medication (Dubernard et al. 2001); the second documented failed hand 
transplant did so largely due to  inadvertent intra-arterial steroid injection (Guoxian et 
al. 2004).  A number of hand transplant recipients from China have had rejection 
episodes linked directly to non-adherence with immunosuppressive medication. 
 
Interestingly the HLA matching of the series of facial transplants has not had a 
significant impact on survival.  Of the two deaths, one facial transplant recipient had 
significant HLA mismatches, but his death was very likely multifactorial involving 
post-operative sepsis.  The second facial transplant mortality (in China) had three 
HLA mismatches; his mortality is however thought to be directly linked to 
unilaterally stopping immunosuppressant therapy rather than as a result of 
uncontrollable acute rejection (Gordon et al. 2009). 
 
It has been proposed that HLA matching might reduce the doses of 
immunosuppression required to control rejection, reducing the risk of side effects 
(Duquesnoy 1998).  However, to date there have been no clear differences in 
immunosuppression required, number of acute rejection episodes, or functional 
outcome in the human hand transplant cohort relating to HLA mismatch.  
 
Given that the recipient of a facial transplant is likely to be healthy, it is possible that 
the immunological response to a facial graft will be more robust than following liver 
or heart transplantation, where recipients may be immunologically-suppressed due to 
hepatic failure or cardiogenic shock respectively (Cendales and Hardy 2000).  
However, episodes of acute rejection in hand and facial transplantation have so far 
proved controllable, and it has been reported that immunosuppressive requirements 
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for some hand transplants are lower than renal allografts (Dubernard et al. 2002; 
Dubernard et al. 1999).   
 
Both donor and recipient in the first partial face transplant shared five HLA antigens 
(recipient: HLA-A2,3; B8,44; DR3,7; donor: HLA-A2,3; B8,44; DR-15,3) 
(Devauchelle et al. 2006).  An immunosuppressive protocol of antithymocyte 
globulins, tacrolimus, mycophenolate mofetil and prednisolone was used during the 
immediate transplant period.  At least two biopsy-defined episodes of cellular 
rejection have been recorded (Dubernard et al. 2007; Kanitakis et al. 2006), with 
donor-directed cytotoxicity noted at an early stage, disappearing at a later stage.  It is 
unclear whether this was accompanied by any induction of detectable antibodies to 
the mismatched donor HLA class II antigen (DR15).  The relatively high level of 
HLA-A, -B and -DR matching may favour survival by reducing the overall risk of 
rejection episodes occurring.  However, to date there is not enough evidence from the 
relative paucity of transplants performed to advocate a minimum level of HLA class I 
and II matching of donor-recipient pairs in facial transplantation.  The less 
conventional procedure of  post-transplant donor bone marrow infusion was also 
performed in the first partial face transplant with the aim of inducing immunological 
tolerance to the facial graft (Devauchelle et al. 2006), but this procedure has not been 
utilised in subsequent facial grafts (Paraskevas et al. 2007) performed elsewhere.  
 
One obvious disadvantage of HLA matching would be a reduction in the size of the 
suitable donor pool, potentially leading to a prolonged wait for a suitable donor, or to 
compromise in other areas such as aesthetic matching.  Invoking a full HLA match 
might therefore preclude widespread uptake of facial transplantation as an option in 
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the reconstruction of the severely disfigured face.  It is nevertheless important for pre- 
and post-transplant research and monitoring purposes to determine the patient HLA 
type and antibody status.  The candidate facial transplant recipient should therefore be 
HLA-typed pre-operatively to the highest resolution possible (using direct sequencing 
or bead-based Luminex technologies).  Similarly, in the immediate pre-transplant 
period a potential donor could be rapidly HLA-typed using moderate-resolution 
phototyping or PCR-SSP (Bunce et al. 1995) which will provide information on the 
level of HLA matching available.  Pre-transplant assessment of the potential 
recipients HLA-specific antibody status should also be performed, preferably with 
high resolution flow cytometric or Luminex microsphere-based methods (Gibney et 
al. 2006).  Similarly, regular screening of post–transplant recipient sera enables 
monitoring of antibodies specific to all possible mismatched classical class I and II 
antigens on the facial graft (HLA-A, -B, -C, -DR, -DQ and -DP), as well as 
mismatched non-classical MICA molecules (Mizutani et al. 2005).  Such screening is 
informative both in defining the recipient’s immunological response and predicting 
potential rejection episodes, particularly in conjunction with biopsy-driven analysis of 
graft tissue histopathology (Kanitakis et al. 2006). 
 
1.5.5. Crossmatching 
The purpose of the crossmatch test is to determine whether a potential transplant 
recipient has circulating antibodies directed against mismatched donor HLA antigens.  
This test is considered a prerequisite to renal (Doxiadis et al. 2003), heart (Tambur et 
al. 2000), lung (Palmer et al. 2002) and intestinal transplantation (Ruiz et al. 2003), as 
a positive result is indicative of a high probability of hyperacute and vascular 
rejection.  The crossmatch assay utilises donor spleen, lymph node or peripheral blood 
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as a source of T lymphocytes (expressing classical HLA class I antigens) and B 
lymphocytes (expressing both class I and II antigens).  Fresh recipient sera collected 
within 24 hours of a potential transplant and selected historic sera are reacted with 
donor T and B cells in a complement-dependent lymphocytotoxic (CDC) test (Smith 
and Rose 2006) or flow cytometric crossmatch (Scornik 1995).  The latter is 
considered the more specific and highly sensitive method of detecting donor HLA-
specific antibodies, and can be conveniently performed on donor serum.  
 
Flow cytometric crossmatching can also be adapted to detect different 
immunoglobulin subclasses, although most laboratories focus on IgG. Both methods 
of crossmatching can detect donor HLA and non-HLA specific antibodies.  If the 
specificity of antibodies causing a positive crossmatch were against non-HLA 
molecules, this should not be a veto to proceeding with the transplant.  However, the 
interpretation of a crossmatch result is multifactorial and needs to be performed by 
experienced personnel who are capable of considering any result in the context of 
both donor and recipient’s HLA types, and the recipient’s known antibody profiles as 
previously determined by screening.  
 
If a potential transplant recipient has never experienced a sensitising event (e.g. blood 
transfusion, previous pregnancies or organ transplant) then theoretically the 
production of HLA-specific antibody may not occur and a crossmatch test may not be 
necessary.  This theory has been tested in a number of renal transplant units where 
pre-operative crossmatching has been successfully omitted in a sub-group of highly-
selected immunologically non-reactive patients (Kerman et al. 1998).  However, 
given that the incidence of humoral rejection in facial CTA is not yet fully known, 
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pre-transplant crossmatching is prudent given the serious consequences of facial 
allograft rejection.  
 
In the facial transplantation setting, we suggest that rapid flow cytometric allogeneic 
cross-matching using donor lymphocytes and recipient sera should be performed.  
This process will help determine the likely risk of rejection, and can be performed 
within a reasonable time frame in the context of facial graft harvesting to allow 
appropriate interpretation of the results (Figure 1.1).  A summary of the matching 
procedures recommended in facial transplantation is given in Table 1.1.   
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Figure 1.1.  Proposed mechanism of donor face procurement: interaction with 
matching process. 
 
 
 
Notification of possible donor, brain death confirmation 
 
Transplant co-ordinators contacted, relatives consented 
 
Donor blood taken early for: cross-match, tissue type, blood group, infective 
agents 
Specimens transferred to recipient laboratory 
 
Recipient called, recipient blood taken 
Recipient face dissection commenced 
Cross-matching process commenced 
Donor teams mobilised 
 
Blood group, tissue type, 
infective status result 
 
Donor face dissection commenced 
Cross-match result 
Organ transplant mobilisation 
 42 
Table 1.1.  Summary of the process of immunological matching and monitoring 
required in facial transplantation. 
 
Process Method Timescale Essential (E) / 
Recommended (R) §  
Recipient HLA typing:  
moderate-high resolution 
 
Bead-based Luminex 
technology   
Direct sequencing 
Pre-operative R 
Recipient screening for 
antibodies to HLA class 
I/II antigens: moderate-
high resolution 
 
Bead-based Luminex 
technology   
 
Pre-operative 
three-monthly  
R 
Recipient & donor ABO 
matching 
 
Standard blood typing  Pre-operative E 
Donor HLA typing: rapid 
assessment 
Phototyping 
PCR-SSP* 
 
Pre-operative R 
Cross-matching:  
allogeneic and 
autologous 
CDC† 
Flow cytometry  
 
Pre-operative  
Pre-operative  
Post-operative 
E 
E 
R 
 
Recipient screening for 
HLA-specific antibodies 
 
Bead-based Luminex 
technology   
 
Post-operative 
three-monthly  
R 
Graft tissue 
histopathology 
Tissue biopsy 
monitoring 
Post-operative R 
 
* PCR-SSP: polymerase chain reaction using sequence-specific primers; † CDC: 
complement-dependent cytotoxic cross-matching; § Recommended processes (R) are 
required mainly for monitoring and/or research purposes; essential processes (E) are 
required in order for the operation to proceed. 
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1.5.6. Blood Group Matching 
In solid organ transplantation, donor-to-recipient matching for major (ABO) blood 
groups was traditionally considered important to prevent hyperacute rejection 
secondary to anti-A or anti-B antibody activation.  Exceptions to this view generally 
include: liver transplantation (Gugenheim et al. 1990); after antibody removal by 
plasmapharesis or immunoadsorption (Higgins et al. 1996; Tyden et al. 2005; Winters 
et al. 2004); and following recipient immunomodulation of the immune system (Glotz 
et al. 2004; Vieira et al. 2004).  The liver for example is considered a relatively 
immunoprivileged organ, the implanted liver adsorbing circulating antibodies.  
Hyperacute rejection is rarely seen, although there is a greater risk of acute rejection 
and poorer long-term survival in blood group incompatible transplants (Donaldson 
and Williams 1997).  Such transplants are only considered in exceptional 
circumstances where delay to obtain a matched graft is of great risk to the recipient.   
 
Such a clinical scenario clearly does not apply to facial transplantation.  We consider 
that additional processes to modulate or remove antibodies from the recipient would 
overcomplicate the whole facial transplant process without a clear evidence base for 
its implementation.  A low-risk strategy should therefore ideally be adopted.  Both 
donor and recipient of the first partial face transplant shared the same blood group 
(O+) (Devauchelle et al. 2006), and such an approach is probably prudent.  
Nevertheless, it is important to note that the fourth facial transplant was performed 
successfully (in Cleveland, USA) despite donor and recipient being blood group A 
and AB respectively (Siemionow et al. 2010).  If shown to be reproducible, this could 
have significant impact on the availability of facial donor grafts globally.  
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1.6. The Matching of Infectious Disease Status 
The rationale behind serological screening of the donor for infectious disease status is 
to minimise the risk of transmission of significant infections to the 
immunocompromised recipient.  It is also important that a careful and detailed history 
of potential exposure and “at risk” behaviour is obtained, along with an accurate 
diagnosis of cause of death.  In the UK, the practice is to routinely screen for the 
following: human immunodeficiency virus (HIV) -1 and -2; hepatitis B virus (HBV) 
surface antigen and core antibody; hepatitis C virus (HCV) antibody; human T-cell 
lymphotropic virus (HTLV) -1 and -2 antibody; cytomegalovirus (CMV) delta agent; 
toxoplasma antibody; syphilis; and Epstein-Barr virus (EBV) antibody (British 
Transplantation Society 1998). 
 
1.6.1. Hepatitis and HIV 
The transmission of HBV or HIV from an infected donor is high if the donor is 
positive for HBV surface antigen or for HIV antibody.  The risk of transmitting HCV 
with an extrahepatic allograft from a donor who is positive for anti-HCV antibody is 
approximately 50%, with the risk approaching 100% if the donor's blood contains 
HCV RNA (British Transplantation Society 2003).  In the US, an estimated 4.2% of 
cadaveric donors are positive for anti-HCV, with 1% positive in the UK (British 
Transplantation Society 1998).  One approach has been to transplant organs from anti-
HCV-positive donors only into critically ill patients awaiting heart, liver, or lung 
allografts, older patient with a limited expected life span, or patients awaiting renal 
transplantation who have been unable to find a suitable donor because of prior 
sensitization to MHC antigens, for whom a particular matched donor represents a 
unique opportunity.  Organs from donors positive for anti-HCV are not used for 
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younger patients. Recent evidence shows that heart transplants from anti-HCV 
positive donors confer shorter survival to recipients (Gasink et al. 2006).  Clearly, as a 
life-enhancing procedure, facial transplantation using a donor who is positive for 
HIV, HCV or HBV would be hard to justify.  Therefore we propose that all donors 
should have negative virology results for these agents prior to graft harvesting.  
Donors with a history of possible exposure to HIV should also be excluded, as there is 
a time lapse after infection before the antibody appears.    
 
1.6.2. Cytomegalovirus  
Cytomegalovirus can be a devastating complication affecting long-term outcome in 
solid organ transplantation.  At highest risk for developing primary CMV infection 
are CMV-negative recipients of a CMV-positive graft.  Re-infection with a donor 
viral strain is more common than reactivation of a recipient viral strain, and is likely 
to produce more severe and frequent disease episodes.  Serious CMV disease often 
depends on the total burden of immunosuppression (British Transplantation Society 
2003).  Knowledge of CMV status and immunosuppressive regimen therefore allows 
clinicians to adopt appropriate clinical strategies to prevent CMV infection.  This can 
be via pre-emptive screening, prophylactic anti-viral medication or reduction of 
immunosuppressive intensity. 
 
Of the first 18 hand transplants that were reported, 17 donors and 17 recipients 
received prior testing for CMV, although CMV status was not used as a criterion for 
donor selection (Schneeberger et al. 2005).  Infection or disease due to CMV 
complicated the postoperative course in five of the nine recipients challenged with the 
virus.  Importantly, in some cases a close time correlation between CMV replication 
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and episodes of acute rejection suggests a causative link (Schneeberger et al. 2005).  
Of the three femoral transplants reported, one recipient suffered from a transmitted 
CMV infection at seven weeks post-transplant (Hofmann and Kirschner 2000).  
 
In the series of facial transplants performed so far worldwide, CMV remains a 
considerable issue, with severe valgancyclovir-resistant CMV viraemia complicating 
the course of the third transplant recipient and coinciding with a rejection episode – 
here the donor was CMV-positive, the recipient was negative and the patient suffered 
a severe viraemia episode coinciding with the timing of CMV seroconversion 
(Gordon et al. 2009).  Many therefore feel that CMV remains the major infectious 
threat in facial CTA.  Some authors advocate the avoidance of CMV-mismatch and 
mandatory prophylaxis with valgancyclovir and anti-CMV hyperimmunoglobulin in 
CTA (Schneeberger et al. 2005).  Although CMV titres can be tightly monitored post-
operatively, and pre-emptive treatment can be commenced if titres begin to climb, 
CMV matching of donor to recipient is ideal and should ideally be a performed in 
facial transplantation.  Prophylaxis against CMV should certainly be considered if 
either the facial transplant donor or recipient is positive, as severe CMV viraemia is a 
predictor of mucosa rejection (Hui-Chou et al. 2010).  In the fourth facial transplant 
case, CMV donor-positive/recipient-negative status meant that maintenance of a high 
level of ganciclovir was a priority post-operatively, and no CMV viraemia has been 
subsequently reported (Siemionow et al. 2009).    
 
1.6.3. Epstein Barr Virus 
In solid organ transplant populations, transmission of EBV to seronegative recipients 
is associated with several clinical scenarios including asymptomatic viraemia, 
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hepatitis and mononucleosis syndrome (Nicholson and Johnson 1994). In addition, the 
risk of post-transplantation lymphoproliferative disorder (PTLD) can increase as 
much as 20-30 fold (British Transplantation Society 1998).  We suggest that EBV 
serology should be performed in both donor and recipient. Seronegative recipients at 
risk of EBV transmission from a seropositive donor should be monitored closely and 
the degree of immunosuppression modulated to minimise risk of development of 
PTLD.   
 
1.6.4. Human Herpes Virus 
In solid organ transplantation, transmission of human herpes virus 8 (HHV-8) from 
donor to recipient has been described, leading to an increased incidence of Kaposi 
sarcoma (Moore 2003).  It would be prudent to test for this agent in donors from areas 
of increased prevalence (such as the Middle East or Africa).  A type 1 human herpes 
simplex infection was reported on the lips of the first partial face transplant, and was 
successfully treated (Dubernard et al. 2007).  
 
1.6.5. Human T-cell lymphoma virus (HTLV) 
Donor screening for HTLV is not routine performed in the UK.  Although the 
prevalence in the UK is very low for these viruses, HTLV-1 infection presents a 
serious threat to the recipient.  Absolute lifetime risk of lymphoma in positive 
individuals approaches 5% in the immunocompetent, with the disease manifesting 
itself more rapidly in organ transplant recipients (British Transplantation Society 
2003).  There is scant data on HTLV incidence in CTA. Nevertheless, in areas where 
infection of potential donors with HTLV is endemic we suggest including it as part of 
the screening test for facial transplantation.   
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1.6.6. Syphilis 
Syphilis is increasingly prevalent worldwide.  Significantly the donor face in the third 
facial transplant performed worldwide was positive for T. pallidum; the T. pallidum 
negative recipient thus received treatment with methylpenicillin (Gordon et al. 2009). 
 
1.7. A Rationale for Minimizing Rejection in Facial Transplantation 
Experience from solid organ transplantation and CTA has demonstrated that matching 
of immunological and infectious disease status should be important considerations in 
facial transplantation.  HLA tissue-typing is undertaken in a variety of solid organ 
transplant programs.  Given the limited availability of facial transplant donors, and the 
paucity of evidence suggesting improved outcome following prospective donor-
recipient HLA matching in comparable CTA groups (such as hand transplantation), it 
is difficult at present to invoke a prerequisite minimum level of HLA matching in 
facial transplantation.  Nevertheless, it is imperative that as much relevant and 
meaningful information as possible should be collected for research purposes.  Pre- 
and post- transplant crossmatching and screening for pre-formed and induced HLA 
specific alloantibodies (in conjunction with regular histopathology investigations) are 
likely to be highly informative to clinicians in the immediate and medium-term post-
operative phase of a facial transplant, for this is when immunological rejection of 
donor tissue is most likely to occur.  In addition, matching for infectious agents is 
required for some viruses (such as HIV and HTLV) but may not be quite as essential 
for others (such as CMV) where effective prophylaxis can be given post-operatively.  
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As the series of facial transplants performed so far have shown, it is no longer a 
question of how to perform a facial transplant, but rather a question of how to achieve 
the best possible outcome.  Of course, parameters established prospectively for donor-
recipient matching can only be validated once a larger cohort of facial transplant 
patients is established.  Final outcome in facial transplantation will depend not just on 
technical accomplishment and immunological success.  Psychological outcome and 
patient satisfaction will be related to the aesthetic endpoint.   At present it is not fully 
clear which aesthetic properties of the allograft are of greatest importance and to what 
degree they need to be matched: it is likely to be of great importance for example to 
obtain a good skin tone match (Chapter 4).  Tissue typing and matching of infectious 
agents must therefore be performed rationally in order to increase the potential facial 
donor pool.  The matching process will also require careful collaboration between 
different units.  Additional aesthetic matching requirements may necessitate the 
establishment of an international recipient database in order to maximise usage of 
potential donors.  As the potential pool of facial transplant donors may be small, time 
may be better allocated to these aspects if we wish to fully optimise outcome in facial 
transplantation.  As has been shown in hand transplantation (Banis et al. 2004), this 
can be a challenging endeavour, but an essential one.   
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1.8. Functional Outcome of Facial Transplantation  
Transplanting skin and subcutaneous tissue in pan-facial injuries with a skin-only flap 
can often improve the mobility of deeper structures (and hence facial movement).  
Grafts have however so far required a number of combinations of skin, muscle, and 
bone (Siemionow et al. 2009), often incorporating complex maxillofacial subunits 
into the graft.  How well the face transplants will ultimately function many years 
down the line is not fully known, yet the results are promising.  Functional recovery 
of the upper lid is still likely to be difficult for example.   
 
The evidence for full neurological recovery following reanastomosis of facial nerves 
is generally poor (Myckatyn and Mackinnon 2003).  However, the results so far in the 
facial transplant group are promising; perhaps this is in part due to the effect of 
accelerated nerve regeneration associated with the administration of tacrolimus 
(Mackinnon et al. 2001).  There have been notable exceptions within the facial 
transplant group however, such as the third facial transplant recipient whose facial 
nerve was more damaged than had been previously thought by the operating surgeon 
(Hui-Chou et al. 2010).  Results for facial graft function on the whole compare 
favourably with the large group of hand transplants however (Wysong 2010).  Reports 
of the first seven facial transplants performed claimed sensory recovery from between 
3 and 6 months, with acceptable motor recovery commencing between 9 and 12 
months (Gordon et al. 2009).  
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1.9. Attitudes to Risk in Facial Transplantation 
In 2004 the Royal College of Surgeons of England suggested that the risks of facial 
transplantation outweighed the benefits (Morris et al. 2004).  These risks pertained to 
psychological adaptation, allograft rejection, and the ethics of life-long 
immunosuppression for a non-lifesaving procedure.  With increasing evidence from 
animal models and hand transplant data, and following partial face transplant cases in 
France and China, it became clear that these risks may not be as high as previously 
thought.  In 2007 the Royal College issued an update in which they stipulated 15 
measures which should be in place before facial transplantation can be considered 
(Morris et al. 2007).   
 
How each individual professional views and frames each risk may actually differ.  For 
example, when compared with facially disfigured or organ transplant recipient groups, 
plastic surgeons are less tolerant of the risks of facial transplantation (Vasilic et al. 
2008).  Although the majority of plastic surgeons in Mathes’ study of 163 American 
plastic surgeons agreed that current techniques do not provide adequate reconstruction 
for severe facial injuries, only 26.2% were in favour of performing facial 
transplantation which includes immunosuppression (Mathes et al. 2009).  Anecdotal 
evidence suggests that many reconstructive surgeons, when asked about whether they 
would undergo a face transplant at present, would refuse due to the risks of lifelong 
immunosuppression; if this were dramatically reduced however, most would go on to 
support it (Clarke 2006, personal communication).  
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1.10. Immunosuppressive Risks in Facial Transplantation 
Immunosuppressive risks include increased predisposition to infection and cancer.  
Rejection is difficult to predict.  Initial estimates were that up to 10% of face 
transplants will reject at 12 months, with 30-50% rejected within the first 5 years 
(Concar 2004).   These estimates were made based on organ transplant populations, a 
group which is not directly comparable to composite tissue transplants.   
 
The incidence of rejection following facial transplantation has been largely managed.  
However, in two of the transplants, rejection has at least partly contributed to patient 
mortality, albeit indirectly.  The first facial graft recipient to die following the 
procedure did so most likely due to medication non-adherence, stopping his 
immunosuppressive drugs and replacing them with a traditional herbal remedy 
(Gordon et al. 2009).   
 
Examining the one-year post-transplant data from the hand transplant cohort, 65% of 
patients experienced acute rejection (Barker et al. 2007b), with all episodes 
successfully reversed.  In the series of 52 hand transplants performed so far (Wysong 
2010), two particularly well documented cases were affected by immunological 
rejection: one due to patient non-compliance (Banis et al. 2004; Dubernard et al. 
2001), and the other due to probable inadvertent intra-arterial steroid injection (Barker 
et al. 2007b).  The increased visibility of a hand transplant probably contributes to 
earlier diagnosis of rejection and subsequent high survival rate.  In acute rejection 
following hand transplantation, cutaneous manifestations present early, and correlate 
with pathological findings (Kanitakis et al. 2005).  Time lag for the incidence of 
chronic rejection has been unpredictable in the hand transplant series, although when 
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compared to solid organ transplant groups this phenomenon may not be as important 
in composite tissue transplantation as previously thought.   Chronic rejection is still 
however undefined in facial transplantation, and the likely incidence is not yet known 
(Hui-Chou et al. 2010).   
 
The immunosuppressive protocols used for renal transplants (comprising 
prednisolone, tacrolimus and mycophenolate mofetil for example) have been used 
successfully in composite tissue allotransplants and are likely to be used for future 
face transplants; immunological tolerance will be the ultimate goal in the future 
(Siemionow and Agaoglu 2005).    
 
Most of the facial transplant recipients reported so far encountered at least one 
episode of acute graft rejection: these have been successfully reversed.  Anecdotal 
evidence suggests that many transplant physicians feel that the risks of 
immunosuppression are thus largely modifiable.  We feel that these risks should not 
therefore preclude surgeons from considering facial transplantation. 
 
1.11. Psychological and Societal Issues in Facial Transplantation 
There should be methods in place to ensure patients selected for any facial 
transplantation programme are suitably adjusted psychologically and able to cope 
with the rigours of radical life-enhancing surgery (Clarke and Butler 2004; Clarke and 
Butler 2005).  These include assessment of cognitive function, mental health status, 
pre-transplant compliance and an analysis of patient attitudes and beliefs.  Some 
commentators view the psychological adjustment required in facial transplantation to 
be problematic; in fact, many psychologists would argue that many of these 
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psychological changes are also modifiable (Clarke and Butler 2005) and methods 
have been described to deal effectively with the psychological adaptation required 
(Brill et al. 2006). 
 
There is need for open and careful public debate about the issues surrounding facial 
transplantation, and this has been addressed following a series of public engagement 
exercises (Clarke et al. 2006) in which societal issues towards facial transplantation 
were examined.  The major barrier remained the risks associated with 
immunosuppression.  When asked hypothetically whether they would accept or 
donate a face transplant, 70% of respondents agreed.  Those that were staunchly 
opposed (11%) identified identity transfer as the main obstacle.  The thought of a 
recipient adopting the donor’s identity may also be disturbing for donor families. 
 
In fact, experiments using free tissue transfer from cadaver-to-cadaver (Concar 2004), 
and with face exchange using laser scanning and photography (Clarke and Butler 
2005), have shown that the resulting face consists of a donor craniofacial skeleton 
with an overlying recipient tissue ‘envelope’ - in effect a new identity altogether.  
This is supported by experimental work in simulated facial transplants where the 
transformed face is not perceived as completely novel, but is more commonly 
identified as the recipient (Pomahac et al. 2010).  Some authors have commented that 
identity is an issue that a face transplant candidate will already be very familiar with 
following their injury (Brill et al. 2006).  Indeed, adaptation has not been such an 
issue for facial transplant recipients as it has been for hand transplant recipients, 
probably because patients need to look into a mirror in order to see their face, whereas 
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their hands are in full view most of the time.  If anything, aesthetic matching is 
perhaps of greater significance than identity transfer in facial transplantation.   
 
1.12. Patient Selection Criteria for Facial Transplantation 
Facial transplantation is major surgery and should not be undertaken lightly.  One of 
the most important issues for the medical team is appropriate patient selection, which 
should be vigorous in its approach and draw on expertise from a range of relevant 
professionals.  Surgeons, transplant physicians, psychologists and psychiatrists are 
likely to be involved in patient assessment and selection.  Selection criteria should 
include physical assessment of the face and its functional deficit, general health 
assessment, and psychological profile.  Even if a patient is felt to be appropriate, 
consideration should be given to alternative options such as psychosocial strategies to 
manage unusual appearance.  These may already have been exhausted, but the patient 
should be fully aware of all options and counselled on advantages and disadvantages 
of each.   
 
The reconstruction of form and function is now of such importance that it is no longer 
acceptable to produce a sub-optimal attempt at structural mimicry.  In fact one can 
argue that the function of a limb or organ is of equal or greater importance to 
successful outcome.  If we are ready and able to produce satisfactory functional 
reproductions of the larynx, the oesophagus and the hand, the next logical step should 
be to continue research on facial transplantation.  In recognition of this, the Ethics 
Committee at the Royal Free Hospital gave its approval to commence patient 
selection for potential whole face transplantation in 2005 (Highfield and Hall 2005).   
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Working on the original Royal College of Surgeons Report on facial transplantation 
(Morris et al. 2004) the UK facial transplantation team has attempted to address each 
concern as a research question.  In doing this they found that the barriers have been 
less substantial than previously thought.  Ultimately, the risks of a procedure are 
never known until the procedure is actually performed – with partial and full facial 
transplantation now already a reality, the truest test of any selection criteria is time. 
How will the first facial transplant be reflected upon fifty years from now?  We do not 
know.  We do however know that fundamental principles of surgery will stand the test 
of time: research, preparation, planning, informed consent, and thorough pre-
operative assessment.  Only by incorporating these into a selection process can the 
likelihood of the most optimal patient outcome be maximised. 
 
1.13. Summary of Chapters 
In the following thesis, a number of the clinical considerations in facial 
transplantation will be explored and examined.   
 
CHAPTER 2 deals with technical aspects of procurement of donor facial graft tissue.  
Clearly facial transplantation is major reconstructive surgery, and the surgeon 
harvesting the graft must be sure of the vascular configuration of the donor or 
recipient face.  Estimates of technical failure in microsurgery are relatively easy to 
predict; the face has a robust blood supply and technical success rates in many 
microsurgical units can reach 96-98% (Kroll et al. 1996).  Two cases have been 
reported of successful scalp and face replantation, one surviving on a single artery and 
two veins (Wilhelmi et al. 2003).  Most plastic surgeons would therefore agree that 
the technical difficulties are significant but not insurmountable.  However, the 
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definition of the facial vasculature can be tricky in the intensive care setting; this 
necessitates the development of an accurate, mobile and user-friendly method of 
defining the facial vessel anatomy.   
 
CHAPTER 3 of this thesis described the development of a skin tonal matching 
system.  This we hope will help in obtaining a satisfactory aesthetic end-point 
following facial transplantation.   
 
CHAPTER 4 describes a system for assessing precisely which donor skin tone would 
be acceptable in some of the common recipient groups the UK facial transplant 
surgeon is likely to encounter. 
 
CHAPTER 5 examines the attitudes of transplant professionals towards facial 
transplantation.  For any face transplant programme to be successful, donor groups 
will need to be enlisted and every attempt should be made to do this in as sensitive a 
way as possible.   The attitudes of health professionals dealing with the donor families 
and obtaining informed consent for donation are therefore of some significance, 
helping to pave the way towards the establishment of a national facial transplantation 
programme.  
 
CHAPTER 6 describes the development of a system to restore form to the donor face 
following facial graft harvest.  The donor face will exhibit a significant facial defect 
following facial graft harvest: this comprises the facial skeleton with or without 
muscle units.  The reconstruction of such a significant defect should be carefully 
considered by any successful transplant programme.  We have designed a system in 
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which a moulded silicone envelope can be fabricated during the graft harvesting 
process.  
 
CHAPTER 7 explores the unique nature of informed consent in facial transplantation. 
This section of the thesis will review the process of informed consent in health 
settings, assessing how applicable the current standards are for facial transplantation.  
The factors which need to be assessed during the screening programme will be 
outlined, producing a new gold standard for ensuring informed consent in facial 
transplantation which categorises the procedure according to both individual and 
process factor. It is hoped that this can be extended to any consent process for radical 
new procedures.   
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Chapter 2 
 
2. The Use of Colour Doppler Ultrasonography in the Assessment of 
Vessels for Facial Transplantation 
 
2.1. Introduction  
The majority of the facial skin is supplied by the paired facial, superficial temporal 
and transverse facial arteries (Figure 2.1).  The facial artery is utilised widely in 
plastic surgery, such as in facial artery musculomucosal (FAMM) (Pribaz et al. 1992) 
and nasolabial flaps (Houseman et al. 2000).  The facial artery has been examined in 
various cadaveric studies (Mitz et al. 1973; Niranjan 1988).  These studies have 
shown wide variability, with few large studies (Lohn et al. 2004) outlining its course 
and terminal branching pattern.  There is little data outlining the course of the facial 
vein, and scant data on the transverse facial vessels.  
 
The facial artery arises from the external carotid artery, the main branch coursing 
above the submandibular gland.  The artery traditionally has a tortuous course across 
the anterior face, the vein a more direct path (Houseman et al. 2000).  The artery runs 
along the masseter muscle, where it becomes more superficial.  It then moves 
gradually anteriorly until it gives off the two labial arteries near the angle of the 
mouth.  Distally, the artery dives deep to the levator labii superioris and zygomaticus 
muscles, running towards the medial canthus whereupon it anastomoses with 
branches of the ophthalmic artery.  The facial vein arises from the confluence of the 
supraorbital and supratrochlear veins in the medial canthus.  It runs in a straight line 
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down to the angle of the mandible, lateral to the artery, before joining the anterior 
division of the retromandibular vein.  
 
 
Figure 2.1.  Blood supply to the face including facial artery and branches, reproduced 
with permission from Gray's Anatomy: the Anatomy of Clinical Practice, 39th Ed, 
Churchill Livingstone, Edinburgh (Standring 2005). 
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The transverse facial artery arises from the superficial temporal artery prior to its 
emergence from the parotid gland; there may alternatively be a direct origin from the 
external carotid artery (Standring 2005).  The transverse facial artery crosses the 
parotid, passing masseter superficially between the parotid duct and the zygomatic 
arch, supplying masseter, the parotid gland and parotid duct.  Anastomoses exist 
between the transverse facial artery and the facial, buccal, lacrimal and infraorbital 
arteries.  The main transverse facial artery perforator occurs in a constant location 
(Whetzel and Mathes 1997), originating at the superficial musculo-aponeurotic 
system and coursing with the superior ligament of Furnas (Basar et al. 2004).  This 
perforator is found approximately 3.1 cm lateral and 3.7 cm inferior to the lateral 
canthus (Basar et al. 2004).   
 
Traditional methods used in pre-operative vascular evaluation of the face, such as 
manual palpation and Doppler probes, have limitations: they have no way of assessing 
flow direction or vessel diameter, and they have restricted capacity for venous 
evaluation.   Colour Doppler sonography has been used to assess flow diameter, 
velocity and pulsatility in small blood vessels (Foley and Erickson 1991).  Although 
there have been studies of the vasculature in cervical lymph nodes (Na et al. 1997), 
submandibular glands (Ariji et al. 1998) and masseter muscle (Ariji et al. 2001), there 
are few studies on colour Doppler sonography in delineating the blood supply to the 
anterior face (Nagase et al. 1997).  Zhao et al (Zhao et al. 2002) used colour Doppler 
to assess the main trunk and labial and buccal branches of the facial artery in 46 
volunteers, detecting 100% of facial artery main branches, and 92.4% of buccinator 
branches.  In this chapter we clarify the distribution of the facial vessels and described 
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the transverse facial vessels in the anterior face using high-frequency colour Doppler 
ultrasound in a large series of healthy individuals.  
 
2.2. Materials and Methods 
A total of 200 facial arteries/veins, and 200 transverse facial arteries/veins were 
examined in 100 consecutive healthy volunteers (41 men, 59 women; 89 right-
handed, 11 left-handed; 65 Caucasian, 16 Asian, 11 Afro-Caribbean and 8 Oriental; 
age 20 to 57 years, mean 32.3 years) recruited from two departments at the Royal 
Free Hospital (Department of Accident & Emergency and the Department of Plastic 
Surgery).  The study was approved by the Royal Free Hospital Research Ethics 
Committee.  All participants were informed of the study aims and gave written 
consent to participate. 
 
Measurements were taken with the SonoSite MicroMaxx™ System 3.2 ultrasound 
machine (SonoSite Inc., Bothell, WA) furnished with an SLA 13.6 MHz wide-
bandwidth linear active matrix transducer.  All images were obtained in the 
superficial setting using a multifocus with an image depth of 2.2 cm for the facial and 
superficial temporal vessels and 3 cm for the transverse facial vessels.  The settings 
were chosen to optimise colour Doppler flow measurements; artefact was minimised 
by altering the wall filter and pulse-repetition frequency.  The linear transducer 
transmits parallel ultrasound beams in sequence, creating a field only as wide as the 
probe length.  The short depth of field was chosen to maximise the potential pick-up 
rate of the small calibre vessels, which are found anatomically within the superficial 
facial tissues.  The SLA probe is small, thin and held at an angle; this was chosen to 
allow examination to be most optimally applied around the contours of the face.  
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Colour gain was set at 2033 Hz.  All measurements were made with the patient 
horizontal on the same couch in a room kept at a constant temperature of 20-22°C.  
Measurements of flow diameter were obtained when the vessel was maximally 
dilated.  The probe was kept at right angles to the skin, and flow diameter 
measurements were taken perpendicular to the vessel.  The machine’s digital callipers 
were placed at the outer limit of the vessel wall, and a flow diameter measured 
vertically.  All measurements were made at the same points on the face.  
Measurements were performed after confirming the presence of arteries or veins on 
the basis of their waveform in the audible Doppler mode (Figure 2.2).  
 
 
Figure 2.2.  Doppler signal showing arterial wave pattern. 
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The facial artery and vein were scanned in three different positions (Figure 2.3).  The 
landmarks used to measure distance from the facial artery or vein were: the 
mandibular crossing point (position 1), measured parallel and superior to the inferior 
border of the mandible; the laterality to the cheilion (position 2), measured 
horizontally from the angle of the mouth; and the point at which the facial vessel 
crosses a line drawn between the cheilion and the lateral canthus (position 3).  
Variation in branching of the facial vessels was documented up to the level of the 
nasal ala, corresponding with this final position.  Anomalous drainage patterns were 
recorded. 
 
The transverse facial vessels were found emerging from the superficial temporal 
vessels at the anterior border of the masseter muscle (position 4), travelling across the 
cheek in a reference line from the external auditory canal to the anterior nasal spine.  
Flow diameter was assessed perpendicular to the vessel.  Distance was measured from 
the centre of the vessel to the lateral canthus.  A flow diameter measurement of the 
superficial temporal artery and vein was taken concurrently.  This was achieved by 
placing the probe perpendicular to the vessel 1 cm antero-superior to the tragus of the 
ear.  All measurements were repeated bilaterally in all vessels.  
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Figure 2.3.  Landmarks for the measurement of the facial artery (FA) and transverse 
facial artery (TFA).  Solid black lines represent probe application.  Distances were 
recorded from: the mandibular crossing point (position 1), the point at which the 
vessel crosses a line drawn laterally from the gnathion (G); the laterality to the 
cheilion (position 2), the point at which the vessel crosses a line drawn laterally from 
the cheilion (C); and the approach to the nasal ala (position 3), representing the point 
at which the vessel crossed a line drawn from the cheilion to the lateral canthus (LC).  
The TFA was measured as it crossed the anterior border of the masseter (M), and the 
distance measured from this point (position 4) to the lateral canthus (LC). 
 
 
 
Position 2. 
Position 3. 
Position 1. 
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The distribution patterns of the facial artery and vein were categorised according to 
the final branch of the facial artery that was detected up to and including the nasal ala 
(Figure 2.4).  This was adapted from the system described by Koh et al (Koh et al. 
2003) consisting of: angular, lateral nasal and alar (grouped together here as Types I-
III), superior labial (Type IV), inferior labial (Type V) and undetected, or submental 
(Type VI).  
 
Angular
Alar
Inferior 
labial
Superior 
labial
Lateral 
nasal
Submental
Type I Type II Type III
Type IV Type VIType V
 
Figure 2.4.  Distribution pattern of the facial artery: angular (type I); lateral nasal 
(type II); alar (type III); superior labial (type IV); inferior labial (type V); and 
submental (type VI).  
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2.3. Results 
The main branch of the facial artery was detected at the lower mandibular border 
(Figure 2.5) in 99.5% (n=199) of cases.  The accompanying facial vein was found in 
97.5% (n=195) of cases, lateral to the artery in all cases. 
 
 
Figure 2.5.  Right facial artery (FA) and vein (FV) at the mandibular crossing point 
(position 1). 
 
At the mandibular crossing point (position 1: Figure 2.5) the flow diameter of the 
facial artery ranged from 1.1 to 3.7 mm (mean ± SD, 2.6 mm ± 0.45); the facial vein 
diameter ranged from 1.8 to 5.8 mm (mean ± SD, 3.1 mm ± 0.61).  Lateral to the 
cheilion (position 2: Figure 2.6) the diameter of the facial artery ranged from 1.1 to 
3.5 mm (mean ± SD, 2.1 mm ± 0.41); the facial vein diameter ranged from 1.2 to 4.5 
mm (mean ± SD, 2.6 mm ± 0.55).  Although the facial artery and vein were largely 
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located together at the mandibular crossing point (mean artery-to-vein distance 7.9 
mm) the facial artery and vein diverged from each other more widely lateral to the 
cheilion (mean artery-to-vein distance 11.8 mm).  At the nasal alar base, crossing the 
line drawn from the cheilion to the lateral canthus (position 3: Figure 2.7), the 
diameter of the facial artery ranged from 0.9 to 2.7 mm (mean ± SD, 1.8 mm ± 0.39); 
the facial vein diameter ranged from 1.2 to 4.9 (mean ± SD, 2.4 mm ± 0.64).  
 
 
Figure 2.6.  Laterality to the cheilion (position 2). FA = facial artery, FV = facial vein 
 
 
 
 
 
Orbicularis 
oris 
FA 
FV 
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Figure 2.7.  Crossing the cheiliocanthal line (position 3). a) FA = facial artery, b) FV 
= facial vein. 
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The numbers of arteries in each distribution group (type I-VI, with type I-III grouped 
together) are summarised in Table 2.1.  These are compared with distribution patterns 
from previous cadaveric studies.  
 
Table 2.1.  Distribution patterns of the facial artery. 
 Number of facial arteries (%) 
 Type I-III Type IV Type V Type VI 
(Renshaw et al. 2007)* 
(n=200) 
152 (76) 43 (21.5) 4 (2) 1 (0.5) 
(Lohn et al. 2004) 
(n=200) 
170 (85) 20 (10) 6 (3) 4 (2) 
(Mitz et al. 1973)       
(n= 50) 
42 (84)  5 (10) 4 (8) 0 (0) 
(Niranjan 1988)  
(n=50) 
48 (96) 2 (4) 0 (0) 0 (0) 
* Current study 
 
A total of 144 (72%) of all the facial arteries examined were symmetrical, with 56 
(28%) of arteries asymmetrical.  It is interesting to note that more of the symmetrical 
arteries were of Type I-III, and that the rarer variants, especially Type IV, were more 
likely to be asymmetrical (Table 2.2).  One can thus extrapolate that if a type I-III 
facial artery is located on one side, the chances of finding a symmetrical arterial 
distribution is higher than had a type IV or V artery been found. 
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Table 2.2.  Facial artery variation. 
 No. of arteries, 
n=200 (%) 
No. of symmetrical 
arteries, n=144 (%) 
No. of asymmetrical 
arteries, n=56 (%) 
Type I-III 152 (76) 126 (87.5) 26 (46.4) 
Type IV 43 (21.5) 18 (12.5) 25 (44.6) 
Type V 4 (2) 0 (0) 4 (7.1) 
Type VI 1 (0.5) 0 (0) 1 (1.8) 
 
 
The facial artery and vein distances from the three different points on the face 
described previously were used to calculate the mean position of the facial artery and 
vein, which are shown in Figure 2.8.  The mean flow diameter of facial artery and 
facial vein, along with the distance from each of the three points on the face is shown 
in Tables 2.3 and 2.4.   
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Figure 2.8.  The path of the facial artery (FA) and facial vein (FV) in the anterior 
face.  Values (mm) represent distance (mean ± SD) of the vessel from three fixed 
landmarks, as shown from lateral to medial: the mandibular crossing point (1); 
laterality to the cheilion (2); and crossing a line drawn from the cheilion to the lateral 
canthus (3). 
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Table 2.3.  Facial artery: mean flow diameter and mean distance from three fixed 
landmarks: the mandibular crossing point (position 1); laterality to the cheilion 
(position 2); and crossing a line drawn from the cheilion to the lateral canthus 
(position 3). 
 
Position Mean (± SD) diameter (mm) Mean (± SD) distance (mm) 
1 2.6 (0.5) 66 (6.6) 
2 2.1 (0.4) 18 (3.8) 
3 1.8 (0.4) 18 (5.4) 
 
 
Table 2.4.  Facial vein: mean flow diameter and mean distance from three fixed 
landmarks:  the mandibular crossing point (position 1); laterality to the cheilion 
(position 2); and crossing a line drawn from the cheilion to the lateral canthus 
(position 3). 
 
Position Mean (± SD) diameter (mm) Mean (± SD) distance (mm) 
1 3.1 (0.6) 74 (6.2) 
2 2.6 (0.6) 29 (5.7) 
3 2.4 (0.6) 31 (5.4) 
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The transverse facial artery was present in 75.5% (n=151) of cases; the accompanying 
vein was found in 58% (n=116).  The flow diameter of the transverse facial artery 
ranged from 0.7 to 3.1 mm (mean ± SD, 1.6 mm ± 0.46), with the transverse facial 
vein diameter ranging from 0.7 to 3.7 mm (mean ± SD, 1.8 mm ± 0.56).  The mean 
distance from the lateral canthus to the transverse facial artery and vein was 58 mm ± 
6.02 and 59.7 mm ± 6.59 respectively.  The flow diameter of the superficial temporal 
artery ranged from 1.1 to 4.3 mm (mean ± SD, 2.3 mm ± 0.43), that of the vein 
ranging from 1.2 to 4.3 mm (mean ± SD, 2.7 mm ± 0.51). 
 
In one case the facial artery was undetectable (Type VI), with a transverse facial 
artery dominance (diameter 2.3 mm, Figure 2.9).  However, three out of four 
individuals with a short rudimentary facial artery (Type V) had an absent transverse 
facial artery.  While the facial artery was more variable in its course, the facial vein 
was more predictable in position.  On one occasion the facial vein was absent, 
replaced by a transverse facial vein which ran into the superficial temporal vein.  This 
was in a hemiface with a normal arterial supply.  
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Figure 2.9.  Large 2.3 mm right transverse facial artery (TFA) in a 23 year-old right-
handed female with absent (Type VI) right facial artery.  
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Mean transverse facial artery flow diameter was significantly larger in females than 
males (one-way ANOVA test: 1.65 mm vs. 1.43 mm; p=0.009).   A greater distance 
from the lateral canthus was noted in males than in females for both the transverse 
facial artery (60.59 mm vs. 56.7; p=0.002) and vein (63.46 mm vs. 57.99 mm; 
p<0.001).  The facial artery was found further from the gnathion in males than in 
females (69.5 mm vs 63.42 mm; p<0.001), as was the facial vein (77.46 mm vs. 71 
mm; p<0.001).  At position 3 (approaching the nasal ala), the facial vein was found 
further away from the cheilion in males than in females (33.28 mm vs. 28.8 mm; 
p<0.001). 
 
Only one significant difference was noted between racial groups (one-way ANOVA 
test, p=0.001), that of mean distance from the transverse facial vein to the lateral 
canthus (Caucasian 58.59 mm, Asian 61.77 mm, Oriental 68.36 mm, Afro-Caribbean 
59.42 mm).   Increasing age was associated with an increased mean distance of the 
facial artery from the cheilion at position 3 (bivariate correlation, p=0.002).  
Handedness was not associated with either increased flow diameter or distance from 
facial landmarks using the one-way ANOVA test.  
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2.4. Discussion 
This is the first time such a large series of facial vessel scans using colour Doppler 
ultrasound has been described.  The facial artery supplies the submandibular gland, 
masseter muscle and much of the anterior face including the lips.  The assessment of 
facial vasculature is thus of particular importance when considering patient selection 
for facial transplantation (Diver et al. 2006), as the pan-facial injuries being 
considered by the UK facial transplantation team will likely include defects associated 
with severe functional deficits around this area.  
 
The facial vessels were easily found in the anterior face, due to their superficiality to 
the skin.  The mean facial artery diameter at the mandibular crossing angle (2.6 mm) 
correlates with previous studies (Pinar et al. 2005).  The arterial diameter peters out as 
the artery reaches the nasal ala, as described in the cadaver (Lohn et al. 2004).  The 
facial artery was found an average of 18 mm lateral to the mouth, compared with 15.5 
mm quoted elsewhere (Pinar et al. 2005).   The facial vein crossed the mandible at a 
predictable point, similar to that reported in the cadaver (7.4 cm vs. 7.5 cm) (Lohn et 
al. 2004).  Importantly, in keeping with Nagase’s study of facial vessels (Nagase et al. 
1997) the artery and vein diverged widely from each other at the oral commissure.  
The surgeon should be wary of this when planning facial flaps.  
 
This study confirms the branching patterns of the facial artery reported in other series 
(Lohn et al. 2004), although more individuals were reported to exhibit a Type IV 
artery than previously reported (21.5% vs. 10%) (Mitz et al. 1973).  This may be due 
to the methodology used, or simply may represent the wider ethnic mix in our sample 
population.  The main trunk was absent or rudimentary in a small minority of 
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individuals (2.5%), compared with between 0%  and 8% quoted elsewhere (Foley and 
Erickson 1991; Lohn et al. 2004; Mitz et al. 1973; Niranjan 1988).  
 
Importantly, this study verifies clinically the incidence of facial artery absence (Lohn 
et al. 2004): one individual with Type VI (submental variant) facial artery had 
reciprocal transverse facial artery dominance.  This confirms previous observations 
that compensation for an underdeveloped facial artery may come from a more 
developed ipsilateral transverse facial or contralateral facial artery (Pinar et al. 2005), 
and that several arteries may contribute to this phenomenon (Mitz et al. 1973; 
Nakajima et al. 2002; Niranjan 1988).  
 
The branches distal to the ala (Types I-III) were not specifically measured for two 
reasons.  Firstly, our methodology meant that vessels became more difficult to detect 
the smaller they were, with probe application problematic at the side of the nose and 
at the medial canthus.  Secondly, the terminal branching pattern of the facial artery is 
of little importance to a facial transplant graft, where proximal patterns are of more 
significance. 
 
Handedness was investigated as it has been suggested as one of the factors that might 
influence arterial development: right-handed individuals have been reported to have 
higher flow rate in the right external carotid artery than in the left (Bogren et al. 
1994).  No significant associations were found in this study between handedness and 
flow diameter.  
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Figure 2.10.  Mean path of 200 facial arteries and veins in the current study (a); mean 
path of 200 facial arteries and veins in the cadaver (b) (Lohn et al. 2004). 
     a) 
 
     b) 
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Increasing age had little effect on facial vessel diameter or distance.  Gender 
differences in flow diameter of the main trunk of the facial artery have previously 
been found in some studies (Zhao et al. 2002) but not in others (Koh et al. 2003).  In 
the current study there were often larger distances between vessel and fixed 
landmarks in males than females, probably due to the often larger facial proportions in 
males.  Interestingly, flow diameter largely did not differ between sexes, apart from a 
larger mean transverse facial artery diameter in females.  Racial differences in the 
origin and distribution of the facial artery have been reported previously (Mitz et al. 
1973; Nakajima et al. 2002; Niranjan 1988) but other studies have shown quite 
different branching patterns within the same racial group (Koh et al. 2003).  There 
was only one significant difference between racial groups in the current study: that of 
the position of the transverse facial vein, which was considerably further away from 
the canthus in Oriental faces.  
 
There are many benefits to using colour Doppler sonography to assess facial 
vasculature.  It is non-invasive, mobile, easily repeated and (importantly) has the 
ability to image veins.  The facial vessels are easily found in the anterior face, due to 
their superficiality to the skin.  
 
Disadvantages include uncertain reproducibility due to the ‘fluid’ nature of the 
measurements.  Quantitative evaluation using digital callipers is also prone to 
variability (Zhao et al. 2000).  The wide variation and tortuosity of the facial artery 
made visualisation occasionally difficult.  The correct amount of pressure has to be 
maintained on the skin so as not to obliterate the vein wall.  Vein flow varies with the 
respiratory cycle, especially closer to the thorax.  No allowance was made for altered 
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fluid status: although this may be of potential importance in the assessment of the 
facial transplant donor in the acute clinical setting, all individuals in the present study 
were well-hydrated and received oral fluids prior to the assessment.  Additionally, 
vessel flow diameter represents maximal inflation and gives little indication of the 
diameter when collapsed.  The smaller-diameter transverse facial vessels (which lie 
deeper than the facial vessels) sometimes proved difficult to find, and indeed the 
smaller pick-up rate for the vein than for the artery (58% vs. 75.5%) may reflect this.  
Unlike the current study, patients selected for facial transplantation may not have 
normal anatomy.  However, this method could still be used for assessment of the 
health of their vessels to ascertain which vessels remain intact after trauma. 
 
The ability to locate and assess small vessel patency has many other applications in 
facial reconstruction.  Colour Doppler ultrasound can be used in the planning of 
aesthetic procedures such as face lift procedures, since the transverse facial artery 
supplies a large portion of the lateral face lift flap (Whetzel and Mathes 1997).  
 
 
Figure 2.11.  MicroMaxx™ colour Doppler ultrasound system in use. 
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In the realm of facial transplantation, colour Doppler provides a good method of pre-
operative vascular imaging to establish the feasibility of raising facial flaps based on 
the facial vascular pedicle.  As part of this screening process, colour Doppler 
ultrasound could also help in establishing an operative contingency plan to delineate 
an alternative vascular pedicle should the facial artery be absent.  The MicroMaxx™ 
system was chosen as it is mobile, hand-held, easily transported to the bedside, and 
rapidly boots up (Figure 2.11); its robust nature and use in other critical care settings, 
such as in the placement of central venous lines, means that it has particular 
application in the assessment of donor faces for facial transplantation.  Colour 
Doppler ultrasound can be used by clinicians with some initial training in ultrasound 
technique to outline the course, diameter and relations of the facial and transverse 
facial vessels in the anterior face.  This technique should therefore be considered a 
valuable adjunct to the facial reconstructive surgeon’s armamentarium. 
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Chapter 3 
 
3. The Development of a Skin Tonal Matching Scale for Facial 
Transplantation 
3.1. Introduction 
3.1.1. Human Skin Colour  
Human skin acts as a physical barrier: it provides a first-line defence mechanism 
against infection; it protects against the damaging effects of ultraviolet radiation; and 
it acts as a locus for the ultraviolet-driven production of vitamin D (Jablonski 2004).    
Melanins are the skin’s primary pigment.  Two types of melanin exist: pheomelanin (a 
reddish-yellow colour) and eumelanin (a dark brown-to-black colour) (Thody et al. 
1991).  Eumelanin is characteristic of darker or tanned skin, with phaemelanin 
predominating in red-haired Caucasians for example (Thody et al. 1991).     
 
Melanocytes (specialised dendritic cells residing in the epidermal stratum basale) 
produce melanins in specialized cytoplasmic organelles called melanosomes.  These 
vary in size and amount of aggregation depending on skin type: darker individuals 
sport larger melanosomes which are dense and singly dispersed, deflecting more 
ultraviolet light than lighter individuals (Jablonski 2004).  The epidermis of people 
with darkly pigmented skin contains a more tightly packed arrangement of cornified 
cells within the stratum corneum, thus conferring upon it superior barrier properties 
(Taylor 2002).  Variation in pigmentation depends more on the distribution, 
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composition and size of melanocytes rather than their number, which remains 
constant in most individuals (Lin and Fisher 2007). 
 
Human skin colour boasts a large multiplicity of shades.  On average, women have 
slightly lighter skin than men (Jablonski and Chaplin 2000).  Skin that is usually 
exposed to the sun has a more intense red component, due to increased vascularization 
(Andreassi et al. 1990; Kollias 1995).  The quantity and type of melanin are 
determined by four to six genes operating under incomplete dominance.  In addition 
there is an interplay between the environment and a few major genes accompanied by 
modifier genes (Jablonski 2004).  With each gene manifesting several alleles, this 
results in a multitude of skin colours.  Humans are able to distinguish a very large 
number of these shades. 
 
3.1.2. The Fitzpatrick System of Skin Phototype Assessment 
Skin type (and tone) can be assessed clinically but very imprecisely.  Traditionally, 
skin phototype is determined by dermatologists and plastic surgeons using the 
Fitzpatrick system (Fitzpatrick 1988).  This classifies skin into six skin phototypes, 
termed types I-VI (Table 3.1).  Four categories are described for white-skinned 
persons (skin type I, II, III, IV), with brown skin classified as skin type V, and black 
skin as skin type VI.  Later the system was modified to include three brown skin 
tones: type IV for light brown, type V for brown, and type VI for dark brown or black 
(Pathak and Fitzpatrick 1993).  The clinical value of this system however lies in its 
ability to predict tanning or burning potential.  This provides an indication of the 
potential for transformation of the skin into cancers caused by ultraviolet radiation 
(e.g. squamous cell carcinoma, melanoma).  It provides the clinician with a quick 
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method of assessing patient skin phototype without the need for scientific 
instrumentation.  However this rating is subjective and even efforts at objective 
measurement of Fitzpatrick type have been focussed on ultraviolet radiation and its 
sequelae (Ravnbak 2010). 
 
Table 3.1.  The Fitzpatrick system of skin phototyping. 
Skin type Colour Reaction to UVA Reaction to sun 
 
Type I Caucasian; 
blond or red hair, freckles, 
fair skin, blue eyes 
Very sensitive 
Always burns easily, never 
tans; very fair skin tone 
Type II Caucasian; 
blond or red hair, freckles, 
fair skin, blue eyes or 
green eyes 
Very sensitive Usually burns easily, tans 
with difficulty; fair skin 
tone 
Type III Darker Caucasian, 
light Oriental 
Sensitive Burns moderately, tans 
gradually; fair to medium 
skin tone 
Type IV Mediterranean, 
Oriental, Hispanic 
Moderately 
sensitive 
Rarely burns, always tans 
well; medium skin tone 
Type V Middle Eastern, 
Latin, light-skinned black, 
South Asian  
Minimally 
sensitive 
Very rarely burns, tans 
very easily; olive or dark 
skin tone 
Type VI Dark-skinned black Least sensitive Never burns, deeply 
pigmented; very dark skin 
tone 
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Melanin pigmentation is either constitutive (i.e. genetically determined) or facultative 
(i.e. secondary to ultraviolet light radiation exposure) (Quevedo et al. 1975); each 
component of the Fitzpatrick system attempts to assign skin either constitutive or 
facultative properties of colour. 
 
Herein lies the problem with applying the Fitzpatrick system to facial transplantation.  
Facial transplantation is a rather unique scenario: the most optimal result will require 
a good aesthetic (or cosmetic) match.  Skin colour is arguably one of the most obvious 
physical characteristics.  Burning (or tanning) ability is of less significance than 
colour or tone per se.  Additionally, although constitutive skin colour has been found 
to be a more meaningful parameter than facultative skin colour in assessing skin type, 
Fitzpatrick skin phototype does not correlate particularly well with measured 
constitutive colour (Andreassi et al. 1990).  Finally, the darker skin types are notably 
underrepresented, leading to limited applicability in these groups. 
 
3.1.3. The British Red Cross Skin Camouflage Matching System 
The British Red Cross use a skin camouflage matching system which is more 
representative of the skin types present in the general population (Glennie and Tagg-
Davis 2000).   
 
The skin tones comprise 11 categories which are most representative of the wide 
variation of skin tone in the UK: 
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 Fair (e.g. red hair, freckles) 
 Slightly tanned white 
 Yellow (e.g. Chinese) 
 Ivory/beige (e.g. Japanese) 
 Olive (e.g. Spanish, Italian) 
 Light golden brown (e.g. light Asian) 
 Reddish brown (e.g. dark Asian) 
 Light to mid-brown 
 Mid brown 
 Brown/black 
 Black/black 
 
Currently, this skin tone scale focussing on the cosmetic aspects of tonal matching is 
probably the closest to what is needed in facial transplantation.  There are however 
problems with this system: it is a crude scale only; there is no definition of what 
constitutes each category; the photographs are not standardised and are poor quality.  
It is clear that a new system of skin tone matching is required. 
 
3.1.4. Methods of Analyzing Skin Tone 
Historically, a number of methods have been used to characterise skin tone.  In the 
nineteenth century, von Luschan (von Luschan 1897) made one of the earliest 
attempts to match areas of unexposed skin using a scale comprised of a series of 
coloured tiles or tablets.   This method remained popular until the emergence of 
spectrophotometry in the mid-twentieth century (Lasker 1954).  Reflectance 
spectrophotometry remains in use for the assessment of skin pigmentation and tone, 
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as it has a number of benefits: there is a constant distance from the light source, and it 
is an objective measurement (Jablonski 2004).   However, the different types of 
portable spectrophotometers available produce different skin reflectance 
measurements which are not directly comparable.  Both skin pigmentation and 
reaction to ultraviolet radiation have been measured with the Derma-Spectrometer 
(Kollias 1995), the Datacolour International Microflash, and the Minolta Chroma 
Meter CR-200 (a colour analyser for measuring the reflective colour of surfaces by 
the tristimulus system) (Andreassi et al. 1990).   
 
These methods are not readily available in most clinical environments.  As the facial 
graft donor will be assessed initially in a high-dependency area, the portable 
assessment of donor facial skin tone using easily-accessible equipment should remain 
the goal of the facial transplant team. 
 
Digital photography is one of the most widely available methods used to measure skin 
tone.  The device can be set up at a fixed distance and at a fixed relative angle - in 
standardised light settings - in order to minimise light reflectance from the subject.  
Pixels within an image can be analysed using commercially available image analysis 
software (Adobe Photoshop CS2, Adobe Systems Incorporated, USA) to give a mean 
value for red, blue and green and luminosity.  A single mean value for red, blue and 
green together can also be obtained: this is termed an ‘RGB value’.  Objective 
analysis of skin tone using such digital imagery has been used in a number of settings, 
such as examining burn depth (Roa et al. 1999), and scrotal skin colour changes in 
monkeys (Gerald et al. 2001). 
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3.2. Methods and Materials 
3.2.1. Case Ascertainment 
Volunteers were recruited from within staff in the Royal Free Hospital, London.  
Written informed consent was formally obtained in all volunteers.  Ethical approval 
was obtained from the University College London Joint Hospitals Ethical Committee.  
No volunteers were ineligible unless they had previous facial disfigurement, facial 
discolouration or make-up, all of which might have skewed the results. 
 
3.2.2. Photographic Studio Set-Up 
Digital photographic images (anterior-posterior face, three-quarter view face, lateral 
face and right forearm/hand) were obtained by a senior medical photographer.  All 
photographs were taken on the same Fuji S2 digital camera and 60 mm Nikon Nikkor 
lens at ISO-200 with a shutter speed of 1/125.  All photographs were taken at a 
distance of two metres from the subject.   
 
The same studio was used in order to allow standardisation of background light using 
electronic flash reflectors and diffusers.  To minimize light drift, we used a tungsten 
bulb of the same wattage at a standard distance from subjects.  Two lights and diffuser 
panels providing front key lighting were positioned at 60˚ two metres from subject; 
full power produced an aperture of f32.  Two lights and diffuser panels providing rim 
lighting were positioned at 45˚ three metres from the subject; half power produced an 
aperture of f22.  A custom white balance setting, using a background white card 
placed one metre behind the subject, was made to record the colour temperature of the 
lighting set up.  The set-up of the studio is highlighted in Figures 3.1 and 3.2. 
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Figure 3.1.  Photographic image procurement in a studio setting under standard, 
optimal and reproducible lighting conditions.  
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Figure 3.2.  Photographic image procurement studio setting. 
 
3.2.3. Monitor and Software Calibration 
Image processing and assessment was conducted using a Dell Optiplex 3GHz 
PC/Nvidia-256Mb video display graphics card with a 21” Sony monitor.  The 
calibration process involved the initial pre-setting of various monitor characteristics to 
specific standardised industry values.  This was followed by a series of sequential 
steps using Gretag Macbeth Eye-One 2 software to ensure that tone and colour were 
displayed accurately (e.g. mid-grey should be displayed as Red=127, Green=127, 
Blue=127).  The monitor-specific profile was then implemented and saved.  To 
accommodate changes in the monitor over time the display profile was revised on a 
monthly basis.  
 
A Gretag Macbeth Colour Checker Colour Rendition Chart™ (McCamy et al. 1976) 
and was used for objective standardization of images (Figure 3.3).  This chart, 
measuring 83mm x 56mm in size, contains 24 coloured patches arranged in a 6-by-4 
array, each colour reflecting light the same way in all parts of the visible spectrum.  
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This chart can be incorporated into photographs of the face without obstructing the 
selected target areas on the face (e.g. nose and forehead).  A Pro-Photo RGB 
reference chart was accessed in order to provide reference values and a visual guide 
(www.colorremedies.com/realworldcolor/downloads.html). 
 
Using the Adobe Photoshop CS2 ACR image converter, the images were converted 
using the ACR 2.4 camera profile. This profile was calibrated so that it matched the 
characteristics of the camera and lighting set-up, ensuring standardisation of image 
workflow.  Each photographic image was taken in RAW image file type, containing 
raw untouched pixel information from the camera sensor.  This was compared with 
the standardized Gretag Macbeth colour spectrum within the frame, and the image 
calibrated accordingly, thus creating a Tagged Image File Format (TIFF) file.   
 
Figure 3.3.  The Gretag Macbeth Colour Checker Colour Rendition Chart™. 
 
When capturing sample images we also captured digital images of black and white 
standards for calibration. Photographic black and white reflection standards were used 
to maximize light absorption and minimize light reflectance, respectively. 
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3.2.4. Image Analysis 
Images were analysed within the Adobe Photoshop CS2 software package (Adobe 
Systems Inc., USA).  Captured image files were loaded into the software application, 
in which pixel intensity values (mean, standard deviation and median) were obtained 
for each of the RGB, red, green, blue and luminosity levels (normal range 0-220, 
where 0 = black and 220 = white) found within the histogram feature of the software 
package (Figure 4.4).  The term ‘RGB value’ refers to an amalgamation of the 
individual values for red, green and blue; this value is calculated automatically within 
Adobe Photoshop CS2. 
 
The RGB method characterizes colour by displaying numeric measures of the three 
basic colour components: ‘hue’, ‘value’, and ‘chroma’.  ‘Hue’ refers to the generally 
accepted interpretation of colour, and is measured by assessing pixel brightness in the 
three colour channels: red, green, and blue.  Channel measures were graphically 
represented in a colour diagram (see Figure 3.4).  ‘Chroma’ refers to the saturation of 
colour and this equates broadly to strength or purity of colour.  The ‘value’, also 
known as brightness, refers to the relative darkness/lightness of the sample. 
 
Faces were grouped into four separate regions: cheek, temple, forehead and nose.  The 
dorsal hand was also analysed for comparison. A 300 x 300 pixel and 100 x 100 pixel 
fixed diameter area was used for analysis in the face and hand respectively.  The 
points taken in the face for analysis remained constant.   
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Figure 3.4. Anterior-posterior image of the forehead region.  Histogram analysis of 
the RGB channel.  
 
The four points used for analysis were defined as:- 
a) ‘Cheek’: the point midway between the angle of the mouth and the root of 
the helix.   
b) ‘Temple’: the point superior to the zygomatic arch, midway between the 
hairline and the lateral canthus;  
c) ‘Forehead’: the central point midway between the glabella and the hairline; 
d) ‘Nose’: the point midway from bridge to tip along the dorsum of the nose.  
 
On the dorsal hand, the fixed diameter area was placed centrally, midway between the 
line of the metacarpophalangeal joints and the line of the radial and ulnar styloid 
processes.  Each analysis was performed on the four facial images (and one dorsal 
hand image) taken in each volunteer. 
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Figure 3.5.  Red Cross skin types (ST).  Fair; slightly tanned white; ivory-beige; 
ivory-beige; yellow; light golden brown; reddish brown; light-to-mid brown; mid-
brown; brown-black and black-black. 
 
 
Fair Slightly tanned white Yellow 
Ivory-beige Olive Light golden brown 
Reddish brown Light-to-mid-brown Mid-brown 
Brown-black Black-black 
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3.3. Results 
A total of 108 individuals were photographed (42 men, 66 women; age range 19-62, 
mean age 35.5).  Each participant was categorised into one of eleven different Red 
Cross skin types (Figure 4.5); there was a 95% independent observer correlation 
(p<0.05).  Mean RGB, blue, green and luminosity values were obtained in each image 
(anterior-posterior face, lateral face and hand) in four areas: forehead, temple, cheek 
and dorsal hand.  From this, a pattern emerged with mean RGB giving a 
representation of specific tonal variation.  The mean values of three forehead images 
(ID 1 = olive, ID5 = brown/black, ID16 = fair) are shown as an example (Figure 3.6). 
 
Figure 3.6.  Colour analysis of the RGB spectrum showing variations in individuals 
from three different Red Cross skin types: a) olive; b) brown/black; and c) fair.  Lum 
= luminosity. 
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Eleven discrete skin tone types were categorised using analysis of standardised facial 
and hand images in the 108 volunteers as defined using mean RGB values within 
Adobe Photoshop CS2. Numbers of subjects examined in each tonal group are shown 
in Table 3.2.   
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Table 3.2.   Numbers of photographic subjects examined (n=108).  
Skin tone (ST1-11) Number 
Fair (ST1)                                16 
Slightly tanned white (ST2)                                              17 
Ivory/beige (ST3)                                                              6 
Olive (ST4)                             11 
Yellow (ST5)                         7 
Light golden brown (ST6)                                                15
Light-to-mid brown (ST7)                                               8
Mid-brown (ST8)                  11 
Reddish brown (ST9)             4 
Brown/black (ST10)                                                        6 
Black/black (ST11) 7 
 
 
Mean RGB values in the four facial regions are shown in Table 3.3 and were 
categorised according to Red Cross skin tone.  Values for the hand region are shown 
in Table 3.4.  The forehead area was chosen as the most easily accessible and 
representative area for sampling, and due to the wider distribution pattern of mean 
RGB values.  A graphical representation of the mean RGB values obtained in the 
forehead view is shown in Figure 3.7.  The scale was then used to attribute skin tone 
to individuals.  Mean RGB values for each Red Cross skin tone in each region in the 
face (forehead, temple, cheek and nose) are shown in Figures 3.8-3.11.  Mean RGB 
values for the hand region are shown in Figure 3.12. 
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Table 3.3.   Red Cross skin tones (termed ST1-11) in the forehead, temple, cheek and 
nose region of the face, categorised according to RGB value.  
  
Skin tone (ST1-11) Value (mean, SE) 
 Forehead Temple  Cheek  Nose 
Fair (ST1)                               211.35 
(1.57) 
209.19 
(2.4) 
209.67 
(2.37) 
193.09 
(2.11) 
Slightly tanned white (ST2)                                              206.90
(2.00) 
203.48
(1.46) 
204.47 
(1.73) 
186.17 
(2.61) 
Ivory/beige (ST3)                                                              191.97 
(3.48) 
200.12 
(3.5) 
202.40 
(3.7) 
178.99 
(5.25) 
Olive (ST4)                             191.88 
(3.09) 
190.18 
(3.5) 
189.00 
(4.43) 
174.18 
(3.57) 
Yellow (ST5)                         171.11 
(5.50) 
175.51 
(7.39) 
180.23 
(5.96) 
168.10 
(6.92) 
Light golden brown (ST6)                                                172.31
(3.73) 
171.24
(4.02) 
170.35 
(4.5) 
162.42 
(2.99) 
Light-to-mid brown (ST7)                                               155.57
(6.58) 
158.26
(6.84) 
161.65 
(7.55) 
152.68 
(5.08) 
Mid-brown (ST8)                  139.22 
(2.80) 
137.77 
(3.65) 
142.54 
(3.83) 
129.27 
(2.65) 
Reddish brown (ST9)             124.33 
(13.27) 
133.05 
(2.03) 
134.07 
(5.03) 
119.22 
(7.84) 
Brown/black (ST10)                                                        102.56 
(5.51) 
102.66
(3.5) 
106.87 
(4.18) 
95.13 
(6.18) 
Black/black (ST11) 81.67 
(3.75) 
96.46 
(7.09) 
103.16 
(4.79) 
74.04 
(3.42) 
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Table 3.4.   Red Cross skin tones (termed ST1-11) in the hand view, categorised 
according to RGB value.  
 
Skin tone (ST1-11) RGB value (mean, SE) 
Fair (ST1)                                208.1 (3.21) 
   
Slightly tanned white (ST2)                                              202.21 (3.88)
   
Ivory/beige (ST3)                                                              188.5 (5.25)
   
Olive (ST4)                             182.7 (3.74) 
   
Yellow (ST5)                         179.05 (8.00) 
   
Light golden brown (ST6)                                                166.94 (4.64)
   
Light-to-mid brown (ST7)                                               161.69 (6.03) 
   
Mid-brown (ST8)                  143.26 (5.24) 
   
Reddish brown (ST9)             127.9 (14.8) 
   
Brown/black (ST10)                                                        118.85 (3.36)
   
Black/black (ST11) 109.73 (7.48) 
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Figure 3.7.  Mean RGB value, range and 95% confidence interval for each of the 
eleven Red Cross skin tones, in the anterior-posterior forehead view (n=108). A 
circle/star represents an outlying image with value outside range. 
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Figure 3.8.  RGB values in each of the Red Cross skin tones, for the forehead region 
(mean, range and range and 95% confidence interval; n = 108).   
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Figure 3.9.  RGB values in each of the Red Cross skin tones, for the temple region 
(mean, range and 95% confidence interval; n = 108).   
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Figure 3.10.  RGB values in each of the Red Cross skin tones, for the cheek region 
(mean, range and 95% confidence interval; n = 108).   
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Figure 3.11.  RGB values in each of the Red Cross skin tones, for the nose region 
(mean, range and 95% confidence interval; n = 108).   
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Figure 3.12.  RGB values in each of the Red Cross skin tones, for the hand region 
(mean, range and 95% confidence interval; n = 108).   
 
 
Using the data from representative forehead images we modified the order of Red 
Cross skin tones according to the assessments of mean RGB value, and compiled a 
scale of discrete skin tone groups which could be used for matching purposes as a 
quick reference chart (Figure 3.13).  Each representative tone was taken from the 
image with the least deviation from the median RGB levels identified previously. All 
images were taken from the same forehead area described previously, to reduce tonal 
variability. 
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Figure 3.13.  Colour scale of skin tones (ST) for use in matching for facial 
transplantation.  ST1 = fair (F); ST2 = slightly tanned white (STW); ST3 = ivory-
beige (IB); ST4 = olive (O); ST5 = yellow (Y); ST6 = light golden brown (LGB); ST7 
= light-to-mid brown (LMB); ST8 = mid-brown (MB); ST9 = reddish brown (RB); 
ST10 = black-brown (Bl Br); ST11 = black-black (Bl Bl). 
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3.4. Discussion 
Donor compatibility in facial transplantation has been substantially focussed on 
morphological or structural issues.  Clearly this leaves a gap in terms of skin tone 
matching, something which cannot be easily and permanently altered.  Using a series 
of standardised photographs we have thus sought to produce a bank of images with 
which we have created a graded system of assessing skin tone, with each skin tone 
assigned a number.  This will allow transplant surgeons to better delineate which skin 
tones to use when performing facial transplant matching.  
 
Accurate analysis of skin colour has been widely examined previously. Many 
different techniques of colour matching have relied on subjective means of analysis, 
such as the use of paint chips. There are a number of problems with using this in 
clinical practice (Gerald et al. 2001).  First, ambient light affect all components of 
colour.  Second, colour chips or cards are vulnerable to wear-and-tear and fading.  
Third, people vary with respect to ‘normal’ and ‘abnormal’ assessment, and various 
factors can further complicate colour assessment: these include fatigue, especially 
important in an after-hours assessment of a donor face by the treating surgeon, and the 
rather high incidence of colour blindness within the population.  Colours adjacent to 
one another can also affect colour appearance. Spectrophotometry overcomes some of 
the subjective objections to using cards, however the considerable expense and the 
fact that there is a problem when multiple spectra are in adjacent distribution, mean 
that its use in this setting is somewhat limited.  We thus sought to address these issues 
by using digital photographic corroboration of colour by means of RGB value 
analysis. 
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We chose the RGB method of image analysis due to its ease of accessibility, ease of 
use, and previous use in similar types of skin tone analyses (Gerald et al. 2001).  All 
images were calibrated in their raw file format, and analysed within Adobe Photoshop 
CS2 as TIFF files.  This was performed in order to preserve maximal image 
information.  Although the JPEG format of photographic image has been used in the 
remote digital analysis of burn depth (Roa et al. 1999), this leads to the compression 
of colour.  The greatest and most significant loss of image information occurs with 
colour more than spatial information (Neild and Davey 2001) so we sought to 
standardise this as much as possible.  The human visual system can distinguish about 
hundreds of different saturation levels, and around 20 different shades, hence we can 
distinguish hundreds of thousands of colours.  When perceiving coloured objects the 
characteristics of the illumination source also have an important influence, therefore a 
standardised photographic studio with reproducible illumination source was used. 
   
Lastly, the concept of an individual’s chronological age is important to the study of 
pigmentation and skin tone: the quantity of metabolically active melanocytes 
decreases over time and could affect whether or not the image is truly representative 
of each group.  As winter months are correlated with lower skin pigmentation rates 
(Chaplin 2004), all photographic images were taken during the winter months in order 
to reduce the potential incidence of additive facultative colour (Quevedo et al. 1975). 
 
It is important to note that for the potential facial graft donor, there is likely to be a 
loss of colour from the face following death.  Therefore any assessment of facial skin 
tone must be done as early as possible following notification to the facial transplant 
team.  In addition, the scale shows a grouping of values towards the fair end of the 
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RGB spectrum, and is thus less discriminating for distinguishing fairer skin types. 
This is easily explained by the more subtle changes in colour saturation values 
existing within these skin types.    
 
We have defined an objective scale to categorise skin tone which we hope will be 
useful in assessing objectively to which category of skin tone a potential facial or 
hand transplant recipient would be assigned to.  In creating this scale we thus hope to 
aid the assessment of the donor face, which could be occasioned remotely in the 
future. 
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Chapter 4 
 
4. Skin Tonal Matching in Facial Transplantation 
4.1. Introduction 
4.1.1. Skin Type Assessment in Facial Transplantation  
As facial transplantation becomes more commonplace, matching will become 
critically important to successful patient outcome.  Donor compatibility in facial 
transplantation has been assessed previously in the cadaveric model; Baccarani et al 
(Baccarani et al. 2007) describe the morphological matching process as comprising 
evaluation of:- 
 
 Gender 
 Skin texture  
 Features (nose, eyes, ears) 
 Size of head  
 
Many of the above factors are modifiable.  As the graft is a pliable entity, head size 
discrepancy may be modified by draping or stretching of the facial graft for a small 
donor face, or by debridement of redundant tissue for a large donor graft.  Skin 
texture differences might occur with a large age discrepancy, although such 
discrepancy may be small compared with other factors.  Gender is included in this list 
but is not likely to be of such critical importance as might be expected, ethical 
considerations notwithstanding, as the facial graft will stretch and distort considerably 
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and any hair-bearing areas are likely to adapt to the recipient’s hormonal 
environment.  Pronounced and distinctive soft tissue features however - most notably 
the nose - can cause the chimeric face to resemble the donor to an unacceptable 
degree (Baccarani et al. 2007).  In contrast, non-distinguishing soft tissue facial 
features are likely to mould to the recipients underlying facial skeleton, creating a 
hybrid chimeric face which primarily resembles the recipient.  This has been 
confirmed by cadaveric studies on identity transfer in mock facial transplantation 
(Siemionow 2006). 
 
The psychosocial sequelae associated with facial disfigurement should not be 
underestimated.  These derive somewhat from a functional inability to send symbolic 
facial messages, which when coupled with altered aesthetic appearance can lead to 
psychological morbidity such as stigmatisation, social anxiety and avoidance, poor 
self-image and self-esteem, and substance abuse (Furr et al. 2007).  Clearly 
unacceptable facial cosmesis plays a large role in the evolution of these sequelae.   
 
A total of 52 hand and 13 face transplants have been performed worldwide (Wysong 
2010).  Although these have been matched for gender, and broadly by race, no 
indication has been given as to how precisely skin type matching was achieved, and 
no-one has yet described a system for assessing skin tone (an important component of 
the process) in either donor or recipient.   
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4.1.2. Importance of Skin Tonal Matching to Facial Transplantation  
Skin colour distribution, independent of facial form and skin surface topography, 
seems to have a major influence on the perception of facial age and judgments of 
attractiveness and health (Fink et al. 2006).  This is further supported by the fact that 
skin tonal mismatches following surgery (such as skin grafting) can cause 
psychological morbidity.  We feel that robust system for aesthetic matching of skin 
tone is therefore required for any facial and hand transplantation programme for the 
following reasons: 
 
a) Composite tissue transplantation is unique.  Both the face and hand are visible 
to the naked eye, in direct contrast to solid organ transplants where aesthetic 
considerations are of no consequence. 
 
b) The donor pool for facial transplantation will be restrained by the need for 
matching for gender and/or age. By ascertaining which skin tone 
donor/recipient matches are acceptable, we can increase our potential donor 
pool. 
 
c) The outcome following facial transplantation needs to be considerably better 
than that achieved with standard plastic surgical reconstructive techniques in 
order to justify its choice as a reconstructive modality. 
 
d) The impact of a facial graft may be lessened if the transplant looks similar to 
the recipient, or has minor discrepancies (Goering 2004). 
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4.2. Methods and Materials 
4.2.1. Recipient Facial and Hand Transplant Images 
A data set highlighting the distribution pattern in each of the RGB areas for each 
image was obtained as previously discussed in Chapter 3.  A group of eleven antero-
posterior facial images and dorsal hand images was chosen to represent each Red 
Cross skin tone according to mean RGB value (see Section 3.3).  Using this data set, 
we chose two representative groups to act as recipient faces: skin tone 2 (‘slightly 
tanned white’) and skin tone 6 (‘light golden brown’).  The first group was chosen as 
it represented a common tonal group within the indigenous UK population; the second 
group represented a large minority group within the local population, which 
demonstrated contrasting RGB tonal values within the data set previously obtained.  
The two groups were chosen to provide sufficient contrast between light and dark 
recipient tones.  A representative image for each skin tone was chosen by assessing 
which image lay closest to the mean RGB value for its group.  In this way, both a 
male and female recipient face and hand were obtained for both recipient skin tones 2 
and 6; appropriate donor face and hand tones were similarly obtained for types 1 to 
11. 
 
4.2.2. Creation of Simulated Face and Hand Transplant Images 
Using the data set we obtained previously, we created a series of simulated facial and 
hand transplants, colour-matched to represent each skin tone identified.  This was 
achieved in the following way.  Areas likely to be grafted in a full facial transplant or 
a hand transplant were first delineated in the anterior-posterior facial and dorsal hand 
images respectively.  In the face, this area extended laterally anterior to the ear to 
include the whole face and chin, mirroring the likely facial graft in a whole facial 
 115 
transplant (Baccarani et al. 2007).   The distinction between normal and altered skin 
inferiorly was made at the superior neck level.  This was chosen to provide sufficient 
contrast to perform questionnaire analysis of a realistic tonal mismatch.  Part of the 
neck was included to allow inclusion of the likely site of facial vessel anastomosis 
corresponding with the site reported from previous partial face transplants 
(Devauchelle et al. 2006).  In the hand, the simulated transplant was designed at the 
mid-forearm level to coincide with the site of graft attachment in previous hand 
transplants.  
 
The face and hand transplant simulations were performed using the ‘Colour Match’ 
facility within the Adobe Photoshop CS2 programme (Adobe Systems Inc., USA).  In 
each image, the area of facial or hand transplant simulation was altered ten times in 
order to produce ten colour-matched images (giving eleven images in total, including 
the original).  This reproduced the eleven skin tones identified in the previous 
photographic part of the study, providing eleven facial and hand transplant 
simulations.  The order of hand or facial simulation images was randomised using true 
random generator techniques (www.random.org, Appendix B) and made into a 
customized flipchart booklet.  Images were shown one-by-one, in a random order 
within a customized flip-chart.  Each image occupied its own page on the flipchart, 
and each volunteer was shown the complete flipchart once to avoid repeated direct 
comparison between different shades.  The process was repeated in both 
representative skin tone groups to make a series of simulated facial transplants 
(Figures 4.1 and 4.2).  A sample of simulated hand transplant images is shown in 
Figure 4.3.      
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Each colour-matched image was compared with the original tone from which the 
colour was sampled.  There were no significant differences between mean RGB 
values of each simulated image and mean RGB values of the original donor image for 
each of the images  (p>0.05, two sided).    
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Figure 4.1.  Facial transplant simulations using a skin tone 2 (slightly tanned white) 
male recipient with overlying sampled donor skin tones.  Each image is presented in a 
randomised order (1 = brown-black skin tone overlay, 2 = olive skin tone overlay, and 
so on).   
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Figure 4.2.  Facial transplant simulations using a skin tone 6 (light golden brown) 
female recipient with overlying sampled donor skin tones.  Each image is presented in 
a randomised order (1 = slightly tanned white skin tone overlay, 2 = control image, no 
overlay, and so on).   
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Figure 4.3.  Hand transplant simulations using a skin tone 2 (slightly tanned white) 
female recipient with overlying sampled donor skin tones.  Each image is presented in 
a randomised order (1 = ivory-beige skin tone overlay, 2 = fair skin tone overlay, and 
so on).   
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4.2.3. Case Ascertainment 
A total of 122 volunteers were recruited into the study (61 males, 61 females) after 
correctly identifying their own facial skin tone type on a panel of images representing 
each of the eleven discrete skin tones previously identified (Figure 3.5).  The 
volunteer’s skin tonal type was recorded by two independent assessors.  There was a 
95% correlation between volunteer and assessor evaluation of volunteer skin tone 
(Pearson correlation, p<0.05).  Volunteers who correctly assessed their own skin tone 
were recruited into the study, in order to eliminate responses based on potentially 
aberrant perceptions of skin tone.  We chose to study observations made by two 
representative skin tone types: skin tone 2 (‘slightly tanned white,’ n=60) and skin 
tone 6 (‘light golden brown,’ n=62).  
 
4.2.4. Questionnaire Study 
For the questionnaire part of the study, volunteers were firstly asked to state which of 
the eleven facial images and eleven hand images represented the original non-altered 
image.  They were then asked to state how confident they were in their choice, 
marked on a modified Likert scale (-7.0 to 7.0), ranging from ‘not confident’ to ‘very 
confident’ respectively.  The volunteers then used the same scale to rate a series of 
randomised simulated face and hand transplant tonal mismatches in terms of: 
 
a) Acceptability 
b) Attractiveness 
c) Normality   
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The Likert scale and questionnaire used are shown in Appendix C.  For responses 
which required an estimation of whether simulations were deemed broadly 
acceptable, normal or attractive by participants, a response was termed ‘positive’ if it 
was above zero; a response was termed ‘negative’ if it was below zero.   
 
‘Acceptability’ was defined as how socially acceptable the participant would find 
each of the simulated facial or hand transplants.  ‘Normality’ was defined as how 
close to the average or normal face or hand each of the simulations appeared.  
‘Attractiveness’ was defined as the perception of the physical traits of an individual as 
being aesthetically pleasing or beautiful.  Each of these terms was clearly framed 
within the context of the participant appraising a simulated transplant of their own 
face.   
 
Gender of participant was linked with the image viewed, such that all the men viewed 
the same 11 pictures created on one male recipient image, and all the women viewed 
the same 11 pictures based on one female image.  All volunteers within the skin tone 
2 (slightly tanned white) group viewed transplant simulations created on a skin type 2 
recipient; similarly, all skin tone 6 (light golden brown) volunteers viewed 
simulations of a skin tone 6 recipient. 
 
4.3. Results 
4.3.1. Correlations between Acceptability, Attractiveness and Normality 
There were significant correlations between acceptability, attractiveness and 
normality in all skin tones (p<0.01, Pearson correlation, two-tailed).  This occurred in 
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both simulated hand transplant and facial transplant images, and in both skin tone 2 
and skin tone 6 participant groups.    
 
4.3.2. Skin Tone 2 (Slightly Tanned White) Participants 
A total of 30 males (aged 23-60, mean 34) and 30 females (aged 22-59, mean 34) 
from skin tone 2 were recruited into the questionnaire part of the study.  There was no 
gender difference in correct identification of the control face (χ2 = 1.176, df = 1, p = 
0.278) or hand (χ2 = 0.162, df = 1, p = 0.688).  When asked to make a choice over 
which simulation was the control image, there was no difference in confidence rating 
between facial (p = 0.45) or hand (p = 0.693) transplant images.  There were no 
gender differences in the percentages of correct and incorrect responses, with no 
significant difference in mean confidence ratings given by male and female 
participants assessing simulated facial transplant (t = 0.757, df = 57, p = 0.45, two-
sided) and hand transplant (t = 0.397, df = 57, p = 0.693, two-sided) control images.   
 
i. Skin Tone 2 (Slightly Tanned White) Facial Transplant Simulations 
The mean rates of acceptability for skin tone 2 (slightly tanned white) participants are 
shown in Table 4.1. There were statistically significant differences between mean 
levels of acceptability for each donor skin type simulation examined (F(10, 590) = 
238.183, MSE = 4.915, p < 0.001, one-way repeated measures ANOVA) as shown in 
Figure 4.4. 
 
There was a statistically significant interaction between gender and donor skin tone on 
acceptability (F(10, 580) = 5.362, MSE = 4.577, p < 0.001, one-way repeated 
measures ANOVA).  Post hoc application of the independent samples t-test showed 
 123 
mean acceptability ratings were significantly greater for males than females for light 
golden brown donor simulations (t = 3.894, df = 58, p < 0.001, two-sided); light-to-
mid brown simulations (t = 4.893, df = 58, p < 0.001, two-sided); and mid-brown 
simulations (t = 2.997, df = 58, p = 0.004, two-sided).  For this group of skin tone 2 
participants, more groups were deemed acceptable (and thus potentially available for 
matching) for males than for females: a total of six donor skin tones for males, 
compared with three acceptable donor skin tones for females (excluding the control 
facial transplant simulation).  Male participants stated that there were more numerous 
acceptable mismatches for facial transplant simulations than for the hand transplant 
simulations (six donor skin types compared with three donor skin tones, excluding the 
control simulation).  The percentage of participants who rated the tonal mismatches 
acceptable is shown for both facial and hand transplant simulations (Figure 4.5). 
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Table 4.1.  Mean (±SD) acceptability ratings of facial transplant simulations (skin 
tone 2 participants, n=60).  Simulations were laid onto a skin tone 2 recipient face 
(scale ranged from most acceptable (7) to most unacceptable (-7)). * = Control image;          
§ = Significant gender difference at the p < 0.05 level. 
 
Donor skin tone (ST1-11)                        Mean acceptability (±SD)                                 
Fair (ST1)                                4.810 (1.702)                                  
            Male 
      Female 
Slightly tanned white (ST2)    
            Male 
      Female 
     3.04 (1.499)   
     4.58 (1.881)   
5.398 (1.525) * 
     5.5 (1.314)   
     5.296 (1.727)   
      
      
      
      
Ivory/beige (ST3) 
            Male 
      Female                                                             
4.248 (2.151)   
     4.167 (2.236)   
4.330 (2.097)   
 
      
      
Olive (ST4) 
            Male 
      Female          
3.983 (2.210)   
     4.137 (2.038)   
     3.383 (2.095)   
      
      
Yellow (ST5) 
      Male 
      Female                         
-.276 (3.566)   
     .223 (3.484)   
     -.776 (3.635)   
 
      
      
Light golden brown (ST6)  
            Male 
      Female                                           
-1.103 (3.375) §  
     .420 (3.428)   
     -2.627 (2.572)   
      
      
Light-to-mid brown (ST7) 
            Male 
      Female                                             
 1.270 (3.512) §  
     3.157 (2.250)   
     .616 (3.575)   
 
      
      
Mid-brown (ST8) 
            Male 
      Female                                                          
-4.188 (2.234) §  
     -3.377 (2.514)   
-4.999 (1.573)   
 
      
      
Reddish brown (ST9) 
            Male 
      Female          
-5.128 (1.810)   
     -4.737 (1.947)   
     -5.520 (1.599)   
 
      
      
Brown/black (ST10) 
            Male 
      Female                                                                                                           
-5.420 (1.582)   
     -5.217 (1.742)   
-5.623 (1.405)
 
      
 
Black/black (ST11) 
            Male 
      Female                                                       
-5.765 (1.433)   
     -5.753 (1.364)   
-5.776 (1.522)   
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Figure 4.4.  Donor skin tones for a simulated facial transplant performed onto a skin 
tone 2 (slightly tanned white) recipient; 95% confidence interval error bar graphic for 
mean acceptability (acceptance) values as rated by skin tone 2 participants.  Error bars 
that do not overlap with one another indicate statistical significant differences. 
* = Control image.  
 
Donor skin tone 
* 
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Figure 4.5.  Percentage of skin tone 2 (slightly tanned white) respondents rating 
donor-recipient skin tonal matches acceptable in hand and face transplant 
simulations onto a skin tone 2 (slightly tanned white) recipient (n=60).  * Control 
image. 
 
In terms of perceptions of attractiveness, skin tone 2 (slightly tanned white) male 
participants were more likely to accept tonal mismatches than females, with a 
statistically significant interaction between gender and skin tone on attractiveness 
rating using independent sample t-test.  Attractiveness ratings were higher in males 
for light golden brown donor simulations (t = 2.161, df = 58, p = 0.035, two-sided), 
for light-to-mid brown simulations (t = 5.187, df = 58, p < 0.001, two-sided), and for 
mid-brown simulations (t = 2.348, df = 58, p = 0.022, two-sided).  
 
* 
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The interaction between donor skin tone and perceptions of normality was also 
significant, with males reporting higher rates of normality than females when viewing 
images of light golden brown simulations (t = 3.994, df = 58, p < 0.001, two-sided); 
light-to-mid brown simulations (t = 6.809, df = 58, p < 0.001, two-sided); mid-brown 
simulations (t = 3.627, df = 58, p - 0.001, two-sided); and reddish brown simulations 
(t = 2.07, df = 58, p = 0.043, two-sided).  Mean values of acceptability, attractiveness, 
normality for the facial transplant simulations are shown in Figures 4.6 to 4.11.  
 
Figure 4.6.  Mean, range and standard error of ratings of acceptability of facial 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) males.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
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Figure 4.7.  Mean, range and standard error of ratings of attractiveness of facial 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) males.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle. 
 129 
 
Figure 4.8.  Mean, range and standard error of ratings of normality of facial 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) males.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
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Figure 4.9.  Mean, range and standard error of ratings of acceptability of facial 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) females.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
 
Female Face: Acceptability 
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Figure 4.10.  Mean, range and standard error of ratings of attractiveness of facial 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) females.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
 
Female Face: Attractiveness 
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Figure 4.11.  Mean, range and standard error of ratings of normality of facial 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) females.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
 
ii. Skin Tone 2 (Slightly Tanned White) Hand Transplant Simulations 
There were statistically significant differences between the mean levels of 
acceptability between the different donor skin tone simulations (F(10, 590) = 237.96, 
MSE = 4.623, p < 0.001, one-way ANOVA).  There was a significant interaction 
between gender and donor skin tone on acceptability (F(10, 580) = 5.131, MSE = 
4.321, p < 0.001) as highlighted in Table 4.2 and Figure 4.12.   
 
Female Face: Normality 
 133 
Table 4.2.  Mean (±SD) acceptability ratings of hand transplant simulations (skin tone 
2 participants, n=60).  Participants assessed simulations laid onto a skin tone 2 
recipient hand (scale = acceptable 7, unacceptable -7). * = Control image;                    
§ = Significant gender difference at the p < 0.05 level. 
 
Donor skin tone (ST1-11)                    Mean acceptability (±SD)                                
Fair (ST1)                 4.489 (1.577)  
      Male 
      Female 
       Slightly tanned white (ST2)  
      Male 
      Female 
     4.190 (1.525) 
     4.788 (1.596) 
.863 (1.225) * 
     5.903 (1.178) 
     5.822 (1.289) 
      
      
      
      
Ivory/beige (ST3) 
            Male 
      Female                                                             
4.644 (1.612) 
     4.260 (1.703) 
     5.028 (1.439) 
 
      
      
Olive (ST4)  
            Male 
      Female          
-2.026 (3.475) § 
     -.990 (3.395) 
     -3.063 (3.289) 
      
      
Yellow (ST5)  
      Male 
      Female                         
-2.476 (3.058) § 
     -1.297 (2.977) 
     -3.655 (2.7) 
      
      
Light golden brown (ST6)  
            Male 
      Female                                           
-2.975 (2.799) 
     -2.643 (2.554) 
     -3.307 (3.030) 
      
     
Light-to-mid brown (ST7)  
            Male 
      Female                                            
 -.319 (3.692) § 
     .997 (3.581) 
     -1.635 (3.364) 
           
Mid-brown (ST8) 
            Male 
      Female                                                          
-4.947 (2.149) 
     -4.917 (2.037) 
     -4.977 (2.291) 
      
      
Reddish brown (ST9) 
            Male 
      Female          
-5.271 (2.251) 
     -5.480 (1.818) 
     -5.063 (2.629) 
      
     
Brown/black (ST10) 
            Male 
      Female                                                                                                           
-4.723 (2.549) 
     -4.420 (2.903) 
     -5.025 (2.145) 
      
     
Black/black (ST11) 
            Male 
      Female                                                       
-5.409 (2.024) 
     -5.457 (1.794) 
     -5.361 (2.261) 
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Figure 4.12.  Donor skin tones for simulated hand transplants performed onto 
a skin tone 2 (slightly tanned white) recipient; 95% confidence interval error 
bar graphic for mean acceptability (acceptance) values.  Error bars that do not 
overlap with one another indicate statistical significant differences.  
* = Control image. 
 
Independent samples t-test mean acceptability ratings for the hand simulations were 
significantly higher in males than females in three donor groups: olive (t = 2.402, df = 
58, p = 0.020, two-sided), yellow (t = 3.214, df = 58, p = 0.002, two-sided), and light-
to-mid brown (t = 2.934, df = 58, p = 0.005, two-sided).   Mean attractiveness ratings 
were significantly higher for male participants looking at simulations of the following 
donor skin tones: olive (t = 2.284, df = 58, p = 0.026, two-sided), yellow (t = 3.156, df 
= 58, p = 0.003, two-sided), and light-to-mid-brown (t = 3.962, df = 58, p < 0.001, 
Donor skin tone 
* 
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two-sided).  There was a significant interaction between gender and donor skin tone 
when looking at perceptions of normality in the hand transplant simulations (F(10, 
570) = 6.235, MSE = 3.360, p < 0.001), with significantly increased ratings of 
normality reported by male participants when assessing the following donor skin tone 
simulations: olive (t = 2.460, df = 58, p = 0.017, two-sided), yellow (t = 3.294, df = 
58, p = 0.002, two-sided), and light-to-mid brown (t = 3.669, df = 58, p = 0.001, two-
sided).  Acceptability, attractiveness and normality for the hand transplant simulations 
is shown graphically in Figures 4.13 to 4.15. 
 
Figure 4.13.  Mean, range and standard error of ratings of acceptability of hand 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) males.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
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Figure 4.14.  Mean, range and standard error of ratings of attractiveness in males 
of skin tone 2 (slightly tanned white) when assessing hand transplant simulations.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
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Figure 4.15.  Mean, range and standard error of ratings of normality of hand 
transplant simulations, as assessed by skin tone 2 (slightly tanned white) males.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
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4.3.3. Skin Tone 6 (Light Golden Brown) Participants 
A total of 31 males (age 21-61, mean 28.3) and 31 females (age 21-60, mean 33.6) 
from skin tone 6 (light golden brown) were entered into the study.  The majority of 
participants (females: face 25/31, hand 23/31; males: face 28/31, hand 26/31) could 
correctly identify the control image, with no gender difference in correct identification 
of the control face (χ2 = 1.17, df = 1, p = 0.79) or hand (χ2 = 0.876, df = 1, p = 0.349).  
For the male group, there was no significant difference between the mean confidence 
rating for identification of the control images (face 3.61, hand 3.752; p = 0.45), 
although for females there was a discrepancy (face 2.697, hand 2.213; p = 0.02).  
There was no significant difference in mean confidence ratings given by male and 
female participants assessing the simulated facial transplant control images (t = 1.541, 
df = 60, p = 0.129, two-sided).  However, there were higher mean confidence ratings 
for males than females (t = 2.755, df = 60, p = 0.008, two-sided) in the hand transplant 
group. 
 
iii. Skin Tone 6 (Light Golden Brown) Facial Transplant Simulations 
There were statistically significant differences between mean levels of acceptance for 
each donor skin type simulation examined (F(10, 600) = 125.886, MSE = 6.307,         
p < 0.001, one-way repeated measures ANOVA).  There was a statistically significant 
interaction between gender and donor skin tone on acceptability (F(10, 590) = 11.192, 
MSE = 5.391, p < 0.001, one-way repeated measures ANOVA) as shown in Table 4.3.  
Post hoc application of the independent samples t-test showed significantly greater 
acceptability ratings for male than female participants when viewing the following 
simulations: yellow (t = 5.447, df = 60, p < 0.001, two-sided); reddish brown (t = 
5.407, df = 60, p < 0.001, two-sided); and mid-brown (t = 4.517, df = 60, p < 0.001, 
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two-sided).  Interestingly however, females expressed significantly higher 
acceptability ratings than males when viewing slightly tanned white donor simulations 
(t = -2.099, df = 60, p = 0.04, two-sided). 
 
Mean attractiveness ratings were significantly higher for male participants looking at 
facial transplant simulations using the following donor skin tones: yellow (t = 4.153, 
df = 60, p < 0.001, two-sided); reddish brown (t = 4.02, df = 60, p < 0.001, two-sided); 
and mid-brown (t = 3.872, df = 60, p < 0.001, two-sided).  Interestingly males 
expressed higher attractiveness ratings than females when assessing the control light 
golden brown images (t = 3.67, df = 60, p = 0.001, two-sided).  Females on the other 
hand expressed higher attractiveness ratings than males when looking at simulations 
using the fair donor skin tone (t = -2.136, df = 60, p = 0.037, two-sided). 
 
There were significantly increased ratings of normality reported by male than female 
participants when rating the following donor skin tone simulations: yellow (t = 4.871, 
df = 60, p < 0.001, two-sided); mid brown (t = 3.482, df = 60, p = 0.001, two-sided); 
and reddish brown (t = 6.688, df = 60, p < 0.001, two-sided).  Again, males rated the 
control light golden brown images more ‘normal’ than did females within the same 
skin tone group (t = 2.689, df = 58, p = 0.009, two-sided). 
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Table 4.3.  Mean acceptability ratings of facial transplant simulations (skin tone 6 
participants, n=62).  Participants assessed simulations laid onto a skin tone 6 recipient 
face (scale = most acceptable 7, most unacceptable -7). * = Control image;                  
§ = Significant gender difference at the p < 0.05 level. 
 
Donor skin tone (ST1-11)                        Mean acceptability (SD)                                 
Fair (ST1)                 -4.318 (1.769)  
      Male 
      Female 
       Slightly tanned white (ST2)  
      Male 
      Female 
     -4.710 (1.469) 
     -3.926 (1.972) 
-3.260 (2.853) § 
     -4.000 (2.010) 
     -2.519 (3.368) 
      
      
 
     
Ivory/beige (ST3) 
            Male 
      Female                                                             
.885 (3.539) 
     .268 (3.413) 
1.503 (3.609) 
 
      
      
Olive (ST4)  
            Male 
      Female          
-1.261 (3.598)  
     -1.497 (3.465) 
     -1.026 (3.768) 
  
      
Yellow (ST5)  
      Male 
      Female                         
1.194 (3.737) § 
     3.326 (2.719) 
     -.939 (3.407) 
      
      
Light golden brown (ST6)  
            Male 
      Female                                           
5.237 (1.879) * 
     5.884 (1.315) 
     4.590 (2.127) 
      
     
Light-to-mid brown (ST7)  
            Male 
      Female                                             
 3.361 (2.487)  
     3.560 (2.414) 
     3.168 (2.581) 
           
Mid-brown (ST8) 
            Male 
      Female                                                          
2.632 (3.131) § 
     4.197 (1.315) 
1.068 (3.446) 
      
      
Reddish brown (ST9) 
            Male 
      Female          
-2.681 (2.778) § 
     -1.103 (2.797) 
     -4.258 (1.652) 
      
     
Brown/black (ST10) 
            Male 
      Female                                                                                                           
-4.737 (1.683) 
     -4.716 (1.887) 
-4.758 (1.482)
      
     
Black/black (ST11) 
            Male 
      Female                                                       
-5.169 (1.570) 
     -5.290 (1.467) 
 -5.048 (1.683) 
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iv. Skin Tone 6 (Light Golden Brown) Hand Transplant Simulations 
Application of the independent samples t-test showed significantly greater 
acceptability ratings for males than females when viewing yellow (t = 11.206, df = 60, 
p < 0.001, two-sided) and olive (t = 5.59, df = 60, p < 0.001, two-sided) donor 
simulations.  However, females expressed significantly higher acceptability ratings 
than males when viewing slightly tanned white (t = -2.829, df = 60, p = 0.006, two-
sided) and light-to-mid-brown (t = -11.669, df = 60, p < 0.001, two-sided) donor 
simulations (Table 4.4). 
 
Mean attractiveness ratings were significantly higher for male participants assessing 
olive (t = 5.716, df = 60, p < 0.001, two-sided) and yellow (t = 11.75, df = 60, p < 
0.001, two-sided) hand transplant simulations.  Of note however, female ratings of 
attractiveness were much higher in the following donor skin tone simulations:  light-
to-mid-brown (t = -17.965, df = 60, p < 0.001, two-sided); ivory-beige (t = -3.036, df 
= 60, p = 0.004, two-sided); slightly tanned white (t = -4.225, df = 60, p < 0.001, two-
sided); fair (t = -2.97, df = 60, p = 0.004, two-sided); and interestingly reddish brown 
(t = -2.588, df = 60, p = 0.012, two-sided).   
 
There were significantly increased ratings of normality reported by male participants 
when assessing olive (t = 5.67, df = 60, p < 0.001, two-sided) and yellow (t = 11.881, 
df = 60, p < 0.001, two-sided) donor skin tone simulations.  However, interestingly 
females expressed significantly higher ratings for normality in the light-to-mid brown 
simulations (t = -23.752, df = 60, p = 0.001, two-sided), along with lesser but still 
significantly higher ratings in the ivory-beige (t = -2.684, df = 60, p = 0.009, two-
sided) and slightly tanned white (t = -3.583, df = 60, p = 0.001) donor group. 
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Table 4.4.  Mean acceptability ratings of hand transplant simulations (skin tone 6 
participants, n=62).  Participants assessed simulations laid onto a skin tone 6 recipient 
hand (scale = most acceptable 7, most unacceptable -7). * = Control image;                 
§ = Significant gender difference at the p < 0.05 level. 
 
Donor skin tone (ST1-11)                       Mean acceptability (SD)                                 
Fair (ST1)                 -4.229 (2.102)  
      Male 
      Female 
       Slightly tanned white (ST2)  
      Male 
      Female 
     -4.681 (1.624) 
     -3.777 (2.434) 
-2.261 (3.233) § 
     -3.361 (2.54) 
     -1.161 (3.507) 
      
      
      
 
Ivory/beige (ST3) 
            Male 
      Female                                                             
-2.477 (3.233) 
     -3.1 (2.876) 
-1.855 (3.406) 
 
 
      
Olive (ST4)  
            Male 
      Female          
1.303 (4.139) § 
     3.697 (3.164) 
     -1.09 (3.603) 
      
      
Yellow (ST5)  
      Male 
      Female                         
1.208 (4.501) § 
     4.881 (1.546) 
     -2.465 (3.306) 
      
      
Light golden brown (ST6)  
            Male 
      Female                                           
5.294 (1.563) * 
     5.552 (1.516) 
     5.035 (1.591) 
      
     
Light-to-mid brown (ST7)  
            Male 
      Female                                             
1.273 (4.670) § 
     -2.587 (3.337) 
     5.132 (1.559) 
           
Mid-brown (ST8) 
            Male 
      Female                                                          
-4.439 (1.648) 
     -4.426 (1.75) 
-4.45 (1.568) 
      
      
Reddish brown (ST9) 
            Male 
      Female          
-4.590 (2.220) 
     -5.113 (1.523) 
     -4.068 (2.671) 
      
     
Brown/black (ST10) 
            Male 
      Female                                                                                                           
-4.652 (1.638) 
     -4.648 (1.392) 
-4.655 (1.876)
      
     
Black/black (ST11) 
            Male 
      Female                                                       
-5.042 (1.583) 
     -5.3 (1.33) 
-4.784 (1.785) 
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Figure 4.16.  Percentage of skin tone 6 (light golden brown) respondents rating 
donor-recipient skin tonal matches acceptable in hand and face transplant 
simulations onto a skin tone 6 (light golden brown)  recipient.  * Control image. 
* 
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Figure 4.17.  Mean, range and standard error of ratings of acceptability of facial 
transplant simulations, as assessed by skin tone 6 (light golden brown) females.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
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Figure 4.18.  Mean, range and standard error of ratings of attractiveness of facial 
transplant simulations, as assessed by skin tone 6 (light golden brown) females.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
 
 146 
 
Figure 4.19.  Mean, range and standard error of ratings of normality of facial 
transplant simulations, as assessed by skin tone 6 (light golden brown) females.  
Simulated donor skin tone is listed on the left.  The control image is highlighted in 
blue; values which lie outside the range are highlighted with a circle or star. 
 
For the skin tone 6 respondents, there were more acceptable groups available for 
males than for females (males, four groups; females, three groups).  In the skin tone 2 
group, more acceptable groups were available for males than for females (males, six 
groups; females, three groups).  There was generally more scope in variability of tonal 
matching in skin tone 2 than skin tone 6 individuals (Table 4.5).  Skin tonal 
mismatches were often more tolerated in facial than in hand transplant simulations, as 
highlighted in Figures 4.20-4.23. 
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Figure 4.20.  More facial transplant skin tonal mismatches are tolerated than hand 
transplant tonal mismatches.  Graph shows acceptability ratings for face transplant 
simulations in skin tone 2 (slightly tanned white) participants: five groups in total 
are deemed broadly acceptable.  Donor skin tones are listed on the left.  Error bars 
show mean and 95% confidence interval.  * Control image. 
 
* 
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Figure 4.21.  More facial transplant skin tonal mismatches are tolerated than hand 
transplant tonal mismatches.  Graph shows acceptability ratings for hand transplant 
simulations in skin tone 2 (slightly tanned white) participants: three groups are 
deemed broadly acceptable.  Donor skin tones are listed on the left.  Error bars 
show mean and 95% confidence interval.  * Control image. 
 
* 
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Figure 4.22.   More facial transplant skin tonal mismatches are tolerated than hand 
transplant tonal mismatches.  Graph shows acceptability ratings for facial 
transplant simulations in skin tone 6 (light golden brown) participants: five groups 
are deemed broadly acceptable.  Donor skin tones are listed on the left.  Error bars 
show mean and 95% confidence interval.  * Control image. 
 
* 
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Figure 4.23.   More facial transplant skin tonal mismatches are tolerated than hand 
transplant tonal mismatches.  Graph shows acceptability ratings for hand transplant 
simulations in skin tone 6 (light golden brown) participants: four groups are 
deemed broadly acceptable.  Donor skin tones are listed on the left.  Error bars 
show mean and 95% confidence interval.  * Control image. 
 
 
 
 
 
 
 
* 
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Table 4.5.  Acceptability of facial and hand transplant simulations for participants of 
slightly tanned white (ST2) and light golden brown (ST6) skin tone.  Both viewer and 
simulated transplant recipient share the same skin tone. * Control image. 
 
 Sample no. (%) reporting acceptable donor-
recipient match 
Donor skin tone (ST1-11) Recipient skin tone (ST1-11) 
Face   
Slightly tanned white 
(ST2) 
Light golden brown 
(ST6) 
Fair (ST1)                                58 (96.7) 2 (3.2) 
Slightly tanned white (ST2)                                              59 (98.3)* 7 (11.3) 
Ivory/beige (ST3)                                                              57 (95) 35 (56.5) 
Olive (ST4)                             56 (93.3) 23 (37.1) 
Yellow (ST5)                         29 (48.3) 22 (64.5) 
Light golden brown (ST6)                                                22 (36.7) 60 (96.8)* 
Light-to-mid brown (ST7)                                               39 (65) 54 (85.2) 
Mid-brown (ST8)                  3 (5) 49 (79) 
Reddish brown (ST9)             2 (3.3) 11 (17.7) 
Brown/black (ST10)                                                        1 (1.7) 1 (1.6) 
Black/black (ST11) 0 (0) 1 (1.6) 
Hand                            
  
Fair (ST1)                                60 (100) 4 (6.5) 
Slightly tanned white (ST2)                                              60 (100)* 14 (22.6) 
Ivory/beige (ST3)                                                              59 (98.3) 14 (22.6) 
Olive (ST4)                             14 (23.3) 40 (64.5) 
Yellow (ST5)                         12 (20) 36 (58.1) 
Light golden brown (ST6)                                                10 (16.7) 62 (100)* 
Light-to-mid brown (ST7)                                               28 (46.7) 37 (59.7) 
Mid-brown (ST8)                  3 (5) 0 (0) 
Reddish brown (ST9)             3 (5) 2 (3.2) 
Brown/black (ST10)                                                        3 (5) 0 (0) 
Black/black (ST11) 3 (5) 0 (0) 
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4.4. Discussion  
A number of the findings in this study have practical implications for the facial 
transplant matching team.  First, skin tonal mismatching was tolerated more in the 
face than in the hand simulated transplants.  This could be for a number of reasons.  
Perhaps individuals feel that they can see their hand themselves, whereas their face is 
less immediately visible.  Results from the facial transplant cohort performed so far 
would seem to support this, with adaptation seemingly easier to affect in facial graft 
recipients than in hand transplant recipients (Wysong 2010).  Perhaps the quite 
marked skin tonal difference at the level of the anastomosis in a hand transplant may 
cause the patient to consider the mismatch more prominent, whilst at the level of the 
facial anastomosis, there is a natural line where the face meets the neck.  It is not 
unusual for the neck to exhibit different skin tonal characteristics than the face, 
because of altered ultraviolet light exposure and different structural skin composition.  
This difference may therefore simply occur because of the site of the anastomosis.  
This may have clinical repercussions were for example the facial reconstructive 
surgeon to decide to transplant part of a face, with the line passing through a natural 
sub-unit.  It would be interesting to know if these results would be reproduced in such 
a case.   
 
Second, there were significant interactions between gender and skin tone on 
acceptability (p<0.001), with males reporting higher mean acceptability ratings than 
females.  More groups were available for matching in males than in females.  In skin 
tone 6 participants, significantly higher acceptability ratings for simulations using 
skin tone 2 (slightly tanned white) donor were found in females than in males.  We 
therefore suggest that accuracy of skin tonal matching may be even more important in 
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female transplant candidates.  This is supported by work in port wine stain patients, 
which suggested that females are far more likely than men to use camouflage make-
up (Lanigan and Cotterill 1989).  Considerably more females than males are 
dissatisfied with some aspect of their appearance in large scale studies, although 
appearance is also increasingly important in men (Harris and Carr 2001).    
 
Females exhibit generally lighter pigmentation than males (Jablonski and Chaplin 
2000).  Some authors have observed that the attraction of human infants and human 
females is partly due to their lighter pigmentation, that lighter-coloured adult females 
are perceived as more feminine than are darker females, and therefore are preferred as 
partners (Frost 1988).  Clearly however there exists considerable cultural variability.  
The skin contains information not just on ethnic origin but also gives an indication of 
whether a person has been exposed to the sun for a long time, which in some cultures 
can reflect socio-economic status.  The colour of skin has always been a subject of 
controversy, and still causes discrimination and unfair treatment of (mainly) non-
white people, but also of any person whose skin tone is viewed as being markedly 
different: such as white albinos in Africa where albinism has for centuries been 
viewed as a stigma (Cruz-Inigo et al. 2011). 
 
In this study there was support for the notion that perceptions differ among 
individuals of differing skin tone.  There was more scope available for variability of 
tonal matching in skin tone 2 (slightly tanned white) than in skin tone 6 (light golden 
brown) participants.  We suggest that this could have occurred for a number of 
diverse socio-cultural reasons.  In the 1960s and 1970s tanning amongst fair 
individuals was thought of positively in the West, suggesting radiant health, well-
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being or wealth – the external sign of being able to afford to travel to sunny 
destinations.  This has encouraged the development of a sun-tanning industry (Randle 
1997).  Although the 1990s brought the advent of pale-looking models into the 
cultural milieu, such perceptions do still remain.  In contrast, in certain Asian societies 
- in whose origins sat the majority of the observers assessing the ‘light golden brown’ 
simulated facial transplant group - a lighter skin is often thought to indicate a higher 
social status and sun avoidance is actively pursued.  Indeed, in some countries skin 
bleaching agents containing hydroquinone or steroid preparations are readily available 
to apply to the skin (Taylor 2002).   
 
All volunteers viewed images of their own gender and skin tone.  This was done for 
two reasons.  First, we wished to eliminate perceptions of attractiveness within the 
opposite sex, which may have biased some of the questionnaire responses. Second, as 
the primary beneficiary of a composite tissue allotransplant is the recipient, it is the 
recipient’s perception of his own appearance which is of paramount importance.  
Clearly onlookers’ perceptions are significant as well, and the facially disfigured do 
report experiencing considerable morbidity as a direct consequence.  However, it is 
satisfaction with oneself which ultimately will dictate psychological recovery 
following surgery to correct facial disfigurement.  Participants thus viewed images of 
their own skin type and gender to assess self perception, specifically because facial 
transplantation is not primarily proposed to address external ‘societal’ perceptions.  
The concepts of proximity to the ‘norm’ or ‘average’, coupled with one’s perceived 
physical attractiveness and social acceptability were all chosen as important indicators 
of satisfaction in one’s own body image.  Subjective self-assessment of skin tone per 
se clearly differs somewhat among individuals however.  In one study of Caucasians, 
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36.4% overestimated their own skin pigmentation level, with 16.4% underestimating 
it (Harrison and Buttner 1999).   We therefore decided to have only those participants 
correctly identifying their own skin tone participating in the study.  
 
Two recipient skin tones (‘slightly tanned white’ and light golden brown’) were 
chosen.  This was done in order to provide two of the most likely facial transplant 
recipient groups which a facial transplant team working in the UK might be expected 
to encounter (UK Census 2001).  All the recipient and donor groups were age-
matched in order to prevent the introduction of age-related bias into the observers’ 
ratings.     
 
We chose to use RAW and TIFF files because analysis of other photographic formats 
such as JPEG formats can lead to compression of colour.  This is particularly 
prominent in burn scars for example where large colour gradients exist.  We felt that 
similar gradients existed in the simulated facial transplant images.  The choice of 
digital photographic imagery was done in order to affect as close to a real transplant 
simulation as possible.  Clearly a real facial transplant recipient may have potentially 
unusual facial bony architecture compared with the donor, and likely prominent 
scarring, all of which might act to detract from a skin tonal mismatch.  Participants 
looking at real facial transplant recipients may accept tonal mismatch if this is 
accompanied by an overall improvement in appearance and facial morphology.  
Nevertheless this study is important because it highlights a theoretical basis for the 
matching of potential facial and hand transplant skin tone in commonly encountered 
skin types found in the UK. 
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Chapter 5 
 
5. Analysis of Attitudes towards Facial Transplantation 
 
5A. The Transplant Professional’s Perspective 
5.1. Introduction 
Facial reconstruction presents a serious challenge, with current treatment options 
limited in terms of satisfactory function and cosmesis.  Facial transplantation is now 
emerging as a realistic option for the reconstruction of severe facial disfigurement 
(Clarke and Butler 2005), with a number of facial transplants now performed 
worldwide (Devauchelle et al. 2006).  As with any new procedure, the identification 
of potential surgical and psychological risk is an important part of the development 
process and the ethical aspects of this radical reconstructive approach have stimulated 
a polarised debate (Butler et al. 2004; Rumsey 2004; Wiggins et al. 2004).   
 
With human facial transplantation no longer an unknown, many of the risks about 
facial transplantation can be now be quantified, although the longer term outcomes 
will clearly be important in positioning this procedure as part of the reconstructive 
options for severe facial injury (Butler et al. 2005).  The UK facial transplantation 
team have taken a pragmatic approach to the ethical aspects of facial transplantation, 
designing a systematic research strategy which encompasses the areas identified as 
priorities in the Royal College of Surgeons’ Working Party Report (Morris et al. 
2004).  We have expanded this framework to include issues identified by the general 
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public, relevant health professional groups such as transplant coordinators and 
potential donor families.  
 
Engagement with the general population has produced important information about 
public attitudes and beliefs towards the procedure.  Notions exist of how acceptable 
the donation of facial material might be.  This has allowed us to challenge the 
suggestion that no-one would be prepared to donate the face of a loved one (Clarke et 
al. 2006).  The general public also worry about the potential for identity transfer 
(Clarke et al. 2006).  Even in its simplest form (i.e. the use of soft tissue resurfacing) 
the use of a cadaveric face may result not only in an alteration in the recipient’s 
appearance, but in the acquisition of some superficial facial characteristics of the 
donor (e.g. eyebrows).  This question has been addressed by authors modelling likely 
identity transfer, using laser scanned images and exchange of their own faces (Clarke 
and Butler 2005).  These studies suggested the creation of a new or third face, rather 
than the transfer of recognisable features.  
 
The need for lifelong immunosuppression has also been highlighted as a barrier to 
facial transplantation (Morris et al. 2004).  Immunosuppressive risks include the 
predisposition to infection and cancer.  However, suggestion that skin might be more 
allogenic than other tissues has not been supported in the cohort of patients 
undergoing successful hand and abdominal wall transplantations (Brenner et al. 2002; 
Renshaw et al. 2006).  Thus the level of immunosuppressive risk for facial 
transplantation patients is no greater than that accepted by patients undergoing renal 
transplantation, which is undertaken for similar gains in quality of life.  Butler et al 
(Butler et al. 2005) have suggested that it is increasingly difficult to justify one 
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procedure and not another where the risks are essentially the same.   Furthermore, 
Brill and colleagues have suggested that most risks are both predictable and 
manageable and that this includes psychological risks (Brill et al. 2006). 
 
Potential patient groups, potential donor families and relevant health professionals 
have also been sampled using both qualitative and quantitative methodologies.  The 
latter two groups are of interest due to their focus on the donor family.  This may lead 
to a different set of attitudes and concerns compared with those relating to the 
recipient.  Transplant coordinators and related health professions have unique 
experience of the practical procedures of transplantation and donor issues.  They will 
be involved in recruitment of facial donors if the procedure becomes a clinical reality.   
We therefore undertook a review of UK health professionals’ attitudes and beliefs 
about facial transplantation.  This group was sampled to provide information about 
the practical issues concerned with organ retrieval, their concerns for donor families 
and the perceived impact on the transplant programme as a whole. 
 
5.2. Methods and Materials 
5.2.1. Design 
A mixed qualitative and quantitative study design was used.  A focus group was used 
to identify the issues highlighted by transplant coordinators.  The main themes were 
then developed into a questionnaire which was administered to a study group 
attending training days (Appendix D).  The study complied with all the ethical 
requirements for research within a National Health Service institution, and was 
granted ethical approval by the local research ethics committee. 
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5.2.2. Sample 
The focus group comprised five transplant coordinators who were current members of 
the North Thames Regional Donor Transplant Coordinators Team.  The focus group 
was surveyed before the reporting of the first partial facial transplantation in France, 
although all members of the group had read about the procedure as a hypothetical 
development in professional journals. 
 
The groups sampled by questionnaire comprised 170 health professionals attending 
separate study days, in Oxford, Cambridge and Bristol in late 2005 – before the first 
partial facial transplantation but after the procedure had been discussed hypothetically 
in professional journals. 
 
Nurses (including theatre staff) comprised eighty percent of the sample; 18% were 
transplant co-coordinators.  Fifteen percent had been in post for up to one year, 42% 
between one and three years, and 43% three years or more.  The groups were sampled 
after a lecture delivered by the consultant surgeon leading the UK facial transplant 
programme. 
  
5.2.3. Procedure 
Each focus group was told that we were interested in their attitudes to facial 
transplantation, and that we were keen to elucidate any problems they anticipated with 
respect to their own work.  The following one-hour discussion was recorded verbatim. 
The resulting transcript was assessed and all issues grouped under three main themes: 
those related to organ retrieval, those affecting the transplant team, and those 
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impacting on the donor family.  A questionnaire was generated to elicit the attitudes 
of the larger group to these items. 
 
The questionnaire study was completed after an educational session which included 
video, written and pictorial information about the reconstructive challenges of facial 
injury including case examples, and technical explanation of the surgical procedures 
involved in free tissue transfer.  Examples were given of ‘exchanged’ faces between 
two of the research team members, generated by computer modelling from 
photographic and laser scanned images (Figure 5.1) (Clarke and Butler 2005).  
 
 
 
Figure 5.1.  Morphing of face B donor onto face A recipient (left); morphing of face 
A donor onto face B recipient (right). Courtesy of Mr David Bishop, Medical 
Illustration Department, Royal Free Hospital, London. 
 161 
 
Barriers to facial transplantation were also presented to provide a balanced 
presentation.  These included the problems of early graft rejection and the problems of 
immunosuppression, illustrated by the first hand transplantation in which failure to 
comply with medication contributed to graft rejection.  Suggested figures of acute and 
chronic rejection as outlined in the Royal College of Surgeons report were made 
explicit.  The aim of the exercise was to present the current issues in face 
transplantation - including both the advantages and disadvantages of the procedure - 
in an accessible format.  Participants were then asked for consent to complete an 
anonymised questionnaire.  A subset of participants (n=81, those attending the second 
set of two study days) were asked to rank the importance of the issues identified by 
the focus group. 
 
5.3. Results 
5.3.1. Quantitative Data 
A total of 170 people completed the questionnaire; of these participants, 129 (76%) 
were in favour of facial transplantation now and 39 (23%) felt that further research 
was needed before the procedure took place.  No participant was against facial 
transplantation in principle.  There was no impact of role or length of time in post on 
this decision.  
  
Sixty-three respondents (36%) reported knowing someone with a facial disfigurement.    
There was a statistically significant association between being in favour of face 
transplantation and knowing someone with a facial disfigurement or dysfunction 
(χ22=8.28, p=0.016).  
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The Friedman test was conducted for each grouping of items to identify whether the 
issues had been systematically ranked rather than randomly ordered.  Post-hoc pair 
wise comparisons using the Friedman test and Sign test were used to identify 
homogeneous subsets of ranked items.  Table 5.1 shows the rank order assigned by 
the questionnaire respondents to the organ retrieval issues (most important issue 
ranked first and least important ranked last).  
 
Those items ranking highest related to impact on the donor family, in particular 
appearance after retrieval, whereas factors impacting on the organization as a whole 
were ranked lower.  Application of the Friedman test for the issues in Table 5.1 shows 
that there is consistency in rank ordering over a random assignment (Friedman 
χ
2
6=95.7, p<0.001).  A post-hoc analysis of the ranks using a pair-wise application of 
the Sign test indicates that the top 2 items in Table 5.1 (appearance after retrieval and 
development of donor criteria) form a homogeneous subset (p=0.541), as do 
development of facial prosthesis and liaison with other retrieval teams (p=0.0151).   
The final three items (increasing overall time of organ retrieval, amount of tissue 
retrieved, and delay to operating room time in host hospital) also form a homogeneous 
subset (p=0.410).  
 
Table 5.2 summarizes the percentage of respondents classifying appearance after 
retrieval to be more important than the other comparator issues and additionally gives 
the percentage of times that appearance after retrieval was judged to be equally 
important.  Table 5.3 summarizes the percentage of respondents classifying 
development of donor criteria to be more important than the other comparator 
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retrieval issues.  The data in Tables 5.2 and 5.3 demonstrate that the top 2 ranked 
items are consistently identified as most important by the majority of the 
questionnaire respondents.  
 
Table 5.1.  Rank order of organ retrieval issues. 
Organ retrieval issues Mean ranking 
Appearance after retrieval 2.62 
Development of donor criteria 2.98 
Development of facial prosthesis 3.81 
Liaison with other retrieval teams 4.18 
Increasing overall time of organ retrieval 4.68 
Amount of tissue retrieved 4.77 
Delay to theatre time in host hospital 4.97 
 
 
Table 5.2.  Percentage of respondents ranking appearance after retrieval to be more 
important. 
Organ retrieval issue % more important % of tied rankings 
Development of donor criteria 44 17 
Development of facial prosthesis 57 33 
Liaison with retrieval teams 64 17 
Increasing overall time of organ retrieval 75 7 
Amount of tissue retrieved 72 14 
Delay to theatre time in host hospital 77 9 
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Table 5.3.  Percentage of respondents ranking development of donor criteria to be 
more important. 
Organ retrieval issues % more important % of tied rankings 
Appearance after retrieval 39 17 
Development of facial prosthesis 51 19 
Liaison with retrieval teams 71 25 
Increasing overall time of organ retrieval 65 14 
Amount of tissue retrieved 70 14 
Delay to theatre time in host hospital 73 7 
 
Table 5.4 illustrates the rank order assigned by questionnaire respondents (n=81) to 
the issues affecting the retrieval team.  The items ranked of highest importance were 
those specifically relating to education, team building, and development of links 
between teams.  Negative impact on other transplant programs was ranked lower than 
team support issues.  
 
Application of the Friedman test for the issues in Table 5.2 shows that there is 
consistency in rank ordering over a random assignment (Friedman χ26=109.5, 
p<0.001).  A significantly higher percentage of respondents (50%) regarded educating 
professionals about facial transplantation to be more important than development of a 
specific retrieval team (Sign test, z=2.85, p=0.004, two-sided), with 29% giving tied 
rankings to these 2 items.  Likewise, a significantly higher proportion of respondents 
(49%) regarded development of specific retrieval team to be of greater importance 
than development of working links between coordinators and the main facial 
transplant team (Sign test, z=2.08, p=0.037, two-sided) with 24% of the respondents 
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giving a tied ranking.  Fifty-one percent of respondents ranked development of 
working links between coordinators and the main facial transplant team to be more 
important than impact of facial transplantation on operating room and intensive care 
unit (ICU) staff (Sign test, z=2.02, p=0.044, two-sided), with 19% of respondents 
giving tied rank values.  Application of the Friedman test indicates that there is some 
evidence that impact of facial transplantation on operating room and ICU staff, 
debrief and support for health professionals, and negative impact on other 
transplantation programs form a relatively homogeneous group (Friedman χ22=5.55, 
p=0.062), as do negative impact on other transplant programs and press intrusion 
(z=1.47, p=0.143, two-sided).  However, a significantly higher percentage of 
respondents (73%) rated impact of facial transplantation on operating room and ICU 
staff to be more important than press intrusion (Sign test, z=5.46, p<0.001, two-
sided), with 13% giving equal ties.  Likewise, a significantly higher percentage of 
respondents (73%) rated debrief and support for health professionals to be more 
important than press intrusion (Sign test, z=5.54, p<0.001, two-sided), with 12% 
giving equal rank importance.  Table 5.5 shows the rank order assigned by 
questionnaire respondents (n=81) to the donor family issues identified by the focus 
group.  
 
Responses indicate concern for support in the long term.  However, responses are less 
dispersed than on the previous scales with many respondents assigning tied ranks.   
Interestingly, the question of whether the recipient will resemble the donor is ranked 
low, as is potential press intrusion for the family.  Application of the Friedman test 
indicates that there is structure in the rank positions in excess of a random assignment 
(Friedman χ26=21.0, p<0.002).  The top 4 ranked issues form one homogeneous 
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subset (Friedman χ23=0.933, p=0.818) and the other 3 issues form another 
homogeneous subset (Friedman χ22=1.11, p=0.573). 
 
Table 5.4.  Rank order of issues affecting retrieval team. 
Team issues Mean ranking 
Educating professionals about facial transplantation 2.58 
Development of specific retrieval team 3.36 
Development of working links between 
coordinators and the main facial transplant team 
3.58 
Impact of facial transplantation on operating room 
and intensive care unit staff 
4.0 
Debrief and support for health professionals 4.27 
Negative impact on other transplant programs 4.56 
Press intrusion for health professionals 5.65 
 
 
Table 5.5.  Rank order of issues affecting the donor family. 
Donor family issues Mean ranking 
Likelihood of benefit for the recipient 3.57 
Long-term support for donor family 3.58 
Discussion of the process involved 3.87 
Viewing by relatives after retrieval 3.90 
Consent issues and consent form 4.05 
Will recipient resemble the donor? 4.28 
Donor family press intrusion 4.75 
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5.3.2. Qualitative Data 
The questionnaire also contained an open question inviting respondents to suggest any 
other issues that they believed to be important and which had not been included on the 
questionnaire.  Seventeen participants (20%) responded to this open-ended question, 
listing the following: 
 
 Need for increased public awareness of the reasons for facial transplantation 
(two respondents). 
 Plans in the event of graft failure (four respondents) 
 Plans in the event of poor psychological adjustment to the new face by the 
recipient (one respondent) 
 Suggestion for improved terminology: ‘donation of facial tissue’ rather than 
‘face transplantation,’ and ‘retrieval’ rather than ‘harvest’ of tissue (one 
respondent) 
 Should the donor family meet the recipient? (two respondents) 
 
5.4. Discussion 
The first important finding in this study is that the substantial majority of transplant 
professionals support the development of facial transplantation as a reconstructive 
option, and that none objected to the concept in principal.  A minority were in favour 
of further research before the procedure is offered.  Clearly, since the surgical team 
will rely on the UK transplant co-coordinators to recruit and consent donor families, it 
is important to establish broad support for this procedure at the outset, and to identify 
any concerns which need addressing before the procedure is finally approved.   
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The relationship between knowing someone with a disfigurement and being in favour 
of facial transplantation is interesting and has been reported previously in a 
convenience sample assessed at the Royal Society (Clarke et al. 2006), the 
independent academy of science in the United Kingdom.  This result suggests that 
those who are familiar with the problems that the facially disfigured encounter may 
find it easier to justify a radical new technique.  This is supported by responses to the 
open-ended question in the questionnaire, namely, that more efforts should be made to 
educate the general public about the reasons why facial transplantation is being 
proposed.  
 
However, it is important to note that user groups might interpret this finding in a 
different way.  Rumsey (Rumsey et al. 2005) has reported that visible difference (cf. 
disfigurement) is very readily associated with the need for surgical intervention, even 
though many people manage an unusual appearance successfully without resort to 
surgical treatment.  Therefore there should be no attempt to justify facial 
transplantation simply on the basis of the beliefs of observers, as this would overlook 
the evidence that psychosocial interventions are effective in teaching management 
skills where the principal problem is one of social interaction.  The UK facial 
transplantation team has stressed the role of these non invasive interventions both in 
the selection and management processes of facial transplantation, and continue to 
elicit the input of relevant user groups as part of the continuing public engagement 
process.  We would therefore interpret this relationship as justifying further research 
into how need is assessed and addressed using a variety of strategies both biomedical 
and psychosocial.  
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It is important that we continue to position facial transplantation as a treatment option 
for severe facial injury and not as an automatic treatment choice for anyone with a 
facial difference. This also helps people understand that this is not a procedure that 
has any application in cosmetic treatments. 
 
The questionnaire study supports the focus group findings which suggest that the 
main concerns of transplant professionals can be divided into the following factors: 
 
 Factors impacting on the donor family, including the appearance of the body 
after the face has been removed 
 Support for the team liaising with the families  
 Clear strategies to ensure that the process of retrieval does not disrupt the 
existing practices of retrieval for other organs   
 
There was thus general support for facial transplantation in principle, provided there 
is an efficient process with effective support for all involved.  
 
Methodologically, the use of a ranking process was useful despite the number of 
respondents who assigned equal ranks to all items, thus endorsing all issues as equally 
important.  The clustering of items allows not only a calculation about their relative 
importance compared with each other, but also further information about how they are 
categorized by the respondents.  For example, the “provision of a facial prosthesis” 
was originally proposed by the UK facial transplant group as potentially reassuring to 
the donor family; however, within the focus group, transplant coordinators perceived 
this to be a means of preserving the dignity of the individual in the operating room 
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and protection for operating room staff.  This finding is supported by the results of the 
questionnaire in which the “provision of a facial mask” forms a homogeneous subset 
with “liaison with other retrieval teams” rather than to “appearance after retrieval,” 
which forms a subset with “development of donor criteria.” 
 
The importance of education and team building identified by the focus group is 
supported by questionnaire respondents, as illustrated in Table 5.2.  Interestingly, the 
impact of facial transplantation on the transplant program as a whole, which was an 
issue flagged by the facial transplant team, is not identified as a primary concern by 
professionals already working in the transplant setting.  It is also clear that press 
intrusion, again a potential issue with a new procedure, is consistently ranked of lower 
importance than other factors affecting the team and its links with the facial 
transplantation team.  Finally, responses concerned with factors affecting the donor 
family are less dispersed than in the previous sections, with a homogeneous subset 
formed by four items.  Of interest is the issue of identity transfer, represented as “will 
recipient resemble donor?” which is ranked low.  This contrasts markedly with early 
studies by the facial transplantation group in which this item was ranked highest by 
people most concerned about the concept of facial transplantation.  It is likely that the 
provision of computer-generated images demonstrating the “third face” concept 
together with the photographs of the first partial facial transplantation have helped to 
reduce anxiety about this hypothetical problem with the procedure. 
 
Methodologically, the use of a questionnaire study to validate the findings of a focus 
group has proved useful.  The endorsement of items, together with the few 
respondents who identified issues that were not listed on the questionnaire provides a 
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justification for the use of focus groups as an appropriate methodology for eliciting 
the concerns of specific groups in continuing public engagement studies. 
 
We have sampled the concerns of transplant coordinators and other relevant health 
professionals with regard to facial transplantation.  Results demonstrate a substantial 
majority in favour of the procedure with the needs of the donor family, support for the 
team, and the development of clear management pathways identified as the main 
issues of concern.  The development of these procedures is now a priority. 
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5B. The Transplant Donor Family Focus Group  
5.5. Introduction 
As facial transplantation becomes an option for the reconstruction of severe facial 
disfigurement, the question of how to maximise potential donation of facial tissue will 
become more significant.  Every individual has their own notion of how best to 
approach facial graft donation.  This may vary from the pre-existing beliefs held by 
facial transplant teams.  Some evidence does exist regarding the opinions of transplant 
professionals (Clarke et al. 2007) and the scientific community (Clarke et al. 2006) 
towards facial transplantation, but the attitudes of donor families toward facial 
transplant donation have not yet been studied in the literature.  For the facial 
transplant team it is of great interest to assess what opinions regarding facial 
transplantation exist, whether these might affect the potential for donation, and what 
modifying factors could alter this potential.  Clearly the donor family may have 
different reference points and priorities than either the recipient family or the 
transplant team.  These attitudes were therefore examined using a specially selected 
donor focus group. 
 
5.6. Methods and Materials 
A research study was designed using a qualitative analysis of themes using a 
homogenous focus group.  Five families with previous experience of donating their 
relatives’ organs were asked in writing to participate in the focus group.  All the 
families had had previous contact with the transplant co-ordinator researcher, lived 
close to the research facility, and could communicate effectively in English.  Families 
had previously consented to the retrieval of tissues and organs from their loved ones 
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within the preceding two years.  Although all families were willing to participate, 
only three families were actually able to participate within the time frame available.  
A total of six participants from these three families attended the focus group.  All 
participants gave informed consent and were free to withdraw at any time.  They were 
fully debriefed about the purpose of the session prior to it commencing. 
 
The group was given instructions that the team was seeking to investigate their 
attitudes regarding the donation of facial transplant tissue.  The researchers took on 
the role of moderator, commencing the discussion by providing open-ended questions 
to elucidate the group’s opinions on a selection of topics relevant to facial tissue 
donation.  Participants were asked whether it would have been difficult had they been 
approached to give consent for facial graft retrieval.  They were asked to talk about 
the issues that they thought were important in facial transplantation.  Later in the 
discussion, participants were asked whether they wished to know more information 
about the risks of the procedure, the likely recipient, and the possible effects on the 
donor family.  This was provided in verbal and audiovisual form by the three 
members of the facial transplant team: surgeon, psychologist and transplant co-
ordinator.  Current reconstructive techniques were discussed, along with a short 
synopsis of the current issues surrounding facial transplant surgery.  At all times the 
researchers attempted to paint a balanced picture of the risks and benefits of facial 
transplantation.   
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The transcript from these discussions was analysed and coded into the following 
themes for the purposes of analysis: 
 
 The timing of body viewing  
 Provision of a post-retrieval donor facial prosthesis  
 Identity transfer issues associated with facial tissue donation 
 The appropriateness of transplant professionals asking families to donate 
facial tissue 
 The need to raise awareness of facial transplantation 
 Contact with the donor family after the transplant process 
 Information provision to donor families 
 The preferred sequence of requesting donation of facial tissue  
 Preferred terminology to use in reference to facial tissue donation 
 
5.7. Results 
5.7.1. Timing of Body Viewing  
Some families needed access to the donor body after death for much longer than 
others.  One participant went in to see her husband three times, and “kept going back 
into the chapel…”  This was done so that her “lasting memory” could be “intact.”  For 
another participant this was done to convince her that there were no signs of life.  Had 
she known that facial graft donation was a specific wish of her loved one, this 
particular participant would not have kept going back to see the body: she stated that 
she returned on multiple occasions for “purely selfish” reasons. 
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5.7.2. Provision of Post-Retrieval Donor Facial Prosthesis 
Most participants felt that they spent ample time in the intensive care unit, where 
there was a lot of time to say goodbye.  It was felt that the maximally adjusted family 
is one who says goodbye when the individual is still on life support, rather than when 
the individual is in the undertakers.  The provision of a post-retrieval donor facial 
prosthesis was therefore not thought to be essential by this focus group, as such a 
mask did not appear to confer much advantage to the participants.  However, it was 
felt by the group that the provision of a donor prosthesis was “better than nothing.” 
 
5.7.3. Identity Transfer 
Families needed reassurance in this regard, although they were generally much less 
concerned once they had seen the computer simulations of the likely appearance of a 
facial transplant.  However there was some variation, with some families much more 
concerned than others.  One participant was “not sure” of their loved one’s “face on 
someone else.”  One participant commented that the resultant recipient face would not 
look like the donor, as the dead donor never looked like the recipient.  Another 
participant suggested that “everyone has a double of themselves,” and that there are 
many people in the world who look very similar to each other.  The group was 
however concerned that the donor and recipient should be sufficiently age-matched. 
 
5.7.4. Asking for Consent to Donate Facial Tissue  
Participants thought that it was important that the unit proposing facial transplantation 
were perceived as a specialist unit within the field.  Overall there was a strong 
message that it was acceptable for transplant professionals to ask families whether or 
not they would agree to donation of facial tissue.  The worries about offending people 
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or worrying them were not supported and there was a strong presumption in favour of 
asking for facial tissue.  Indeed, one participant herself suggested to the hospital that 
her husband’s organs might be donated.  Another participant remembered saying at 
the time that it was “okay to ask the question” when she was asked to consent to 
retrieval of her loved one’s organs.  It was however felt by participants that the whole 
family should be asked, even if some members might be “so traumatised.”  There 
should be “family agreement” and families would not want to proceed if there were 
no consensus.   
 
One participant was at first reluctant to donate her daughter’s organs, but then 
reconsidered and decided that her daughter would have approved of the idea.  
Families felt that transplant donation was a method of dealing with their loss “in a 
positive way” at a time “when people are sympathising.”  Therefore donation was 
thus seen to be a good way of trying to deal with their loss.  It was felt that the whole 
process would be made easier by including face and hand transplant donation as one 
of the options on the national donor card.  In this way, some responsibility could be 
taken away from the family.  The focus group concluded that transplant professionals 
“don’t have the right not to ask” for donation of facial tissue, and felt that the 
opportunity to donate organs is a privilege. 
 
5.7.5. Raising Awareness of Facial Transplantation 
The families in the focus group were very pro-transplantation.  It was a “waste not to 
do it.”  Some participants said that they might themselves donate: “it wouldn’t matter 
to me if my face were taken away.”  The families were very keen on anything that 
could be done to raise awareness.  It was considered that there was not enough 
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material available regarding transplant donation.  One participant felt that “people 
need to know how much easier this makes the aftermath of a tragedy.”  Transplant 
donation acted to bring a kind of positive element to their loss, helping to take 
attention away from the fact that the individual had died.  One participant suggested 
producing posters with an image of a donor surrounded by scattered images of 
transplant recipients who had been “helped…to a new life.”  In this way transplant 
donation could be seen more of a celebration of their loved one’s life.  This could be 
one place where the media could be used in a positive fashion.   
 
 
5.7.6. Contact Post-Transplant 
The sending of letters to the donor family on the anniversary of the donation was 
discussed.  People supported the idea of contact with the facial transplantation team 
but only after “a considerable time.”  Meeting the recipient was discussed as an 
option, but only after a long time frame, when they felt stronger.  It was suggested 
that five years may be an appropriate period of time to wait before meeting the facial 
transplant recipient. 
 
It was very much felt that “remembering is important.”  The families “used to be 
uneasy” about contact – “now there is much more benefit.”  It was felt that the 
process needed to be “more about how families feel later on. The real pleasure comes 
years on….that people genuinely get better lives.”  Families did feel sorry that friends 
did not receive contact from the transplant group post-donation, and that consequently 
their friends did not benefit from this to help them grieve.   
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It was noted that participants only wanted to hear good news regarding the transplant 
recipient.  They would not want to hear if the recipient had died, nor would they 
would not want “surprises.”  However, participants would want to know first about 
events surrounding the facial transplant recipient before reading about them in the 
press.  Concerns were also raised regarding how the transplant team would manage 
potential press intrusion post-transplantation, and how one might prevent the recipient 
from “selling their story.”   
 
5.7.7. Information Provision 
In order to explore the notion that the most ideal families for facial graft donation 
were the ones most prepared, the option was given to the group to hear a short 
presentation on issues surrounding facial transplantation.  All participants 
unanimously agreed to see the presentation.  The provision of information was 
perceived as a good idea by the focus group.  In fact, the participants wished that 
more information were available: “It needs to be on the agenda. We would have 
donated…if [X] had wanted it.”   
 
It was felt that the provision of an educational booklet was beneficial, and that this 
booklet would not be upsetting for families to read.  However, the nature of this 
information provision was deemed important.  Specifically, families felt that they 
would benefit from knowing about the kind of patient that facial transplantation 
would be offered to: participants “would want to know what [the recipient] looked 
like.”  This was regarded as a helpful aid in the decision-making process.  One 
participant considered that the facial disfigurement exhibited by Simon Weston was 
“not that severe,” and that he was well-adjusted and thus would not merit facial 
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transplantation.  Another participant stated that she was more likely to agree to 
retrieval of her relative’s face were the recipient a child, as such a recipient “had their 
whole life in front of them.”  Families stated that information should not however be 
too graphic as to dissuade families from donating.      
 
Families would want to feel that there was a good reason for taking facial tissue.  One 
person within the group had refused consent to brain tissue for research – this request 
had been shocking to her because it did not seem like a “good reason” for taking her 
daughter’s tissue.  She distinguished between this and giving a new face to a child, 
which she felt would have been more of a valid reason to donate.   
 
5.7.8. Sequence of Requesting Facial Tissue Donation 
The families favoured the phrase ‘facial tissue’ rather than ‘facial transplant’ or ‘facial 
graft’.  When asked about the sequence in which transplant professionals should ask 
about tissue or organ donation, the families favoured placing consent to donation of 
facial tissue last in the sequence.  Some participants were hesitant about the donation 
of corneas: “…don’t let them have my eyes, I still need to see…”  This is in keeping 
with previous work suggesting that refusal of corneal donation be set as the cut-off 
point to facial tissue donation (Clarke et al. 2008).  
 
5.8. Discussion 
There is little published work about the attitudes of families intimately involved with 
transplant donation.  Overall, this donor family focus group was positive towards 
facial transplantation.  The group thought that the facial transplant team would in time 
find a donor.  The main obstacles were seen to be lack of information (“not enough 
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publicity”) and issues surrounding identity (“looking like loved ones”).  The research 
findings were surprising in parts (such as the relative lack of added value provided by 
making a facial prosthesis), but confirmed previous pre-conceived ideas we had 
towards aspects of the facial donor graft procurement process (such as requesting 
facial tissue at the end of the consent sequence). 
 
Focus groups have recently become popular ways of performing qualitative 
psychological research.    In transplantation, they have been used in a number of 
different settings to investigate the reasons behind the relative paucity of organ donors 
(Peters et al. 1996), bone marrow donation rates amongst African Americans 
(Glasgow and Bello 2007) and donor/recipient attitudes toward living renal 
transplantation (Pradel et al. 2003).  Our methods were similar to those used in earlier 
work (Clarke et al. 2007) examining attitudes towards facial transplantation in 
transplant co-ordinators.  The number of participants within the focus group was in 
keeping with recommendations for accurate transcription of focus group discussions 
(Willig 2001).   
 
Participants were defined as ‘concerned’ rather than ‘naïve’ due to their direct interest 
in the transplant donation process.  The nature of our assessments, performed on 
families who had already experienced donation first-hand, meant that there was no 
need to extrapolate data from normal volunteers with no prior experience of organ or 
tissue donation. 
 
The flexible open-ended nature of qualitative research can call into question the 
validity of its findings.  However, this same flexibility also enables participants to 
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challenge the researcher’s own pre-conceived research questions, and can bring with 
it additional valuable data which would not ordinarily be obtained with quantitative 
methodology.  Group members are able to respond to each other and develop 
arguments, providing data which would not otherwise be obtained.  In addition, the 
less artificial nature of the focus group acted to increase the validity over standard 
semi-structured interview techniques.  The ability for people to interact with others 
who have faced similar life experiences can also be of benefit.  This contact with 
other individuals can assist both participant and researcher. 
 
It might be suggested that the invitation to attend a focus group may in itself lead to 
stress for the individual, if the session were not planned and timed appropriately.  
However, all participants were under no pressure to attend the focus group and gave 
of their time freely; the sessions occurred one-to-two years post-bereavement.  In this 
study, participants were made aware that they were free to challenge the researcher’s 
pre-conceived ideas at any time, or to correct any underlying assumptions that may 
have been made. 
 
Many of the issues explored were unique and hypothetical, lending themselves well to 
qualitative methodology: the questions we asked were by definition open and 
provisional, more concerned with ‘how’ than ‘what.’  The relatively small numbers in 
our data set do mean that caution needs to be exercised when generalising about the 
donor group as a whole.  However, through exploring the experience set of the 
individuals within this focus group, we have obtained a valuable insight into possible 
future behavioural events.  At least some of our participants’ responses were products 
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of societal influences, and so it could be inferred that ‘each individual mode of 
appropriation of the social….. is potentially generalisable’ (Willig 2001). 
 
This is first time a group has examined facial transplantation by utilizing the 
experience base of families with prior exposure to donation of organs and tissues.  
This provides us with much valuable data regarding how future facial tissue 
procurement programmes should be organised.  It appears that asking for donation of 
facial tissue should not be seen as problematic, providing that adequate information is 
provided to families.  Programmes should focus on raising awareness, and continue to 
maintain contact with donor families after facial tissue donation.   
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Chapter 6 
 
6. An Artificial Prosthesis to Reconstruct Donor Defects Following 
Facial Transplantation 
 
6.1. Introduction 
Facial transplantation is becoming an option for the reconstruction of facial defects 
following severe facial injury including burns (Butler et al. 2005; Butler et al. 2006).  
The reconstruction of the donor face post-operatively is of some importance, due to 
recommendations that a donor body be restored to a good aesthetic appearance 
following organ harvesting (Robertson 2004).  
 
The face is the unique identifier, providing both familial characteristics and 
information about identity.  The inability to recognise a face has been likened to a 
bereavement reaction.  Although family members may want to grieve with the donor 
body immediately post-harvesting, often this grieving process is performed once the 
diagnosis of brain death has been established within the confines of the intensive care 
unit.  The reconstruction of donor facial features is therefore likely to be of maximal 
benefit to the transplant recovery team itself; indeed, the appearance of the donor face 
after retrieval and the development of a suitable facial prosthesis rank highly in 
surveys of health professionals involved in transplantation (Clarke et al, unpublished 
data).  Despite discussion of altered identity, recent public engagement exercises 
suggest that identity issues are not likely to significantly reduce access to donor faces 
(Clarke et al. 2006). 
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A number of surgical options to reconstruct the donor face have been suggested, such 
as autologous skin grafting.  This may add time to the harvesting procedure, and may 
delay other potential transplant harvest teams.  In addition, lifelike and cosmetically-
acceptable reconstruction using these methods is difficult.  This may be due to post-
operative bleeding, numerous stitch lines, and technical difficulty in the application of 
grafts around areas such as the nose or ears.  Indeed, the facial graft may include large 
soft tissue areas such as the nose, which may be difficult to reconstruct using these 
methods.  
 
Another option is the production of an artificial facial prosthesis (Nandini and Nair 
2003).  We describe a method of fabricating an artificial prosthesis made from 
silicone which provides a very satisfactory match for the reconstruction of the facial 
transplant donor face.  It is easily fabricated within the time frame required for facial 
graft harvesting, a figure likely to approach four hours according to experimental 
mock human facial transplantation models (Siemionow et al. 2006).  
 
6.2. Materials and Methods 
The first stage of the process begins with impression-making.  An alginate impression 
material is applied to the donor face.  This sets relatively rapidly: a full impression 
can be taken within 30 minutes.  This may be done in the intensive care unit setting 
whilst awaiting transfer to theatre.  
 
The second stage involves the transportation of the resultant impression moulage to 
the laboratory where an exact replica of the donor facial morphology is reproduced by 
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means of a plaster of Paris cast mould (Figure 6.1).  This can be produced within 30 
minutes.  
 
 
 
Figure 6.1.  A plaster of Paris mould is fabricated from an impression taken of the 
donor face prior to transplant harvest. 
 
 
The third stage involves the application of a silicone putty material (Dupiter® silicone 
putty SP8001/2 and Activator SP8010, Bracon Dental Laboratory Products, 
Etchingham, UK) over the plaster cast to reproduce the facial plaster of Paris.  Once 
the silicone putty sets, it is removed from the cast and inset into plaster of Paris set 
within a pre-fabricated steel box (Figure 6.2, right).  After setting has taken place, two 
layers of red soft adhesive dental carding wax (Associated Dental Products Ltd, 
Parton, UK) are applied.  This reproduces the thickness of the skin and subcutaneous 
tissues required (approximately 5 mm).  Plaster of Paris is poured into this wax-coated 
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moulding box; once filled, a lid is applied to stop the plaster from contracting, and the 
box left to set for approximately 30 minutes.  This produces a second cast, which 
retains much of the underlying characteristics of the face (Figure 6.2, left).  
 
 
 
Figure 6.2.  Silicone putty is produced of the cast and inset within a pre-fabricated 
box (right) to which a wax layer is applied.  Applying a layer of plaster of Paris over 
this wax-coated moulding produces a second cast (left) which retains the underlying 
characteristics of the face. 
 
 
The final stage involves the mixing of a silicone elastomer (CF3-2186 Part A & B, 
Polymer System Technology Ltd, High Wycombe, UK) with an appropriate prosthetic 
colourant to obtain the skin tone required.  This silicone elastomer is poured into the 
moulding box, and the second cast placed on top to create a silicone ‘sandwich’ which 
sets in approximately one hour (Figure 6.3).  Even in its simplest form (involving soft 
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tissue resurfacing) a donor facial graft will most likely result in the loss of superficial 
facial characteristics such as eyebrows.  These can be added easily to the prosthesis 
using artificial hair, or using hair harvested pre-operatively.  In addition to this donor-
specific method of face transplant donor prosthesis fabrication, we have also produced 
a panel of generic masks of all facial types and genders.  These have been constructed 
in case unforeseen constraints prevent the immediate fabrication of a donor-specific 
prosthesis.     
 
 
Figure 6.3.  An artificial silicone prosthesis is created, to which additional 
facial characteristics may be added. 
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6.3. Discussion 
In order to obtain a satisfactory aesthetic appearance, there must be input from a 
dedicated bioengineering technician.  The benefits of this method however are 
numerous: it can be performed relatively quickly and cheaply; the prosthesis can be 
made whilst the surgeon is harvesting the donor face; components such as hair and 
eyebrows may be incorporated; and the skin tone can be matched as far as possible 
with the donor.  The silicone material is pliable and stretchable and can be trimmed to 
the required shape of defect.  Any underlying bleeding under the prosthesis will not 
affect it (due to the robust nature of the material) but rather may help in achieving a 
more life-like result.  This contrasts with the often unsightly bruising and haematoma 
occurring in immediate skin-grafting of the face.  Disadvantages include the inherent 
artificial nature of any facial prosthesis, but this may improve in the future with 
advances in biomaterials.  In addition, the mask needs to be tonally matched to the 
donor face, although any mismatch can be hidden easily and is thus of minor 
importance.  Nevertheless, the tone chosen for the prosthesis must be lighter in shade 
in order to take cadaveric pallor into account.  
 
Methods have been described to reconstruct tissues using artificial prostheses (such as 
those to reconstruct ears or mandibles following neoplasia or trauma) (Nandini and 
Nair 2003) but the use of artificial prostheses has yet to be described in the 
reconstruction of the facial transplant donor. We hope the method described above 
will aid in improving the perceived acceptability of facial transplantation to both 
transplant teams and potential donors. 
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Chapter 7 
 
7. Informed Consent for Facial Transplantation  
7.1. Introduction 
Now that facial transplantation is a reality, attention has been focused on functional, 
aesthetic and immunological outcomes.  However, throughout the process of writing 
this thesis, the elucidation of a robust informed consent process has been a key goal.  
Obtaining informed consent is always challenging in new procedures where risk 
cannot be quantified, as highlighted by The Royal College of Surgeons of England 
(Morris et al. 2004) and others (Agich and Siemionow 2004; Goering 2004; The 
Lancet 2005).  Consent should be a continual process throughout the selection and 
subsequent planning stages.  The purpose of this chapter is to highlight the current 
issues surrounding informed consent as applicable to face transplantation and to 
present a strategy for ensuring a robust consent process as the procedure becomes 
established as part of the reconstructive hierarchy. 
 
Informed consent has traditionally been interpreted as a legal rather than as an ethical 
obligation of doctors (Gattellari et al. 2002).  However, there is now greater emphasis 
on patient choice in the UK (Department of Health 2005) with patients encouraged to 
ask questions particularly with regard to the risks of the procedure, alternative forms 
of treatment including the option of no intervention, and clear advice about the likely 
impact on lifestyle associated with their choice.  
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The process of informed consent can therefore be seen as a more open exchange of 
information structured under five main headings: disclosure, decision, understanding, 
capacity to give consent and voluntarism (del Carmen and Joffe 2005).  
 
7.2. Disclosure  
The doctor is obliged to disclose any significant risks to the patient (Pleat et al. 2003).   
The emphasis must be on adequate information, enough to make a reasoned decision 
about whether or not to proceed.  This should involve an exhaustive discussion of all 
known risks, irrespective of severity and including likelihood and impact, along with 
discussion of side-effects with potentially severe or fatal consequences.  
 
Finding out how much information patients want to know is clearly important.  As a 
group for example, women with ovarian cancer want as much information as possible 
at every stage of the disease and prefer to be involved in any decision-making (Tiller 
et al. 2005).   Not all patients wish to be informed however. Some try to actively 
avoid information about their disease, reducing the emotional impact of the disease; 
this is termed cognitive avoidance.  Some commentators warn that providing detailed 
information to those who do not want it and imposing choice on those who prefer their 
doctors to assume responsibility for making treatment decisions is harmful and may 
increase anxiety levels (Tobias and Souhami 1993). 
 
Clinicians frequently underestimate patients' desire for information and discussion and 
overestimate patients' desire to make decisions (Strull et al. 1984).  A need for more 
information does not necessarily equate to a desire to become more involved in 
decision-making although some evidence supports this (Timmermans et al. 2004).  A 
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lack of information giving is associated with heightened levels of anxiety, as is 
requesting greater patient involvement in decision-making (Gattellari et al. 2002). 
 
Integrating all this evidence into a clear strategy for information-giving is therefore 
difficult.  However, for face transplantation, it is proposed that a clear understanding 
of risk is necessary in order to justify the procedure on ethical grounds.  For this 
reason, only patients who are prepared to engage in a working partnership with 
clinicians are appropriate for the procedure.  This means fill disclosure of information 
and an active role in decision making.  Information should comprise technical details 
avoiding jargon, screened with a readability formula such as the Flesch-Kincaid 
(Flesch 1974) or Fry (Fry 1968) formulae.  Details of facial anatomy should similarly 
be appropriate to the individual level of understanding. Information could, in line with 
government initiatives (Department of Health 2005), include details about the 
individual clinician or unit, as patients may wish to use this information to base their 
decisions. 
 
As with any new procedure, disclosure in facial transplantation is limited by the lack 
of data on outcome.  Consent to innovative treatment is an area insufficiently explored 
in the literature.  Conceptually, the component of our understanding of consent which 
involves the taking of an unknown degree of risk can be separated off from the 
component which involves the proposed benefits or harms of the procedure.  It may 
be the uncertainty itself which predominates, or the sense of being ‘first-to-go,’ or the 
sense of being at the hands of surgeons who are taking a step into the unknown.  In 
most clinical trials, the degree of uncertainty may be relatively small – we may be 
uncertain how beneficial a new treatment is, or how common or severe the known 
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side effects are, but the likelihood of entirely novel and unexpected side-effects, or of 
dramatically overestimating the benefits of the new treatment, is small. 
 
The disclosure of risk in facial transplantation should begin with general risks such as 
anaesthetic complications, technical problems and graft failure (Morris et al. 2004).  
Specific features of facial transplantation then require special consideration, such as 
immunological rejection.  The Royal College of Surgeons report estimates the risk of 
graft loss to be around 10% from acute rejection, with chronic rejection accounting 
for loss of graft function in 30-50% at 2-5 years (Morris et al. 2004).  These figures 
are derived from studies of solid-organ transplant recipient populations.  A more 
analogous group would be hand transplantation (Lanzetta et al. 2004).  Acute 
rejection episodes occurred in 70% of hand transplants (Banis et al. 2004).  One graft 
loss was blamed on ongoing acute rather than chronic rejection, but with pathological 
features within the skin resembling those of graft-versus-host disease (Kanitakis et al. 
2003).  Acute rejection resulted in one inadvertent intra-arterial steroid injection 
leading to graft loss, but it is unclear if the graft might have survived had this episode 
not occurred (Lanzetta et al. 2005).  Chronic rejection is not a pronounced feature in 
hand transplantation to date.  In addition, comparison of chronic rejection rates to 
renal transplantation may also not be appropriate, as some long-term renal graft 
failure is due to drug parenchymal damage and is not immunologically-mediated.  
Although only speculative at present (as long-term skin and subcutaneous tissue 
immunological reactivity is not yet known), the expected incidence of chronic 
rejection may therefore differ significantly between renal and facial transplant groups.  
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Facial abnormality will rarely lead to death, but graft rejection could do, in serious 
cases; this has been borne out by the two deaths reported so far post facial transplant. 
Details must therefore be given of alternative reconstructive options, including those 
which would be undertaken if the transplant were to be rejected.  Special 
consideration must also be given to altered appearance and its implication, even 
where there is already experience of extensive disfiguration.  
 
A summary of the information which should be disclosed to face transplant candidates 
is highlighted in Table 7.1. 
 
7.3. Decision-making 
It is important to assess in what way the recipient of a face transplant would arrive at 
their decision.  People have been broadly categorised into three distinct types of 
decision-maker in health settings: active (where the clinician provides enough 
information for the patient to make up their own mind), collaborative (where there is a 
two-way exchange of information), and passive (where the clinician decides which 
treatment to undertake) (Stiggelbout and Kiebert 1997).  
 
Certain patterns have become apparent when examining decisional preferences in 
certain patient groups.  Approximately 20% of patients choose an active role, with 
80% taking a collaborative or passive role (Doherty and Doherty 2005; Mazur and 
Hickam 1997).  Some patients thus prefer to take primary responsibility, the clinician 
taking no role in the decision making process other than information provision (Tiller 
et al. 2005).  A sizeable minority of cancer patients prefer to relinquish decisional 
control (Gattellari et al. 2002).  It could be argued that allowing patients greater 
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control over their medical decisions might actually disempower them.  Patients may 
try to avoid regret and self-blame for the negative consequences resulting from a poor 
decision.  
 
Married rather than single people (Stiggelbout and Kiebert 1997), older rather than 
younger people (Mazur and Hickam 1997), men rather than women (Stiggelbout and 
Kiebert 1997) and those with lower educational attainment (Tiller et al. 2005) tend to 
prefer the doctor to take decisions for them.  Patients prefer passive decision making 
more than do non-patients, suggesting that the ‘sick role’ (i.e. the act of being a 
patient per se) may be a significant factor in determining the decisional role taken 
(Stiggelbout and Kiebert 1997).  The sick-role theory supposes that the sick do not 
hold themselves responsible for normal role behaviour; this may occur because they 
are in pain, fatigued, on certain medications, or simply ‘unwell.’  In life-threatening 
scenarios patients tend to prefer to hand over control to physicians, whereas in cases 
where morbidity and not mortality are affected they tend to prefer to assume greater 
control (Doherty and Doherty 2005), although there is some disagreement (Mansell et 
al. 2000).  
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Identity 
• The face will adapt to the shape of the underlying bony structure 
• There will be some superficial characteristics of the donor 
• A ‘third’ face is likely which will resemble the recipient more than the donor 
• The recipient will not take on the identity of the donor postoperatively 
Immunosuppression 
• The need for immunosuppression will be life-long 
• Non-compliance will lead to graft rejection  
• There are significant side effects of immunosuppression including cardiovascular, 
infective, and neoplastic complications 
• Regular, thorough monitoring will be necessary for the rest of the patient’s life 
Rejection 
• Rejection may lead to complete graft loss  
• Graft loss can occur at any time 
• Graft rejection may be treated by altering medication or may require further surgery 
• Graft loss may result in an outcome worse than the patient’s preoperative condition 
Psychosocial issues 
• Psychological acceptance of the donor face may take a long time 
• Relationships may be challenging, especially in the early stages when family and 
friends are adjusting to altered appearance 
• Psychological challenges are not yet fully understood 
Surgical issues 
• The risk of technical failure is about 4% 
• Peri-operative risks, including mortality, are similar to other free flap surgery  
Functional recovery 
• Return of facial sensation and function will be variable and difficult to predict 
• Time frame for functional recovery is likely to be months/years 
Media issues 
• Media interest is likely to be high, particularly for the first several patients  
• The donor family may become aware of the recipient’s identity through the media 
Table 7.1.  Information which should be discussed & understood by the patient  
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Some cultures may indeed prefer to delegate their decision making to family 
members.  In some cultures, the wishes of the elders may override those of a younger 
member, although this challenges the concept of voluntarism.  Other groups often 
make decisions at a community or family level.  Many cultural groups can find 
negative discussions offensive and some doctors have been supportive of withholding 
bad news to patients, such as is reported in China (del Carmen and Joffe 2005).  
Whilst respecting patients own values and beliefs, we would argue that facial 
transplantation is a situation in which the decision to proceed must be made by the 
individual themselves.  Successful outcome is dependent on post operative behaviour, 
and in order to comply with strict medical regimen, the individual must make the final 
decision about consenting to surgery.  
 
7.4. Understanding 
A patient can be said to have made an informed choice if they are knowledgeable 
about the operation, have a positive attitude to the procedure and choose to proceed, 
or have a negative attitude to the procedure and choose to decline (Clarke and Butler 
2004; Marteau et al. 2001).  Knowledge in itself has not been shown to increase the 
likelihood of screening; positive attitude on the other hand has a strong association 
with increased uptake (Michie et al. 2005).  The patient’s own values should be 
incorporated in the choice made to proceed with surgery; this may indeed be more 
important than the patient’s level of knowledge.  Moreover, the patient must 
appreciate the relevance to their own situation of any information given (Lidz et al. 
2004). 
 
 197 
Increased disease severity has been shown to lessen the retention of information in the 
consent process (Schaeffer et al. 1996).  There is evidence that patients undergoing 
breast reduction have very poor recall of risks and yet are on the whole satisfied with 
their understanding of the risks involved (Godwin 2000).  The literature has yet to 
reach consensus about what constitutes sufficient understanding and indeed the courts 
have not tended to agree that failure to understand invalidates consent, preferring to 
rely on evidence of adequate disclosure (del Carmen and Joffe 2005). 
 
The UK facial transplantation team propose that adequate disclosure is not enough in 
the case of innovative procedures such as facial transplantation.  The Evaluation to 
Sign Consent Form (DeRenzo et al. 1998) has been validated in a variety of 
populations and can give the surgeon an appreciation of the extent of patients’ 
understanding of a procedure.   Additional written or verbal information has been 
suggested to improve patient understanding, although in femoro-popliteal bypass and 
carotid surgery this did not improve a patient's perceived and actual understanding of 
risks and complications (Stanley et al. 1998).  Use of the cognitive interview 
technique with independent validation of information retained has been utilised as a 
means of demonstrating understanding rather than simply disclosure in a service for 
people with learning difficulties, and this is being developed as a basis for the consent 
procedure in facial transplantation in the UK (Conboy-Hill 2001).  Assessment of pre-
transplant compliance can also provide evidence of patient understanding and 
partnership in care. 
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7.5. Voluntarism 
One of the caveats of informed consent is voluntarism (Macklin 1999).  The patient’s 
own wishes should be the only indication for facial transplantation.  With every 
exciting and novel technique, a surgical team is at risk of imparting their own values 
upon the patient, and through the consent process they might unduly influence the 
patient’s own choice.  This would be achieved by either withholding information 
regarding other options or underplaying the importance of these operative and non-
operative alternatives.  The ultimate decision about whether or not to go ahead with 
the procedure must however be left to the patient.  There must therefore be non-
coercion by the surgical team (Morris et al. 2004).  Added confounding factors are 
related to research into new procedures.  In providing treatment, a surgeon’s primary 
duty is towards patient care; it might be argued that in evaluating a new surgical 
procedure, the surgeon must generate valid data and has a commitment to the wider 
scientific community (Lidz et al. 2004).  Therefore the caveat of voluntarism must be 
rigorously pursued in facial transplantation, and can be ensured through the use of 
patient advocacy.  
 
7.6. Capacity 
Patient capacity to consent requires sufficient ability to maintain and communicate 
stable choices.  These choices must be maintained long enough for their 
implementation (Appelbaum and Grisso 1988).  The ability to make one’s own 
decisions is in practice hard to evaluate and we tend to assume that an adult has the 
capacity unless there is strong conflicting evidence.  Guidelines exist examining the 
ability of patients to evidence a choice and make rational decisions (American 
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Psychiatric Association 1998); these include the ability to manipulate information 
rationally and to appreciate the situation and its likely consequences.   Certain 
conditions may preclude this capacity: thought disorder, short-term memory 
impairment or even extreme ambivalence may lead to a rapid change in the health 
decision that is made.  A patient will require enough memory for words, ideas and 
sequence of events; intelligence, memory and attention-span may affect this cognitive 
capacity (Appelbaum and Grisso 1988). 
 
7.7. Attitude to Risk 
Attitude to risk is important in making rational choices.  This however is difficult to 
define because an individual’s attitude to one type of health risk does not necessarily 
predict their future behaviour towards a different health risk.   A health risk-taker such 
as a smoker for example is not more likely to undergo life-endangering surgery than a 
non-smoker, although they may underestimate their own risks from smoking and 
ignore social conventions which dictate what they do to their health (Weinstein et al. 
2005).  Nevertheless some evidence exists that burns patients (who constitute a 
considerable proportion of potential face transplant candidates) may have a higher 
propensity for risk-taking behaviour, as evidenced by increased rates of accidental or 
violent death in previously burned adults (Onarheim and Vindenes 2005). 
 
There is some evidence showing that people exhibit more risk-taking behaviour when 
there is a chance of erasing a loss (Thaler and Johnson 1990); framing an event as a 
gain leads to more risk aversion (Kahneman and Tversky 1982).  This is because a 
loss reduces perceived desirability of a health outcome more than a gain increases it 
(Edgell et al. 2001).  It is arguable that in the acute stages of recent injury, patients are 
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more likely to be focussed on the consequent loss and therefore more likely to accept 
greater levels of risk involved in reconstructive options.  As their post morbid identity 
develops however, with the gradual evidence that altered appearance does not 
automatically mean a loss of opportunity or life chances, decisions may be made more 
in terms of potential gain, with a reluctance to incur unreasonable risks.  It can 
therefore be argued that the stage at which facial transplantation is contemplated, i.e. 
immediate or delayed, will have an impact on attitude to risk and therefore on 
informed decision-making.  
 
For the patient a face transplant is a one-off gamble, whereas the surgeon incorporates 
clinical evidence into their decision-making process.  Patients are also more likely 
than doctors to accept radical treatments even if they have little chance of success.   
Doctors may feel they have a responsibility for bad outcomes when they have 
supported a particular treatment regime, especially if this treatment is viewed as more 
radical.  Without accepting risks of radical treatments however, many major advances 
in medicine could never have been achieved.  
 
Organ transplant recipients perceived risk/benefit ratios of facial transplantation 
similarly to non-transplanted groups in one preliminary study (Banis et al. 2004).  
Recent evidence suggests that some composite tissue transplant procedures (facial 
transplants especially) convey benefits which are perceived by individuals (including 
those living with immunosuppression) to warrant the risks involved (Brouha et al. 
2006).  A number of populations (renal transplant recipients, patients with facial 
disfigurement, limb amputees and laryngectomy recipients) have been studied using a 
validated questionnaire-based tool (the Louisville Instrument for Transplantation, 
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LIFT) to assess attitude to risk (Barker et al. 2007b).  This was designed to 
objectively assess the opinions of individuals with real-life experiences in the risks 
and benefits of transplantation (Soni et al. 2010).  Specifically the LIFT assesses the 
amount of risk individuals would be willing to accept to receive non-life-saving, but 
quality-of-life improving transplants.  All patient groups stated that they would risk 
the most to receive a face transplant. 
 
There is some evidence that the facially disfigured may have different attitudes to 
immunosuppressive risk (Clarke and Butler 2005), suggesting that familiarity with the 
concepts and treatment of facial disfigurement impacts on attitude.  However, the 
emphasis on face transplantation as a quality-of-life procedure may inadvertently 
trivialise the major problems that this group experience in their day-to-day lives.  In 
planning the way ahead we therefore propose a strategy for informed consent in facial 
transplantation.  This is framed under the headings of factors relating to the 
individual, and factors relating to the process of consent. 
 
7.8. Assessment of the Individual 
7.8.1. Cognitive Function 
Patients undergoing complex appearance-enhancing surgery must have the ability to 
retain and comprehend proposed risk/benefit information.  In one study of heart 
transplant candidates 35% were found to have significant cognitive impairment as 
measured by verbal learning and memory (Putzke et al. 1997); lung transplant 
candidates had essentially normal cognitive function for most tasks but between 25-
50% of patients were impaired on verbal and visual memory tasks (Ruchinskas et al. 
2000).  Therefore a face transplant recipient should be of at least average intelligence, 
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with no evidence of cognitive impairment affecting their decision-making capacity.  
Although it is not appropriate rule out a patient requiring facial trauma reconstruction 
because of an accompanying head injury; it must be clear that such injuries do not 
affect capacity to consent. 
 
7.8.2. Compliance History 
The issue of compliance in transplantation has been reported elsewhere (Rosenberger 
et al. 2005).  Clearly compliance plays a large role in success of composite tissue 
grafts, with the first facial transplant graft failing due to his substitution of 
immunosuppressive medication, and a large group of Chinese hand transplant 
recipients failing due to non-compliance with medication; whether this was due to 
patient factors, or general unavailability of immunosuppressants is unclear (Soni et al. 
2010).  Nevertheless, a previous compliance history comprising attendance to clinic, 
dressing changes, and the taking of prescribed medications gives us documented 
evidence of the ability to understand, prioritise and execute health behaviours 
consistently within the patient’s own environment. 
   
7.8.3. Cultural Assessment and Attitude to Facial Transplantation  
The attitudes of both patient and health professionals towards facial transplantation 
should be positive and concordant, with clear evidence that motivation for surgery lies 
within the individual not the family.   
 
7.8.4. Decision-Making Role 
Given the large stakes involved in undergoing facial transplantation, we would 
suggest that the patient should be collaborative rather than active or passive in their 
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decision-making, which will be evident from their compliance history.  The reason for 
this assertion is that an active decision-maker may be biased in the way they elicit 
information and therefore may not weigh up fully the risks against the benefits; they 
may have already made up their mind to have a face transplant prior to full discussion 
with medical professionals.  A passive decision-maker on the other hand may not 
appreciate the risks of rejection or long-term immunosuppression, and may thus be at 
risk of coercion; the notion of voluntarism must always be preserved.  Decision-
making role can be objectively assessed using the compliance history or from the 
Autonomy Preference Index, a validated set of questions used to establish decision-
making role (Doherty and Doherty 2005). 
 
7.8.5. Attitude to Risk  
Population studies have assessed attitudes to risk in general.   Evidence of high risk-
taking behaviour in one area, such as smoking or indulging in illegal activities or 
high-risk sports for example, does not necessarily predict an individual’s attitude to 
risk in every health decision.  Therefore the assessment of attitude to risk is not a 
particularly helpful construct in face transplantation. 
 
7.8.6. Personality Assessment 
Personality disorder is three times more prevalent in populations of cardiothoracic 
transplant recipients (Stilley et al. 2005) and it is postulated that this may predict 
future non-compliant behaviour.  Some hand transplantation literature suggests 
personality assessment as a screening tool (Carta et al. 2001).  There is ambivalent 
evidence however for the value of assessing personality factors, or an emphasis on 
biological traits, in health settings. It is doubtful if population studies are helpful in 
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the assessment of individual patients’ suitability for face transplant.  Although there is 
a role in assessing psychiatric co-morbidity when obtaining consent, beliefs and 
behaviours may be more useful in predicting health decisions.  Screening programmes 
need to identify patients who have a negative attitude to the operation or who have an 
unrealistic optimism about the risks involved (Weinstein 1984).  
 
7.9. Assessment of the Process of Consent 
Finally, we feel that the process of obtaining consent should be as important as the 
content. Therefore an assessment of the efficacy and validity of this process should be 
made by someone not directly involved with the technical aspects, ideally by an 
informed health professional such as a psychologist within the face transplant team.  
 
The surgeon performing the procedure should ideally obtain consent, as they are 
usually the person best placed to answer questions about operative aspects, but this is 
not exclusive.  Indeed it might be argued that the surgeon performing radical new 
surgery might not be best placed to take consent as they might introduce their own 
bias.  
 
Screening needs to identify those who have a lack of information or who are using it 
inappropriately, but it is not enough to be sure that there has been adequate disclosure 
of information in facial transplantation.  There must be both disclosure and 
confirmation of patient understanding.  This can be evaluated as described above. 
 
It is true that in highly innovative procedures such as face transplantation, there is no 
way of assessing if a patient has made the right decision and will later regret their 
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autonomous choice, but the psychologist can assess if the decision has been made 
which is in line with the patient’s attitudes.  The psychologist should also enquire 
about the patient’s personal goals in having a face transplant. An approach to 
informed consent that recognises the importance of both perceptual processes and 
realistic attitude to risk is proposed as a model for informed consent in face 
transplantation.  The assessment framework outlined makes use of the best evidence 
available in health settings to identify both individual and process factors which must 
be considered in informing and consenting patients.  
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Chapter 8 
 
8. Contribution to Knowledge and Suggested Further Work 
 
This work addresses a number of hitherto unanswered questions in the field of facial 
transplantation.  First, we have described a method of assessing facial vasculature in a 
critical care setting which can be easily performed with relatively minimal training for 
the transplant team member; training on such selective ultrasound techniques was able 
to be performed in a matter of 2-3 weeks only.  The results obtained correlate well 
with anatomical studies.  We thus feel that this is a rapid and remarkably accurate way 
of assessing the vasculature at the bedside for operative planning purposes.  It would 
however be interesting to perform these studies on patients in the critical care setting 
to assess whether these findings can be reproduced on patients with haemodynamic 
instability.  Further study could also include analysis of flow rate, including peak 
systolic velocity, along with more investigation into reverse flow dynamics of both 
artery and vein.  A number of other parameters could also be measured, such as vessel 
wall thickness; however this could only practically be done on larger vessels such as 
facial vein and artery as it is unlikely that meaningful data could be obtained for the 
transverse facial vessels due to their diameter.  It would also be interesting to note if 
vascular status on the critical care setting affects any of these additional parameters 
and an extension of this study on a group of twenty or so critical care patients with 
pre-defined vascular abnormalities could be designed.  This could look at both ease of 
use and comparative data to assess if the technique can indeed be logically extended. 
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Second, we have produced a skin tonal scale to assist clinicians in accurately 
assessing facial donor and recipient skin tone using digital imagery.  This is important 
because for the first time an easily accessible method of assessing skin tone is 
described using widely available and easily accessible digital imagery.  This avoids 
the use of skin phototype nomenclatures used previously, which do not reflect colour 
tone per se, but rather tanning and burning potential.  Instead, the system described 
attributes discrete tonal values to each of the eleven skin tones described, allowing the 
clinician more accuracy in attributing skin tone.   Again, it would be interesting to 
examine if the tonal scale is reproducible in the critical care setting.  Further 
photographic assessments could be planned on the intensive care unit, examining the 
effect of differing ambient lighting levels.  There may also be a requirement needed to 
add allowances to the tonal grading system to account for colour changes associated 
with altered haemodynamic status in brain-dead patients. 
 
Third, we have ascertained the degree of skin tone matching required between donor 
and recipient in two of the most commonly encountered skin tones in the UK.  This 
has produced some surprising results; for example, tonal mismatch is more tolerated 
in facial than in hand transplant simulations.  This is significant, as it challenges the 
notion that a facial graft must (by definition, due to the face’s supremacy in 
attributing attractiveness to an individual) be more matched than an equivalent hand 
transplant - in tonal appearance at least.  That more tonal variation is tolerated by 
males than females is perhaps not as surprising, but this information does allow the 
clinician to plan for a more optimised aesthetic end-point.  Clearly cultural variations 
also exist: in the slightly tanned white group, the preference was for a number of 
darker skin tonal groups; in the light golden brown participants, females preferred 
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lighter tonal mismatches than darker mismatches.  This is perhaps not as remarkable 
given the literature surrounding cultural differences in attitudes towards skin tonal 
variation; however, validation of this in a facial transplant setting is extremely 
important.  These findings are significant because they provide facial and hand 
transplant surgeons with evidence to more rationally assign donor tissue, in a unique 
field of transplantation where there is relatively less availability of tissue.   
 
It is likely that many of the patterns found in the skin tonal mismatch study will be 
similar in the other recipient skin types elucidated in the study, especially those that 
lie within the same spectrum of RGB grade.  However, cultural differences dictate 
that there may be additional factors which facial transplant teams around the world 
may need to take into consideration, depending on the nature of their native 
population.  This study will thus require repeated validation in each of the nine other 
skin types in the future; this could be achieved in conjunction with other international 
teams.  It is hoped that we may be able to produce a more total picture of likely 
acceptable matches in all common facial and hand skin tones.   
 
The development of a system for skin tonal matching using digital photography 
coupled with suitable professional calibration may allow for the process to be 
occasioned remotely via telemedicine in the future.  It is hoped that a system may be 
put in place whereby images of potential donors could be sent electronically to a 
central national or international database, with electronic systems in place to suggest 
suitable tonal matches.  We hope that this study will help clinicians decide where 
exactly to concentrate their efforts when dealing with aesthetic matching in facial 
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transplantation, and suggest a more targeted matching of skin tone in composite tissue 
transplantation in order to optimise this aesthetic end-point. 
 
Fourth, the study of transplant coordinators is important as it provides the facial 
transplant team with answers to many of the questions posed by both critics and 
proponents of the procedure.  The perceived importance of each component of the 
process has been examined and, in many cases, challenged.  The issue of identity 
transfer was not a focus of this group, contrary to previous studies (Clarke et al. 
2006).  The impact of facial transplantation on the larger hospital transplant program 
was not thought to be as important as first thought.  This type of population 
questionnaire study on attitudes toward facial transplantation is of course biased by 
the fact that presentation of facial transplant information was done prior to the study.  
It could be argued that only ‘interested’ parties were taking part, but nevertheless it is 
an important piece of research given the fact that it is this same group who will be 
most intimately involved in the facial tissue retrieval process.  It is interesting to note 
that the group examined in this study had a high rate of knowing someone with a 
facial disfigurement (36%).  This is somewhat higher than other population studies on 
this topic where rates of 14% are quoted (Clarke et al. 2006).  The reason for this is 
unclear, as the phrasing of the questions in both studies was the same; perhaps the 
present study attracted more participants who were acutely aware of facial 
disfigurement as a concept.  
 
The study on donor family focus groups has revealed a number of important factors 
which transplant teams should take into account when planning delivery of face 
transplant services.  Importantly, the asking of families to donate their loved ones’ 
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facial tissue is not as much of a challenge as first thought, providing that adequate 
information is provided and the request is correctly positioned in the context of other 
organ requests.  It might be interesting to repeat the study with more focus groups to 
ascertain if these observations can be reproduced. 
 
This study has highlighted the rationale why donor face reconstruction is necessarily 
occasioned in the operating theatre milieu.  The prosthetic reconstruction is not done 
primarily for the donor family, as one might expect: the families surveyed in this 
study did not report this as a key component of the donation process, as they are not 
likely to view the body post-harvest.  It is the transplant retrieval team who rank 
donor face prosthesis provision a relatively high priority.  The face cannot easily be 
covered up after facial tissue retrieval as one might suggest, partly because access to 
the face and neck will likely be required for a number of reasons, such as lymph node 
retrieval or central venous access. 
 
It is therefore important that we were able to first describe how donor facial 
prostheses might be produced within a necessarily short time frame on an intensive 
care setting.  The inclusion of a prosthetist on the facial transplant team is of key 
importance so that a full mask imprint can immediately be made on a potential donor 
face once one is identified.  We first described how fabrication of such a prosthesis 
can be completed well in advance of the end of the donor graft dissection; global face 
transplant retrieval teams have since followed similar post-harvest prosthetic facial 
reconstructions in their case reports (Pomahac et al. 2011).   
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Lastly, the Royal College of Surgeons Working Party Report (Morris et al. 2007) 
highlights fifteen questions which it feels should be answered before facial 
transplantation can proceed.  The fact that five of these centre on the concept of 
informed consent is significant.  Clearly, life-changing surgery with attendant risks of 
such a wide-reaching nature (from immunosuppressive risk to the risk of media 
intrusion) necessitates the production of a robust consent process; the formalizing of 
this process was thus a key goal in the production of this research.  Any new 
procedure can be challenged on the grounds that informed consent is impossible, but 
this is effectively a barrier to any form of progress.  By examining each of the core 
requirements for informed consent in detail, and reviewing the evidence base, it is 
possible to propose a standard for facial transplantation which not only meets but 
extends the current gold standard for consent in new medical procedures.  The work 
contained in this thesis is being used by teams to help frame discussions prior to facial 
transplantation (Barker 2008).  We hope that this will also have relevance to other 
innovative, novel or potentially high profile medical procedures in the future.  
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Appendix A 
 
Photographic Imaging Calibration Values 
 
Table A.1.  Set up values for calibration of the monitor using the Gretag Macbeth 
‘Eye-One’ monitor calibration system.  This involves the initial pre-setting of various 
computer monitor characteristics to specific standardised values. 
 
Eye-One calibration settings Selected value 
Monitor type CRT  
White Point Colour Temperature (Illuminant Standard D65) 6500°K 
Tonal response curve (contrast) Gamma 2.2 
Luminance level 100 / CRT 
 
 
Table A.2.   Before and after adjustment values 
 
Monitor Settings Pre-set value Pre-adjustment Post-adjustment 
White Point (°K) 6500 6200 6500 
Luminance (cd/m2) 100 97.8 99.9 
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Appendix B 
 
Randomisation of Simulated Facial and Hand Transplant Images 
 
Table B.1. Simulated facial transplant images. 
Image number Skin tone 2 recipient  Skin tone 6 recipient 
 Donor skin tone (1-11) 
 Female  Male Female Male 
1 6 10 8 5 
2 1 8 6† 2 
3 8 2* 7 11 
4 5 9 9 10 
5 9 4 5 3 
6 2* 11 3 9 
7 10 1 1 4 
8 4 3 10 6† 
9 3 6 11 1 
10 7 5 2 8 
11 11 7 4 7 
 
* = Control image: skin tone 2 donor and recipient  
† = Control image: skin tone 6 donor and recipient 
 
 
 
 214 
Table B.2. Simulated hand transplant images 
Image number Skin tone 2 recipient Skin tone 6 recipient 
 Donor skin tone (1-11) 
 Female  Male Female Male 
1 4 8 7 8 
2 1 10 2 5 
3 10 4 6† 4 
4 9 6 9 2 
5 8 9 1 7 
6 7 1 11 3 
7 3 2* 3 11 
8 5 5 8 1 
9 11 11 4 10 
10 2* 7 10 9 
11 6 3 5 6† 
 
* = Control image: skin tone 2 donor and recipient  
† = Control image: skin tone 6 donor and recipient  
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Appendix C 
 
Questionnaire for Facial and Hand Transplant Simulation Study 
 
Please tick each box or mark on the line as appropriate. 
 
Q1. Are you: 
Male   □      Female   □ 
 
Please tick your hair colour: 
Red    □    Blonde   □    Light brown    □ Brown    □   Dark brown   □   Black   □ 
 
Please tick your eye colour: 
Blue    □     Green   □      Brown    □ 
 
What is your age?  ………………………………… 
What is your ethnic group? ………………………………… 
What is your nationality? ………………………………… 
 
When we graft skin we try to match skin as closely as we can, we don’t always obtain 
a close match. The next few questions are designed to examine this degree of 
difference. 
 
Q2.  A number of the images you will be shown have been altered into a different skin 
tone.  Which ONE of the images in EACH series is the original? 
 
 
 
 
 
 
 
 216 
FACES      HANDS 
1. - □     1. - □ 
2. - □     2. - □ 
3. - □     3. - □ 
4. - □     4. - □   
5. - □     5. - □ 
6. - □     6. - □ 
7. - □     7. - □  
8. - □     8. - □ 
9. - □     9. - □ 
10. - □     10. - □ 
11. - □     11. - □ 
 
Q3.  How confident are you about this choice?  Please place a VERTICAL MARK 
onto the line below: 
     FACES 
not             very 
confident            confident 
      
     HANDS 
not             very 
confident                confident 
 
 
Q4.  In the following images of skin grafts of FACES, the skin tone may not be a 
perfect match.  Please tell us, by placing a VERTICAL MARK onto the line below, 
to what extent you think the match is: 
 
     Image 1 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
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     Image 2 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 3 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 4 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 5 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 6 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
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     Image 7 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 8 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
Image 9 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 10 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 11 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
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Q5.  In the following images of skin grafts of HANDS, the skin tone may not be a 
perfect match.  Please tell us, by placing a VERTICAL MARK onto the line below, 
to what extent you think the match is: 
 
     Image 1 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 2 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 3 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 4 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
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     Image 5 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 6 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 7 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 8 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
Image 9 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
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     Image 10 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
 
     Image 11 
acceptable                    unacceptable 
 
unattractive            attractive 
 
normal             abnormal 
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Appendix D 
 
Questionnaire for Transplant Coordinator Study 
 
1.  What is your role in transplant coordination? (Please tick appropriate box) 
Donor transplant coordinator     □ 
Recipient transplant coordinator    □  
Dual transplant coordinator     □ 
Donor liaison nurse      □  
Regional transplant coordinators’ manager   □  
Other, please specify ……………………………….. □ 
 
 
2. Please indicate length of time in your current post: 
Less than 1 year      □ 
Between 1 and 3 years     □ 
More than 3 years      □ 
 
 
3. Do you know anyone with facial disfigurement?   
Yes □ No □ 
 
4. Would you feel comfortable discussing face donation with a donor family? 
Yes □ No □ 
If not, why not?  ……………………………………………………. 
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5. Should face transplantation take place? 
Now □ Not yet □ Never  □  
If not yet, why not? …………………………………………………….. 
If never, why not?  …………………………………………………….. 
 
IN THE FOLLOWING YOU CAN RANK SOME ISSUES THE SAME SCORE 
6. Retrieval Issues (Rank in order from 1-7; 1 = most important, 7 = least 
important) 
Development of donor/recipient specific criteria for face transplant  □ 
Face transplant increasing overall time of organ retrieval   □ 
Delays to theatre lists in host hospital     □ 
Liaison between other organs retrieval teams    □ 
Amount of tissue retrieved       □ 
Appearance of donor after face has been retrieved    □ 
Development of a facial prosthesis      □ 
 
7. Retrieval Issues II (Rank in order from 1-7; 1 = most important, 7 = least 
important) 
Developing a specific designated face retrieval team    □ 
(Surgeons, anaesthetists, scrub nurse, etc.)      
Close link of face transplant team with coordinators    □ 
Educating professionals about the procedure     □ 
Impact of face transplant on theatre and ITU staff    □ 
Debriefing and support for healthcare professionals    □ 
Exposure of healthcare professionals to press intrusion   □ 
Negative impact of face transplant on other transplant programs  □ 
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8. Donor Issues (Rank in order from 1-7; 1 = most important, 7 = least 
important) 
Consent form and consent form issues     □ 
Discussing the process involved in the procedure    □ 
Procedure outcome. Likelihood of benefit for the recipient   □ 
Whether the recipient will resemble the donor    □ 
Viewing by relatives after retrieval      □ 
Long term psychological support for the donor family   □ 
Exposure of donor family to press intrusion     □ 
 
Of all the issues what do you think is the most important issue? 
…………………………………………………………………………………………. 
…………………………………………………………………………………………. 
Are there issues we have not covered? What are they? 
…………………………………………………………………………………………..
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